LIST OF STUDIES WITH RESPECTIVE FUNDING AGENCY

JANUARY 2006 – JANUARY 2014

Principal S. No Department Title Funding Agency Investigator

A randomized, double-blind, placebo-controlled, parallel group study to determine whether, in patients with type 2 diabetes at AACT – Academic 1 Dr. Nihal Thomas Endocrinology high risk for cardiovascular and renal events, aliskiren, on top of Alliance for Clinical conventional treatment, reduces cardiovascular and renal Trials morbidity and mortality.

This prospective, open label, multi –center, observational, single- 2 Dr. Sunil Chandy Cardiology arm registry is designed to XIENCE VEECSS continued safety and Abbott Vascular effectiveness during commercial use in real world settings.

Prospective, randomized, placebo-controlled, double-blind, Dr. Debashish Clinical Immunology multicenter, parallel group study to assess the efficacy, safety and 3 Actelion Danda & Rheumatology tolerability of macitentan in patients with ischemic digital ulcers associated with systemic sclerosis.

Targeted Second- Generation Resequencing for the Molecular 4 Dr. Nihal Thomas Endocrinology Genetic Diagnosis of Maturity Onset Diabetes of the Young Actelion (MODY).

A randomized, active therapy controlled phase 2 study to assess Advaxis Inc, North 5 Dr. Subhashini John Radiation Therapy the safety and efficacy of ADXS11-001 with or without Cisplatin Brunswick as 2nd line therapy for the treatment of recurrent cervix cancer. A multicentre, open label, parallel group, randomized, phase IIB Adventrux Dr. Raju Titus clinical trial to evaluate the safety and efficacy of CofactorTM and 6 Medical Oncology Pharmaceuticals, Chacko 5-FU versus Leucovorin and 5-FU in subjects with Metastatic USA colorectal carcinoma.

FORTIS-M: A phase 3, randomized, double-blind, placebo- controlled study of oral talactoferrin in addition to best 7 Dr. Subhashini John Radiotherapy Agennix Inc. supportive care in patients with non-small cell lung cancer who have failed two or more prior treatment regimens.

AIDS International The BV study: Relationship of Lactobacillus and its phages in training and 8 Dr. Shalini Anandan Clinical Microbiology bacterial vaginosis among women in India. research programme

An evaluation of the safety and efficacy of Moxifloxacin AF Dr. Andrew 9 Ophthalmology Opthalmic solution 0.5% for the treatment of Bacterial Alcon Research Ltd. Braganza conjunctivitis in India.

A 6 day, Phase 3, Multicenter, Randomized, Double-Masked, Parallel Study to compare the safety and efficacy of Gatifloxacin 10 Dr. Sanita Korah Ophthalmology Allergan 0.5% ophthalmic solution BID with that of vehicle in the treatment of acute bacterial conjunctivitis. Allergan.

A Multicentric, double blind, randomized, placebo controlled, paralled group, study to explore the dose dependent response to 11 Dr. Ninan K Chacko Urology three dose levels of Botox (Botulinum Toxin Type A) purified Allergan neurotoxin complex followed by an open label extension phase in patients with urinary incontinence due to neurogenic detrusor overactivity.

A multicentric, double blind, randomized, placebo controlled, paralled group, study to explore the dose dependent response to 12 Dr. Ninan K Chacko Urology three dose levels of Botox purified neurotoxin complex followed Allergan by an open label extension phase in patients with urinary incontinence due to neurogenic detrusor overactivity.

A randomized, double blind, multicenter, study of Denosumab compared with Zolerdronic Acid (Zometa) in the treatment of 13 Dr. Subhashini John Radiotherapy II Amgen Inc bone metastases in men with hormone refractory prostate cancer.

A randomized, double blind, multicenter, study of Denosumab 14 Dr. Subhashini John Radiotherapy II compared with Zolerdronic Acid (Zometa) in the treatment of Amgen Inc bone metastases in subjects with advanced breast cancer.

A randomized, double-blind, multicenter study of Denosumab Dr. Raju Titus compared with zoledronic acid (Zometa) in the treatment of bone 15 Medical Oncology Amgen Inc, USA Chacko metastases in subjects with Advanced Cancer (excluding breast and prostate cancer) or multiple myeloma.

A phase 2, multicenter, open label, randomized trial of AMG 706 Dr. Raju Titus or Bevacizumab in combination with Paclitaxel and Carboplatin 16 Medical Oncology Amgen Inc. Chacko for advanced non-squamous non-small cell lung cancer. Protocol No. 20060136.

17 Dr. Thomas V Paul Endocrinology A Multicenter, International, randomized, Double-blind, Placebo- Amgen, Inc controlled, Parallel-group study to Assess the Efficacy and Safety of AMG 785 Treatment in Postmenopausal Women with Osteoporosis.

Aquaya Institute, Qualitative investigation of community & professional groups in CA, USA and 18 Dr. Vinohar Balraj Community Health India and their interest in water testing. University of Bristol

Assessment of an anti-TFPI aptamer: ARC19499 in correcting the Archemix Corp, 19 Dr. Alok Srivastava Haematology abnormal hemostasis of blood from patients with hemophilia and Cambridge, MA, evaluation of its concentration-effect relationship. USA

An open-label study investigating long-term safety and tolerability of Nasalfent (Fentanyl Citrate Nasal Spray) in the Archimedes 20 Dr. Reena George Palliative Care Unit treatment of Breakthrough Cancer Pain (BTCP) in patients taking Development Ltd. regular opioid therapy.

Improving health worker and Emergency medical technician and 21 Dr. Anand Zachariah Medicine Emergency response centre physician knowledge, skills and Asia Pacific practice in first aid and transport in acute poisoning

Asian Network for A multicenter, multinational serosurvey study for Pertussis 22 Dr. V. Balaji Clinical Microbiology Study of Resistant among children 10-18 years old in Asia Pathogens

23 Dr. Debashish Clinical Immunology ACR/EULAR diagnostic and classification criteria for vasculitis Association of Danda & Rheumatology Medical Toxicology

An open label, multi-centre, prospective study to demonstrate Astellas Pharma 24 Dr. V. Tamilarasi Nephrology safety and efficacy of once daily Advagraf in patients undergoing India Pvt. Ltd kidney or liver transplantation in India.

A double blind, placebo controlled, parallel group, multicentre, randomized, Get Ethics phase 11 survival study comparing ZD AstraZeneca Dr. Raju Titus 1839 (IRESSATM ) (250 mg tablet) plus Committee best 25 Medical Oncology Pharma Private Chacko supportive care in patients with advanced NSCLC who have Limited, Bangalore received one or two prior chemotherapy regimens and who are refractory or intolerant to their most recent regimen.

A Multicentre, Randomised, Double-blind, placebo-controlled, AstraZeneca 26 Dr. Dilip Mathai Medicine Unit I study on the use of Prophylactic Meropenem in patients with Pharma Private Severe Acute Necrotizing Pancreatitis. Limited, Bangalore

A phase II randomized, double blind, placebo controlled, multicentre comparative study of ZD1839 250 mg or 500 mg AstraZeneca (IressaTM) given either continuously or concomitantly with 27 Dr. Subhashini John Radiotherapy - II Pharma Private Cisplatin plus Radiotherapy for the treatment of patients with Limited, Bangalore previously untreated unresected late stage III/IV non-metastatic Head and Neck squamous cell carcinoma.

A Phase II, Randomised, Double-blind, Placebo-controlled, Multi- centre Study to Assess the Efficacy and Safety of AZD8931 In AstraZeneca 28 Dr. Subhashini John Radiotherapy Combination with Anastrozole, Compared to Anastrozole alone, Pharma Private in Post-menopausal Women With Hormone Receptor-positive, Limited, Bangalore Endocrine Therapy-naive, Locally-advanced or Metastatic Breast Cancer (MINT)

A Phase III, Multicentre, Randomised, Double-Blind, Comparative Study to Evaluate the Efficacy and Safety of Intravenous AstraZeneca 29 Dr. DJ Christopher Pulmonary Medicine Ceftaroline Fosamil Versus Intravenous Ceftriaxone in the Pharma Private Treatment of Adult Hospitalised Patients With Community- Limited, Bangalore Acquired Bacterial Pneumonia in Asia.

A phase III, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of 10 mg ZD4054 in combination AstraZeneca Dr. Raju Titus 30 Medical Oncology with docetaxel in comparison with doccetaxel in comparison Pharma Private Chacko with docetaxel in patients with metastatic hormone-resistant Limited, Bangalore prostate cancer.

A phase III, randomized, double-blinded, multi-center study to assess the efficacy of Docetaxel (TAXOTERETM) in combination AstraZeneca Dr. Raju Titus with ZD6474 (ZACTIMATM) versus Docetaxel (TAXOTERETM) in 31 Medical Oncology Pharma Private Chacko combination with placebo in patients with locally advanced or Limited, Bangalore metastatic (Stage IIIB-IV) non-small cell lung cancer (NSCLC) after failure of 1st Line anti-cancer therapy. D4200C0032.

A Phase III, Randomized, Double-blinded, Parallel Group, Multi- centre, study to assess the Efficacy and Safety of ZD6474 AstraZeneca Dr. Raju Titus (ZACTIMATM) in combination with pemetrexed (Alimta®) 32 Medical Oncology Pharma Private Chacko versus Pemetrexed alone in patients with locally advanced or Limited, Bangalore metastatic (stage IIIB or IV) Non-Small Cell Lung Cancer (NSCLC) after failure of 1st line anti-cancer.

33 Dr. Subhashini John Radiotherapy - II A randomized, double blind, parallel – Group, multicentre, phase AstraZeneca III study comparing the efficacy and tolerability of Fulvestrant Pharma Private (FASLODEXTM) 500mg with Fulvestrant (FASLODEXTM) 250mg Limited, Bangalore in Postmenopausal in Estrogen Receptor Positive advanced breast cancer progressing or relapsing after previous endocrine therapy.

A randomized, open label phase IIa study to assess the efficacy AstraZeneca Dr. Raju Titus and safety of AZD4547 Monotherapy versus Paclitaxel in patients 34 Medical Oncology Pharma Private Chacko with advanced gastric or gastro oesophageal junction cancer with Limited, Bangalore FCFR2 polysomy or gene amplification (Shine Study)

A Study to Evaluate the Safety and Efficacy of Vandetanib 150 AstraZeneca Dr Raju Titus and 300 mg/day in Patients with Unresectable Locally Advanced 35 Medical Oncology Pharma Private Chacko or Metastatic Medullary Thyroid Carcinoma with Progressive or Limited, Bangalore Symptomatic Disease.

An international, phase II, randomized, double-blinded, placebo- controlled, multicentre study to assess the efficacy of AstraZeneca Dr. Raju Titus 36 Medical Oncology ZD6474(ZACTIMATM) versus placebo in subjects with Pharma Private Chacko unresectable, locally advanced or metastatic medullary thyroid Limited, Bangalore cancer.

AstraZeneca Dr. Anand Antimicrobial Resistance Monitoring, Training and Research 37 IDTRC Pharma Private Manoharan Center Limited, Bangalore

Endocrinology Dapagliflozin Effect on Cardiovascular Events A Multicenter, AstraZeneca 38 Dr. Nihal Thomas Diabetes and Randomized,Double-Blind, Placebo-Controlled Trial to Evaluate Pharma Private Metabolism the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Limited, Bangalore Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients with Type 2 Diabetes

Molecular Epidemiology of betalactamases (TEM, SHV, CTX-M, AstraZeneca OXA, Amp C & MBL) among Enterobacteriaceae isolates seen in 39 Dr. Dilip Mathai IDTRC Pharma Private Indian medical centers and their susceptibility to novel β- Limited, Bangalore lactam/ β-lactam inhibitor combinations.

A randomized, double-blind, parallel-group, multicentre, phase III study to compare the efficacy and tolerability of fulvestrant (FASLODEXTM) 500 mg with Anastrozole (ARIMIDEXTM) 1 mg AstraZeneca Dr. Selvamani 40 Radiation Therapy as hormonal treatment for postmenopausal women with Pharma Private Backianathan hormone receptor-positive locally advanced or metastatic breast Limited, Bangalore cancer who have not previously been treated with any hormonal therapy (FALCON)

A randomized, international, open-label, multi-centre, phase III study to assess the effect of a patient outreach program on the Dr. Raju Titus AstraZeneca 41 Medical Oncology percentage of time patients with locally advanced or metastatic Chacko Pharmaceuticals medullary thyroid cancer experience grade 2 or higher adverse events during the first 12 months of treatment with vandetanib.

Clinical evaluation studies of 32P – SMPC (samarium phosphate 42 Dr. Alok Srivastava Haematology colloid) injection in chronic haemophilic haemarthrosis or Atomic Energy synovitis.

Mr. Roshan S. 43 Radiology Evaluation of radiation doses from CT scanners – A survey. Atomic Energy Livingstone Atomic Energy Dr. B. Paul Investigation of the use of electronic portal imaging device for 44 Radiation Physics Regulatory Board, Ravindran dosimetry in radiation therapy. India

The epidemiology and transmission dynamics of tuberculosis Australian 45 Dr. K.R. John Community Health (TB) in Southern India, with a focus on risk factors and Research Council household contact patterns.

Professor of Medicine, The Origin trial (outcome reduction with initial glargine 46 Dr. Hertzel Gerstein Chief, Division of AVENTIS intervention) Endocrinology

Dr. Debashish To study the effectiveness of osteoporosis support group in 47 Medicine II Aventitis Danda Indian patients of osteoporosis on Riserdronate (Actonel).

Study of fracture and Bone mineral density in ORIGIN trial 48 Dr. Nihal Thomas Endocrinology Aventitis participants (Origin – Osteoporosis Sub-study).

A Phase III, Randomized, Controlled, Multi Center, Open-Label Dr. Raju Titus Aveo 49 Medical Oncology Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects Chacko Pharmaceuticals with Advanced Renal Cell Carcinoma.

Dr. Raju Titus A Rollover Protocol to Allow Continued Access to Tivozanib (AV Aveo 50 Medical Oncology Chacko 951) for Subjects Enrolled in Other Tivozanib Protocol. Pharmaceuticals

Dr. Raju Titus Aveo 51 Medical Oncology An Extension Treatment Protocol for Subjects who have Chacko participated in a Phase 3 Study of Tivozanib vs. Sorafenib in Pharmaceuticals Renal Cell Carcinoma (Protocol AV-951-09-301).

Dr. Raju Titus Phase 2 placebo controlled, randomized, discontinuation trial of Aveo 52 Medical Oncology Chacko AV951 in patients with renal cell carcinoma. Pharmaceuticals

A Phase I study in patients with severe Hemophilia B (Factor IX 53 Dr. Alok Srivastava Haematology Deficiency) using Adeno-Associated Viral Vector to Deliver the Avigen Inc. Gene for Human Factor IX into the liver.

AYUSH, Ministry of Evaluation of use of selected local health practices as nutritional Health and family 54 Dr. K.R. John Community Health supplement for management of anemia in adolescent girls in welfare, New Delhi, Tirupatur Taluk of Tamil Nadu FRLHT, Bangalore

Dr. Sunil Thomas B. Braun Medical (I) 55 Cardiology Unit III Device Identification: Se QuentTM please DEB. Chandy Pvt. Ltd.

A prospective, multicentric, observational, pilot study on cost analysis of ongoing continuous ambulatory peritoneal dialysis 56 Dr. V. Tamilarasi Nephrology Baxter (CAPD) and Hemodialysis (HD) in India: Patient and provider perspectives.

A Post Authorization Safety and Effectiveness study of Baxter (India) Pvt 57 Dr. Alok Srivastava Haematology RECOMBINATE in India. Ltd

Phase 1, Prospective, Dose-Escalation/Finding Study to Evaluate Baxter Healthcare 58 Dr. Alok Srivastava Haematology pharmacokinetics and Immediate Tolerability of Recombinant Corporation, India Activated FVII (rFVIIa BI) in Patients with Hemophilia A or B and Inhibitors

A Phase 3 clinical study to determine the safety and efficacy of rVWF:rFVIII and rVWF in the treatment and prevention of Baxter Health Care 59 Dr. Alok Srivastava Haematology bleeding episodes in subjects diagnosed with von Willebrand Corporation disease

Prevalence of inhibitors in patients with severe hemophilia A in 60 Dr. Vikram Mathews Haematology Bayer India: Impact of environmental and genetic factors on prevalence.

Utility value of the electronic stethoscope and accelerometer as Mr. Joshua Physical Medicine and Bayer Caregiver 61 clinical tools for detection of joint damage in hemophilic Premkumar Rehabilitation Award arthropathy as correlated with MRI and ultrasound.

Bayer Haemophilia 62 Dr. Sukesh C Nair, Clinical Pathology Evaluating phenotypic heterogeneity of severe hemophilia. Award Program, 2008

Assessment of the effectiveness of prophylactic replacement of Bayer Haemophilia 63 Dr. Alok Srivastava Haematology lower than ‘standard’ doses of clotting factor concentrates in Awards Program children with severe hemophilia A.

Bayer Haemophilia Novel molecular mechanisms leading to haemophilia A 64 Dr. Alok Srivastava Haematology Awards Program phenotype. 2006

65 Dr. Edwin Stephen Surgery II Oral direct factor Xa inhibitor rivaroxaban in patients with acute Bayer Health Care symptomatic deep vein thrombosis or pulmonary embolism – The Einstein VTE treatment program.

AAV vectors for the potential gene therapy of haemophilia B: Dr. Jayandharan G 66 Haematology Modulation of the host immune response via the NF-kB Bayer, Inc. USA Rao pathway.

Measurement properties of ultrasound for assessment of 67 Dr. Sridhar Gibikote Radiology Bayer Healthcare haemophilic arthropathy with MRI correlation.

Evaluation of clinical efficacy, safety and tolerability of Bharat Serum & 68 Dr. Alok Srivastava Haematology Thymogam for Therapy of aplastic anemia. Vaccines

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study 69 Dr. Mathew Joseph Neurological Sciences to Investigate the Efficacy and Safety of Progesterone in Patients BHR Pharma, LLC with Severe Traumatic Brain Injury.

Bigtec Dr. Rajesh Standardization and evaluation of a hand –held micro PCR 70 Clinical Virology Laboratories, Kannangai (Truelab Uno and True prep MAG ) for HIV-1 RNA viral load. Bangalore

Evaluation of a hand-held microPCR (Bigtec Private Ltd) for 71 Dr. Priya Abraham Clinical Virology quantitation of hepatitis B virus (HBV) and hepatitis C virus Bigtec Pvt. Ltd (HCV)

Bill & Melinda 72 Dr. Anuradha Bose Community Health Aetiology of Neonatal Infection in South Asia Gates Foundation Gastrointestinal Comprehensive Investigation into the Risk Factors of Bill & Melinda 73 Dr. Gagandeep Kang Sciences Malnutrition and the Consequences for Child Health. Gates Foundation

Bill & Melinda Development of economical Pneumococcal serotyping assay for Gates Foundation / 74 Dr. V. Balaji Clinical Microbiology invasive and carriage serotype detection. Serum Institute of India

Professor of Global GI Health, Flinders Development of new strategies to improve zinc status in children Bill and Melinda 75 Dr. Graeme Young University, Australia, with environmental enteropathy at risk of diarrhea. Gates Foundation / Gastrointestinal Sciences

Program Officer, Establishment of the efficacy of Fermentable Substrate Hypo- PATH, Bill and Melinda 76 Evan Simpson osmolar Oral Rehydration Solution in the Treatment of Acute Seattle, USA - GI Gates Foundation Diarrhea. Sciences

Dr. B.S. Gastrointestinal Planning for the delivery of a more effective oral rehydration Bill and Melinda 77 Ramakrishna Sciences solution to improve diarrhea control worldwide. Gates Foundation

To evaluate the impact of three feeding regimens on the recovery Bill and Melinda 78 Dr. Anuradha Bose Community Health of children from uncomplicated severe acute malnutrition in Gates Foundation India and to use the evidence to inform national policy.

Dr. Jayaprakash Gastrointestinal Treatment of enteric infections among Indian infants to improve Bill and Melinda 79 Muliyil Sciences their response to oral poliovirus vaccine Gates Foundation Gut Inflammation Markers as Determinants of Response to Bill and Melinda 80 Dr. Anuradha Bose Community Health Treatment and Recovery in Children with Uncomplicated Severe Gates Foundation Acute Malnutrition Undergoing Community Based Rehabilitation. Via the SAM Grant

Bill and Melinda Wellcome Trust Enteric infections, Gut inflammation and response to oral 81 Dr. Ira Praharaj Gates Foundation, Research Laboratory poliovirus vaccine USA

Bill and Melinda Gastrointestinal 82 Dr. Gagandeep Kang Facilitation of the Indian national rotavirus surveillance Program Gates Foundation, Sciences USA

Wellcome Bill and Melinda Mucosal immunity to poliovirus following administration of 83 Dr. Sidhartha Giri Trust Research Gates Foundation, inactivated polio vaccine (IPV). Laboratory USA

International multicentre double blind randomized clinical study evaluating the efficacy and safety of BCD-020 (CJSC BIOCAD, Dr. Debashish Clinical Immunology Russia) and MabThera® (F. Hoffmann-La Roche Ltd., 84 Biocad Danda and Rheumatology Switzerland) in patients with rheumatoid arthritis who had an inadequate response or intolerance to other DMARDs including one or more TNF inhibitor therapies.

Baseline MIC Determination of Sulbactam against Acinetobacter Biocon Limited 85 Dr. Balaji. V Microbiology spp Bangalore

86 Dr. Nihal Thomas Endocrinology A Multicenter, Randomized, Double-Blind, Placebo Control Study Biocon Ltd. of IN-105 tablets (oral insulin) in Patients with Type 2 Diabetes Mellitus who have inadequate Glycemic Control on Optimal doses of Extended Release Metformin Tablets.

A randomized active controlled, parallel group, multi-center, two stage, open label, study comparing safety and immunogenicity of Biocon SA, 87 Dr. Nihal Thomas Endocrinology insugen® R and Insugen® N with Actrapid® and Insulatard in Switzerland patients with type 1 diabetes mellitus.

A-LONG: An Open-label, Multicenter Evaluation of the Safety, Pharmacokinetics, and Efficacy of Recombinant Factor VIII Fc Biogen Idec 88 Dr. Alok Srivastava Haematology Fusion Protein (rFVIIIFc) in the Prevention and Treatment of Hemophilia Inc Bleeding in Previously Treated Subjects With Severe Hemophillia A.

An Open-Label, Multicenter Evaluation of the Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor IX 89 Dr. Alok Srivastava Haematology Fusion Protein (rFIXFc) in the Prevention and Treatment of Biogen Idec MA Inc Bleeding Episodes in Previously Treated Subjects With Hemophilia B

An Open-Label, Multicenter Evaluation of the Long-Term Safety and Efficacy of Recombinant Human Coagulation Factor 90 Dr. Alok Srivastava Haematology VIII Fusion Protein (rFVIIIFc) in the Prevention and Treatment Biogen Idec MA Inc of Bleeding Episodes in Previously Treated Subjects With Hemophilia A.

An Open-label, Multicenter Evaluation of Safety, 91 Dr. Alok Srivastava Haematology Pharmacokinetics, and Efficacy of Recombinant Coagulation Biogen Idec MA Inc. Factor IX Fc Fusion Protein, BIIB029, in the Prevention and Treatment of Bleeding Episodes in Pediatric Subjects With Hemophilia B (Protocol: 9HB02PED)

An Open-Label, Multicenter Evaluation of Safety, Pharmacokinetics, and Efficacy of Recombinant Coagulation Biogen Idec 92 Dr. Alok Srivastava Haematology Factor VIII Fc Fusion Protein, BIIB031, in the Prevention and Research Limited Treatment of Bleeding Episodes in Pediatric Subjects with Hemophilia A (8HA02PED)

An Open-label, Multicenter Evaluation of the Safety, Pharmacokinetics, and Efficacy of Recombinant, Long-acting 93 Dr. Alok Srivastava Haematology Coagulation Factor IX Fc fusion (rFIXFc) in the Prevention and Biogen Idec, USA Treatment of Bleeding in Previously Treated Subjects With Severe Hemophilia B.

XM01-21 (platinum chemotherapy / solid tumours) Efficacy and safety of XM01 compared to placebo and Epoetin beta in patients Dr. Raju Titus 94 Medical Oncology with solid tumours receiving platinum containing chemotherapy. BioGenerix Chacko A multinational, multicentre, randomized, placebo-controlled, double-blind, parallel – group phase III study.

XM01-22 (nonplatinum chemotherapy / solid tumours and non- myeloid hematological tumours). Efficacy and safety of XM01 compared to placebo in patients with solid tumours or non- Dr. Raju Titus BioGeneriX AG, 95 Medical Oncology myeloid heamatological tumours receiving nonplatinum Chacko Germany chemotherapy. A multinational, multicentre, randomized, placebo-controlled, double – blind, parallel – group phase III study.

96 Dr. B.S. Gastrointestinal A study on the reliability of a serological test panel for the Biohit Plc Ramakrishna Sciences diagnosis of atrophic gastritis.

A single arm phase II trial to assess the toxicity and efficacy of hyper - fractionated IMRT (Intensity Modulated Radiotherapy) in Board of Research 97 Dr. Balukrishna. S Radiation Oncology radical treatment of locally advanced head and neck squamous In Nuclear Sciences cell carcinoma.

Non-Uniform Attenuation-correction and Scatter correction in Board of Research 98 Dr. Victor Raj Radiology Myocardial Perfusion SPECT. in Nuclear Sciences

Board of Research Dr. I. Rabi Raja Investigation of optically stimulated luminescence dosimeter for 99 Radiation Physics in Nuclear Sciences Singh clinical dosimetry. (BRNS)

A phase III randomized, double-blind, controlled, parallel group study of intravenous volasertib in combination with subcutaneous low-dose cytarabine vs. placebo + low-dose Boehringer 100 Dr. Vikram Mathews Haematology cytarabine in patients ≥ 65 years with previously untreated acute Ingelheim myeloid leukaemia, who are ineligible for intensive remission induction therapy.

A randomized, double-blind, parallel group study to assess the efficacy and safety of 52 weeks of once daily treatment of orally inhaled tiotropium + olodaterol fixed dose combination (2.5 μg / Boehringer 101 Dr DJ Christopher Pulmonary Medicine 5 μg; 5 μg / 5 μg) (delivered by the Respimat® Inhaler)compared Ingelheim with the individual components (2.5 μg and 5 μg tiotropium, 5 μg olodaterol) (delivered by the Respimat® Inhaler) in patients with Chronic Obstructive Pulmonary Disease (10) A randomized, double-blind, double-dummy, placebo-controlled, parallel group study to assess the efficacy and safety of 48 weeks of once daily treatment of orally inhaled BI 1744 CL (5 µg [2 Boehringer 102 Dr. D.J. Christopher Pulmonary Medicine actuations of 2.5 µg] and 10 µg [ 2 actuations of 5 µg]) delivered Ingelheim by the Respimat® Inhaler, and 48 weeks of twice daily Foradil® (12 µg) delivered by the Aerolizer® Inhaler, in patients with Chronic Obstructive Pulmonary Disease (COPD).

Multicentre, randomized, double-blind, Phase III trial to investigate the efficacy and safety of oral BIBF 1120 plus Dr. Raju Titus Boehringer 103 Medical Oncology standard docetaxel therapy compared to placebo plus standard Chacko Ingelheim docetaxel therapy in patients with stage IIIB/IV or recurrent non small cell lung cancer after failure of first line chemotherapy.

A phase III, randomized, double-blind, parallel group, 24 week study to evaluate efficacy and safety of once daily empagliflozin Endocrinology 10 mg and 25 mg compared to placebo, all administered as oral Boehringer 104 Dr. Nihal Thomas Diabetes and fixed dose combinations with linagliptin 5 mg, in patients with Ingelheim India Metabolism type 2 diabetes mellitus and insufficient glycaemic control after 16 weeks treatment with linagliptin 5 mg once daily on metformin background therapy.

An open label, phase II trial of afatinib with or without Boehringer Dr. Raju Titus 105 Medical Oncology vinorelbine for the treatment of HER2- Overexpressing Ingelheim India Pvt. Chacko inflammatory breast cancer. Ltd

Protocol – CV 181039. A multicenter, randomized,double blind, 106 Dr. Nihal Thomas Endocrinology active-controlled, phase 3 trial to evaluate the efficacy and safety Bristol Myers of Saxagliptin in combination with Metformin IR as initial therapy compared to Saxagliptin monotherapy and to Metformin IR monotherapy in subjects with type 2 diabetes who have inadequate glycemic control.

A comparative study of Entecavir vs. Adefovir plus Lamivudine Gastrointestinal Bristol Myers 107 Dr. C.E. Eapen Vs. Combination Entecavir plus Adefovir in Lamivudine resistant Sciences Squibb chronic Hepatitis B subjects: The DEFINE Study.

A Randomized, Doubld-blind, Parallel, Three Arm, Multicenter, Bristol Myers Phase II trial evaluating the effiacacy and safety of Ipilimumab Squibb (Primary Dr. Raju Titus 108 Medical Oncology (BMS-734016) in combination with Taxol®/Paraplatin® Sponsor – ICON Chacko (Paclitaxel/Carboplatin) compared to Taxol® / Paraplain ® Clinical Research alone in previously untreated subjects with lung cancer. (CRO)

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Trial to Evaluate the Safety and Efficacy Bristol Myers 109 Dr. Nihal Thomas Endocrinology of Dapagliflozin in Combination with Metformin in Asian Subjects Squibb India Pvt. with Type 2 Diabetes who Have Inadequate Glycemic Control on Ltd. Metformin Alone.

A comparative study of chronic hepatitis B subjects treated with Gastrointestinal Entecavir plus Tenofovir combination therapy vs Entecavir 110 Dr. C.E. Eapen Bristol-Myers Sciences monotherapy in adults who are treatment-naïve to Nucleosides and nucleotides: The BE-LOW study.

A comparative study of Entecavir vs Adefovir vs the combination Gastrointestinal 111 Dr. C.E. Eapen in Lamivudine-Refractory chronic hepatitis B subjects: The Bristol-Myers Sciences DEFNE study. A Phase II Study of Dasatinib Therapy in Children and Adolescents with Newly Diagnosed Chronic Phase Chronic Bristol-Myers 112 Dr. Vikram Mathews Haematology Myelogenous Leukemia or with Ph+ Leukemias Resistant or Squibb Intolerant to Imatinib.

An open-label, randomized, multicenter phase III trial of Dasatinib (SPRYCEL®) vs. Standard Dose Imatinib (400 mg) in Bristol-Myers 113 Dr. Vikram Mathews Haematology the Treatment of subjects with newly diagnosed chronic phase Squibb Philadelphia chromosome positive chronic myeloid leukemia - CA180-056.

A Multicenter randomized, double-blind, phase 3b trial to evaluate the efficacy and safety of saxagliptin added to insulin Bristol-Myers monotherapy or to insulin in combination with metformin in 114 Dr. Nihal Thomas Endocrinology Squibb India subjects with type 2 diabetes who have inadequate glycemic Private Limited control on insulin alone or on insulin in combination with metformin.

A Multicenter randomized, double-blind, phase 3b trial to evaluate the efficacy and safety of saxagliptin added to insulin Dr. Nihal Thomas, Bristol-Myers monotherapy or to insulin in combination with metformin in 115 Professor & Endocrinology Squibb India subjects with type 2 diabetes who have inadequate glycemic Dr. Sakthivel Private Limited control on insulin alone or on insulin in combination with metformin.

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Bristol-Myers 116 Dr. Nihal Thomas Endocrinology Parallel-Group, Phase 3 Trial to Evaluate the Safety and Efficacy Squibb India Pvt of Dapagliflozin in Subjects with Type 2 Diabetes with Ltd. Inadequately controlled Hypertension treated with an Angiotensin- Converting enzyme inhibitor (ACEI ) or Angiotensin Receptor Blocker (ARB) and an Additional Antihypertensive Medication.

A randomized phase II Biomarker Neoadjuvant study of Bristol-Myers Dr. Raju Titus Sequential AC followed by lxabepilone compared to Sequential 117 Medical Oncology Squibb Pharm. Chacko AC followed by Paclitaxel in women with early stage breast Research Institute cancer not over expressing HER-2 and Estrogen Receptors.

A multicenter, randomized, double-blind, placebo controlled Bristol-Myers phase 3 trial to evaluate the efficacy and safety of Saxagliptin Squibb 118 Dr. Nihal Thomas Endocrinology (BMS-477118) in combination with Thiazolidinedione therapy in Pharmaceutical subjects with type2 diabetes who have inadequate glycemic Research Institute control on Thiazolidinedione therapy alone.

A phase 3, randomized, double-blind, active controlled, Bristol-Myers multicenter trial to evaluate the safety and efficacy of Squibb 119 Dr. Nihal Thomas Endocrinology Muraglitazar (BMS-298585) compared to Piglitazone in subjects Pharmaceutical with Type 2 diabetes who have inadequate glycemic control. Research Institute

A Multicenter, randomized, double-blind, randomized, double- blind, placebo-controlled, parallel group, phase 3 trial to evaluate Bristol-Myers the safety and efficacy of Dapagliflozin in combination with 120 Dr. Nihal Thomas Endocrinology Squibb Research thiazolidinedione therapy in subjects with type 2 diabetes who and Development have inadequate glycemic control on thiazolidinedione therapy alone.

Brown University, 121 Dr. K.R. John Community Health Eliciting preferences using field experiments and survey data. USA Rural Unit for Health Using community participation to improve the health system in Brown University; 122 Dr. KR John and Social Affairs - India; Utilizing the community DOTS provider for treatment of U.S. National RUHSA tuberculosis in Vellore district. Institute of Health

Quantitative RT-PCR for the prediction of response to BSAC Research 123 Dr. Peter Daley Medicine I chemotherapy in new smear positive HIV positive and negative Grants Tuberculosis patients in South India.

Open label, randomized multicentric clinical trial of Dr. Raju Titus Cadila 124 Medical Oncology mycobacterium w in combination with Docetaxel versus Chacko Pharmaceuticals Docetaxel in metastatic hormone refractory prostate cancer.

A randomized double-blinded controlled trial of the efficacy and Cadila 125 Dr. Nihal Thomas Endocrinology safety of POLYCAP versus its components in subjects with at least Pharmaceuticals one additional cardio-vascular risk factor. India

Canadian Institute of Health Research A life course approach to the aetiology of head and neck cancer: and Fonds de la 126 Dr. Belinda Nicolau Clinical Virology HENCe life studies. Recherche Scientifique de Quebec.

Canadian Institutes Cardio Thoracic Renal Sub-Study in-(Steroids In caRdiac Surgery (SIRS already in 127 Dr. Vinayak Shukla of Health Research Surgery progress) trial) (CIHR)

128 Dr. P. Raghupathy Child Health I Safety and Efficacy of NP-002 (Hepatitis B Immune Globulin) for Cangene Post-Exposure Immuno-prophylaxis of Hepatitis B infection. Corporation

CARIn Division, A comparative study to assess the sensitivity and specificity of Carl Zeiss India 129 Dr. Smitha Jasper Ophthalmology fundus photography devices with remote interpretation (Bangalore) Pvt. for diabetic retinopathy (dr) screening workflow model Ltd.

Rural Unit for Health Establishment of an Innovative model of preventive cancer Catholic Medical 130 Dr. Rita Isaac and Social Affairs - screening and management program for women in rural South Mission Board, USA RUHSA India through Global Health partnerships. & Fogarty USA

An Open, Prospective, Non-Comparative, Multicenter Study to Dr. Mammen Celestial Biologics 131 Haematology Estimate the recovery after a single infusion of Human Factor VIII Chandy Limited Factocel 250 I. U. in patients of Hemophilia A.

Rural Unit for Health Use of Siddha and Antiretroviral Therapy (ART) in patients with Center for AIDS 132 Dr. Rita Isaac and Social Affairs - HIV – Risk and/or Benefit? Research RUHSA

Centers for Disease Control and Dr. Asha Mary Prevention (CDC), 133 Clinical Virology Influenza disease burden in rural communities in India. Abraham Atlanta and Indian Council of Medical Research

Dr. Asha Mary Centers for Disease 134 Clinical Virology Influenza disease burden in rural communities in India. Abraham Control and Prevention (CDC), Atlanta and Indian Council of Medical Research

Central Govt. 135 Dr. K.R. John Community Health Tuberculosis Health education program in Vellore District. Medical College Initiative

Central Norway Regional Health Authority (RHA) Dr. Niranjan A randomized controlled trial of therapeutic hypothermia for and the Norwegian 136 Neonatology Thomas neonatal hypoxic-ischemic encephalopathy. University of Science and Technology (NTNU)

Dr. Anup Gastrointestinal Alterations in mitochondrial lipid composition after Centre for Stem Cell 137 Ramachandran Sciences acetaminophen overdose and its role in JNK translocation. Research

Protocol No. P903-08 “A phase 3, Multicenter, Randomized, Double-blind, Comparative Study to Evaluate the Safety and 138 Dr. D.J. Christopher Pulmonary Medicine Efficacy of Ceftaroline versus Ceftriaxone with Adjunctive Cerexa Inc. USA Clarithromycine, in the Treatment of Adult Subjects with Community-Acquired Pneumonia.

Gastrointestinal A randomized, double-blind, placebo-controlled evaluation of the Cerimon 139 Dr. B.S Ramakrishna Sciences safety, efficacy and pharmacokinetics of multiple doses of Pharmaceuticals Basiliximab with concomitant Corticosteroids, in steroid- refractory ulcerative colitis.

Efficacy and safety of a CFC- Free formulation of Budesonide Chiltern compared with the reference CFC formulation in patients with 140 Dr. D.J. Christopher Pulmonary Medicine International Pvt. asthma: A randomized, double blind trial in parallel group of Ltd. Bombay patients with persistent moderate asthma..

A multi-site, randomized, double-blind, placebo-controlled study to evaluate the safety and immunogenicity of trehalose- Cholera Vaccine 141 Dr. Anuradha Bose Community Health reformulated Peru-15 (choleragarde®) vaccine given Initiative simultaneously with measles vaccine in healthy Indian and Bangladeshi infants.

Effect of yoghurt containing Bifidobacterium lactis BB-12 on Dr. B.S. Gastrointestinal 142 stool frequency and consistency and fecal microbiota in healthy Chr. Hansen Ramakrishna Sciences adult volunteers.

Rural Unit for Health Christian Medical Participatory communication initiative for improving access to 143 Dr. K.R. John and Social Affairs - Association of public health care services for vulnerable communities RUHSA India, New Delhi

Christian Medical Participatory communication initiative for improving access to 144 Dr. K.R. John Community Health Association of public health care services for vulnerable communities. India, New Delhi

A randomized, double-blind, parallel group, prospective study to 145 Dr. D.J. Christopher Pulmonary Medicine evaluate the safety and efficacy of Levosalbutamol Vs Racemic Cipla India Ltd. salbutamol by metered dose inhaler (MDI) in patients with chronic stable asthma.

An open labeled non-comparative study to assess the efficacy, safety and acceptability of salmeterol 500 mcg +Fluticasone 250 146 Dr. D.J. Christopher Pulmonary Medicine Cipla India Ltd. mcg (Seroflo 250) Multihaler in subjects with mild to moderate persistent asthma.

CT/02/07: A randomized, double blind, double dummy, four period crossover study to compare the bronchoprotective effects 147 Dr. D.J. Christopher Pulmonary Medicine of Salbutamol sulphate HFA pMDI Cipla Ltd with a reference Cipla India Ltd. salbutamol sulphate HFA pMDI (Ventolin EvohalerR), Allen and Hanburys, UK using methacholine challenge testing.

National surveillance program to determine antimicrobial resistance among Gram positive and Gram negative bacteria 148 Dr. Dilip Mathai Medicine I Cipla India Ltd. causing infections in the intensive care units in India (The SARI program).

A Phase III Randomized, placebo – controlled clinical trial to assess the safety and efficacy of Odanacatib (MK-0822) to reduce Clinigene Intl. Pvt. 149 Dr. Thomas V. Paul Endocrinology the risk of fracture in Osteoporotic postmenopausal women Ltd treated with Vitamin D and Calcium.

An open label, prospective, multicentre study to evaluate the safety and efficacy of Biomab-EGFR (Nimotuzumab) as induction Clinigene Intl. Pvt. 150 Dr. Subhashini John Radiotherapy II and maintenance therapy in combination with radiotherapy plus Ltd Temozolamide (Concomitant & adjuant) in Indian patients with Glioblastoma Multiforme. A randomized, double blind, double-dummy, multicenter, parallel-group safety and efficacy study comparing salmeterol- Clininvent Research 151 Dr. D.J. Christopher Pulmonary Medicine HFA with salmeterol-CFC both delivered by pressurized metered Pvt. Ltd dose inhaler (pMDI) in patients with chronic asthma. Protocol No. CP/19/03.

Randomized trial of digitex device using mpathy material Vs 152 Dr. Gopal Badlani Urology Coloplast Capio device for pelvic organ prolapsed

A phase III randomized double blind, placebo controlled multi Dr. Aruna Nittin Obstetrics and centric study to assess the efficacy, safety and tolerability of Columbia 153 Kekre Gynaecology Prochieve. 8% progesterone gel in preventing preterm delivery Laboratories, USA in pregnant woman at increased risk for preterm delivery.

Commonwealth Scientific and Dr. B.S. Gastrointestinal Evaluation of StarplusTM modified starches for anti-diarrhoeal 154 Industrial Research Ramakrishna Sciences activity in an animal whole gut perfusion model. Organization, Australia

Council of Scientific Dr. K.N. A study on the colonel diversity and allelic variation in group A and Industrial 155 Microbiology Brahmadathan streptococci causing human infections in Southern India. Research, New Delhi

A study on the possible role of oxidative stress and NFkB Council of Scientific 156 Ms. R. Hemalatha Biochemistry pathway in the pathogenesis of anti-HIV drug( Indinavir) induced and Industrial renal damage in the rats and possible ways to prevent the Research, New damage Delhi

Council of Scientific Cellular neuro-protective mechanisms induced in acute Dr.(Ms.) Anna and Industrial 157 Neurochemistry Lab organophosphate poisoning. Oommen Research, New

Delhi

Council of Scientific and Industrial 158 Dr. S. Snekalatha Physiology Effect of Ascorbic acid on cell mediated immunity Research, New Delhi

Council of Scientific Dr. Vinay Timothy Electrophysiological characterization of ion channel expression and Industrial 159 Physiology Oommen in cultured bovine chondrocytes Research, New Delhi

Epidemiologic and molecular characterization of Extended- Spectrum Beta Lactamase (ESBL) producing Klebsiella spp., E.coli Council of Scientific & Enterobacter SPP isolated from hospital waste water effluent and Industrial 160 Dr. Dilip Mathai Medicine I treatment plant: Comparison with clinical isolates recovered Research, New from patients with serious infections and fecal flora of healthy Delhi controls.

Council of Scientific Comparative study on the revascularization of isolated rat and Industrial 161 Dr. S. Gunasekaran Physiology pancreatic islets after culture and transplantation. Research, New Dr. S. Gunasekaran, Professor, Physiology. Delhi Council of Scientific Genetic testing of susceptibility genes (VHL, RET, SDH) in Dr. Simon and Industrial 162 Endocrinology patients with pheochromocytoma: Impact of early mutation Rajaratnam Research, New detection on patient management in India. Delhi

Council of Scientific and Industrial 163 Dr. Molly Jacob Biochemistry How does zinc protect against NSAID-induced renal effects? Research, New Delhi

Identification of nitrated proteins that may play a critical role in Council of Scientific the pathogenesis of Cyclophosphamide - induced hemorrhagic Dr. Premila and Industrial 164 Biochemistry cystitis in the rat and possible ways to prevent the damage by the Abraham Research, New administration of nitric oxide synthase inhibitors and PARP Delhi inhibitors.

Identification of nitrated proteins that may play a critical role in Council of Scientific the pathogenesis of methotrexate induced small intestinal and Industrial 165 Ms. Kasthuri N Biochemistry damage in the rat and possible ways to prevent the damage by Research, New the administration of nitric oxide synthase inhibitors Delhi

Identification of nitrated proteins that may play a critical role in Council of Scientific Dr. Premila the pathogenesis of methotrexate induced small intestinal and Industrial 166 Biochemistry Abraham damage in the rat and possible ways to prevent the damage by Research, New the administration of nitric oxide synthase inhibitors. Delhi

Dr. Anup Gastrointestinal Induction of glutathione synthesis by glutamine: signaling events Council of Scientific 167 Ramachandran Sciences and the role of mitochondria. and Industrial Research, New Delhi

Council of Scientific Influence of TonEBP and target enzymes in polyuria and and Industrial 168 Dr. Manoj G Tyagi Pharmacology cardiovascular function Research, New Delhi

Council of Scientific Molecular analysis of fine needles aspirates from thyroid Dr. M.J Paul & Dr. and Industrial 169 Endocrine surgery nodules: Prognostic value of BRAF mutational analysis and Rekha Pai Research, New diagnostic utility of BRAF and miRNA markers Delhi

Council of Scientific Dr. Aparna Gastrointestinal Oxidative and nitrosative stress in the pathogenesis of and Industrial 170 Venkataraman Sciences inflammatory bowel diseases: role of Mitochondria. Research, New Delhi

Council of Scientific Centre for Stem Cell Role of cellular adhesion molecules in mesenchymal stem cells and Industrial 171 Ms. Diana M.E. Otto Research and within their bone marrow niche. Research, New Delhi

Council of Scientific Role of mutations in the HFE gene in mediating a selective and Industrial 172 Dr. Sumita Danda Gastroenterology advantage in iron deficiency states – A prevalence study in a Research, New population from Tamil Nadu. Delhi

Council of Scientific 173 Dr. Debashish Clinical Immunology Study of serum cytokines profile and their gene polylmorphisms and Industrial Danda and Rheumatology in India patients with Takayasu’s Arteritis (TA). Research, New Delhi

To evaluate by electron microscopy the effects of methotrexate Council of Scientific on the ultra structural changes in the mitochondria of Dr. Premila and Industrial 174 Biochemistry enterocytes, and to investigate the role of mitochondrial nitric Abraham Research, New oxide synthase in the pathogenesis of methotrexate induced Delhi small intestinal damage.

Council of Scientific To study the possible role of proteins S nitrosylation in Dr. Premila and Industrial 175 Biochemistry methotrexate induced damage to the intestinal epithelial cell Abraham Research, New (IEC-6) Delhi

A comparative study of Inflammatory Bowel Disease in India and Crohn’s and Colitis Dr. B.S. Gastrointestinal 176 the United States to assess environmental risk factors and gut Foundation of Ramakrishna Sciences flora. America

CSIR – Institute of Dr. Joy Sarojini genomics and 177 Microbiology Evaluating immune signatures in TB patients. Michael Integrative Biology, New Delhi

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 Dr. Raju Titus 178 Medical Oncology (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects with CytRx Corporation Chacko Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma Open label, comparative, randomized, multicenter study to Dr. Raju Titus determine efficacy and safety of DRF7295 and FOLFOX4 Dabur Research 179 Medical Oncology Chacko combination as first line therapy in patients with locally Foundation advanced and / or metastatic colorectal cancer.

A double blind, randomized, parallel, placebo control design study to determine the effect of addition of vitamin D to Dalhousie 180 Dr. Dilip Mathai IDTRC conventional anti TB therapy. University

Danish council for Paediatric strategic research 181 Dr. Vrisha Madhuri Musculoskeletal Stem Cells in Tissue Regeneration Orthopaedics and Department of Biotechnology

Study on comprehensive Health and Community Development 182 Dr. K.R.John Community Health programs to improve the health and developmental indicators in Danmission selected tribal areas (Jawadhi hills and Kalrayan hills)

Investigation on the role of computerized radiography with Dr. B. Paul Department of 183 Radiation Therapy photostimulable phosphor plates for portal imaging and quality Ravindran Atomic Energy assurance in radiation therapy.

Permanent seed implant for Ca prostate with 1-125 seeds Department of 184 Dr. Simon Pavamani Radiation Oncology developed by BARC, Mumbai – A Clinical Trial Atomic Energy

Dr. Roshan S. Radiation doses and its impact from Radiological and Department of 185 Radiological Physics Livingstone Cardiological interventions. Atomic Energy (Project co-ordinator) Affiliation: National A longitudinal study of molecular and cellular changes in Department of 186 Dr. Gaiti Hasan Centre for Biological intracellular calcium signaling with neurological correlates in an Biotechnology Sciences, TIFR, SCA1 cohort in South India Neurological Sciences

A Multicentre, open, comparative, randomized, study to optimize dose, duration, safety, efficacy, and cost of two treatment Department of 187 Dr. Dilip Mathai Medicine I regimens with Liposomal amphotericin b (Fungisome) in the Biotechnology treatment

Dr. K. Srinivasa A multi-disciplinary, systems-level investigation into Department of 188 Neurological sciences Babu neurobiology of Parkinson’s disease. Biotechnology

A phase II randomized trial on benefit of amylase resistant starch Department of 189 Dr. Balu Krishna. S Radiation Oncology in reducing acute proctitis in patients undergoing pelvic Biotechnology radiation for carcinoma cervix.

A Phase III Randomized Double Blind Placebo Controlled Trial to Gastrointestinal Evaluate the Protective Efficacy of Three Doses of Oral Rotavirus Department of 190 Dr. Gagandeep Kang Sciences Vaccine (ORV) 116E, Against Severe Rotavirus Gastroenteritis in Biotechnology Infants

Dr. Niranjan A randomized controlled trial of erythropoietin for neonatal Department of 191 Neonatology Thomas hypoxic ischemic encephalopathy. Biotechnology

A study of pharmacogenetic factors in steroid resistant nephrotic Department of 192 Dr. Indira Agarwal Child Health - II syndrome in children Biotechnology A study on the molecular mechanism of pathogenesis of organophosphorus induced chronic neurotoxicity (OPICN); role Dr. Premila Department of 193 Biochemistry of reactive oxygen species (ROS) and mitochondrial pathway of Abraham Biotechnology apoptosis in neuronal cell death and degeneration in a rat model.

A study on the virological and immunological aspects associated Dr. Rajesh Department of 194 Virology with opportunistic viral infections in HIV-1 infected individuals Kannangai Biotechnology in India (south).

Dr. Murugan Centre for Stem Cell A/H1N1 Vaccine Delivery in Mice using Bioresorbable Chitosan Department of 195 Ramalingam Research Nano-and Micro-carriers Biotechnology

Acute organophosphate poisoning and proteolytic pathways of Department of 196 Dr. Anna Oommen Neurochemistry muscle wasting. Biotechnology

An investigation into certain genetic and immunological (HLA, Department of 197 Dr. Priya Abraham Virology MBL2, TLRs & IFN-g gene SNPs) factors that influence the Biotechnology outcome of hepatitis

Dr. Eunice Sindhuvi. Are polymorphisms in iron regulatory genes responsible for Department of 198 Haematology E phenotypic differences in iron metabolism? Biotechnology

Gastrointestinal B and T cell responses to rotavirus infection and vaccination in Department of 199 Dr. Gagandeep Kang Sciences Indian infants. Biotechnology

200 Dr. Sanjay Kumar Centre for Stem Cell Biological studies on chromatin modulators for MSC osteogenic Department of Research fate choices in metabolic bone diseases. Biotechnology

Dr. George M Department of 201 Medicine Biomarker Discovery for early diagnosis of active tuberculosis. Varghese Biotechnology

Cancer stem cells (CSCs) in sporadic and hereditary medullary Department of 202 Dr. Rekha Pai Pathology thyroid carcinoma: Relevance of PROM1 (CD133) in Biotechnology prognostication.

Gastrointestinal Cancer stem cells in squamous cell carcinoma of buccal cavity Department of 203 Dr. BS. Ramakrishna Sciences and tongue: Correlations with clinical behaviour and metastasis. Biotechnology

Dr. Anup Gastrointestinal Cardiovascular complications in liver cirrhosis: Role of nitric Department of 204 Ramachandran Sciences oxide and mitochondria. Biotechnology

Dr. Roy Thomas Department of 205 Neurological Sciences Cellular and network mechanisms of temporal lobe epilepsy. Daniel Biotechnology

Cellular mechanisms of temporal lobe epilepsy: in vitro studies Department of 206 Mr. Deepak. S Neurological sciences on animal models. Biotechnology

Dr. Mammen Centre for molecular genetics for the diagnosis of hematologic Department of 207 Haematology Chandy disorders at Christian Medial College & Hospital, Vellore Biotechnology

Dr. Mammen Centre for molecular genetics for the diagnosis of hematologic Department of 208 Haematology Chandy disorders at Christian Medical College & Hospital, Vellore. Biotechnology Characterization of allelic loss using micro-satellite markers at Neurosciences and Department of 209 Dr. Geeta Chacko 1p,10q,14q,17p,22q and promoter hypermethylation analysis of Pathology Biotechnology TP73 and TIMP3 in meningiomas

Dr. Debashish Medicine II & Characterization of HLA DR4 allelles and candidate non-HLA Department of 210 Danda Rheumatology alleles associated with Juvenile Rheumatoid Arthritis in India. Biotechnology

Comparison of Autologous versus allogenic chondrocyte Dr. P.R.J.V.C. Department of 211 Orthopaedics III transplantation for treatment of articular cartilage defects in Boopalan Biotechnology rabbit knees.

Dr. Deepak Correlation of microRNAs (miRNAs) 183, 375, 9, 9* as predictors Department of 212 Endocrine Surgery Abraham of poor clinical outcomes in Medullary Thyroid Cancer (MTC). Biotechnology

Creation of infrastructural facilities centres of excellence in the Department of 213 Dr. Priya Abraham Clinical Virology identified areas and demonstration project. Biotechnology

Centre for Stem Cell Definition of the role of ATM kinase in cellular differentiation and Department of 214 Dr. Prithi Rajan Research cancer. Biotechnology

Description of mechanisms of action of active principles isolated Dr. Sathya Department of 215 Physiology from Cleistanthus collinus with Preparatory HPLC, and lead Subramanian Biotechnology optimization for potential therapeutic uses

Endocrinology Determining penetrance among first degree relatives of patients Dr. Simon Department of 216 Diabetes and with pheochromocytoma from India: Characterization of SDHx Rajaratnam Biotechnology Metabolism (A, B, C, D), RET, VHL, SDHAF2, TMEM127 and MAX mutations. Development and In-Vivo Evaluation of Gradient Scaffolding Dr. Murugan Centre for Stem Cell Department of 217 System using Dental Pulp-derived Stem Cells for Hard Tissue Ramalingam Research Biotechnology Repair

Development of a chip for studying human fecal microBiota Dr. B.S. Gastrointestinal Department of 218 composition and activity and its application in Patients with Ramakrishna Sciences Biotechnology inflammatory bowel disease.

Differentiation of human periosteal derived Mesenchymal stem Paediatric Department of 219 Dr. Vrisha Madhuri cells into chondrocyte using Parathyroid hormone related Orthopaedics Biotechnology peptide

Donor mesenchymal stem cell infusion for induction of tolerance Department of 220 Dr. George T. John Nephrology in renal transplant recipients. Biotechnology

Dr. Murugan Centre for Stem Cell Dual Stimuli-Responsive Smart Nano carriers with enhanced Department of 221 Ramalingam Research Anti-Cancer Activity in Leukemic Cancer Cells. Biotechnology

Early intervention approach to widen therapy window and MSC/neuro-progenitor transplantation or modulating Pten gene Centre for Stem Cell Department of 222 Dr. Sanjay Kumar by AAV-shRNA vectors leading to axonal regeneration in a non- Research Biotechnology human primate model of spinal cord injury after evaluating the specific aims in a mouse model.”

Gastrointestinal Effect of probiotic and zinc supplementation on systemic immune Department of 223 Dr. Gagandeep Kang Sciences response to oral rotavirus and oral poliovirus vaccination Biotechnology Effect of probiotic and zinc supplementation on systemic immune Department of 224 Dr. Jacob John Community Health response to oral rotavirus and oral poliovirus vaccination Biotechnology

Mr. Nishanth Noel Effects of notch signaling on human mesenchymal Stromal cell Department of 225 Haematology Gabriel homeostasis and differentiation. Biotechnology

Efficacy of `cultured autologous chondrocyte’ transplantation in Department of 226 Dr. Vrisha Madhuri Orthopaedics II the treatment of physical injury in goats. Biotechnology

Dr. Jayandharan G. Efficacy of bio-engineered adeno-associated virus serotype 8 Department of 227 Haematology Rao vectors for the potential gene therapy of haemophilia A Biotechnology

Clinical Immunology Efficacy of Methotrexate and Sulphasalazine in Axial Department of 228 Dr. Sandhya. P & Rheumatology Spondyloarthritis Biotechnology

Efficacy of Stem cell in improvement of left ventricular function Department of 229 Dr. V. Jacob Jose Cardiology in patients with acute myocardial infarction. Biotechnology

Endothelial progenitor cells (EPC), sphingosine-1-phosphate Dr. Asha Mary Department of 230 Virology (S1P) and sphingosine kinase-1 (SK1) as immunomodulators and Abraham Biotechnology immunotherapeutic targets during dengue virus infection.

Establishing cell and molecular biology techniques to generate Department of 231 Dr. R.V. Shaji Haematology human disease specific induced pluripotent stem (iPS) cells. Biotechnology

Establishment of core facility for Clinical Proteomics at Christian 232 Dr. Anup Gastrointestinal Department of Medical College: Application to inflammatory bowel disease and Ramachandran Sciences carcinoma in the gastrointestinal tract. Biotechnology

Dr. Deepak Department of 233 Endocrine Surgery Establishment of Unit of Excellence in Neuroendocrine Tumours. Abraham Biotechnology

Evaluation of Cellular and molecular mechanism of resistance to Department of 234 Dr. Vikram Mathews Haematology Arsenic Trioxide in acute promyelocytic leukemia. Biotechnology

Evaluation of adult stem cells (Haematopoeitic, mesenchymal and gastrointestinal epithelial): biology and potential Department of 235 Dr. Vikram Mathews Haematology applications in tissue regeneration, immune modulation and as Biotechnology vehicles for gene therapy.

Evaluation of mechanisms of resistance, novel therapeutic targets Department of 236 Dr. Vikram Mathews Haematology and therapeutic approaches in leukemia Biotechnology

Evaluation of prognostic markers in patients with Acute Myeloid Department of 237 Dr. Vikram Mathews Haematology Leukemia. Biotechnology

Dr. Ranjith K Evaluation of the role of endogenous precursor cells in enhancing Department of 238 Neurological Sciences Moorthy functional recovery following cold induced brain injury. Biotechnology

Dr. Joy Sarojini Evaluation of Xpert MTB/RIF in the diagnosis of childhood and Department of 239 Microbiology Michael extra pulmonary tuberculosis. Biotechnology

Dr. Jayandharan G Exploiting adeno-associated virus (AAV) modulated host cellular Department of 240 Haematology & Rao Centre for Stem Cell microRNAome to improve its therapeutic gene transfer. Biotechnology Research

Expression of miR-200 family, miR-205 and cell surface proteins Department of 241 Dr. Rekha Pai Pathology as markers of metastasis in thyroid tumors using real-time PCR Biotechnology and Immuno-histochemical analysis

Centre for Stem Cell Is complementing a growth factor for stem cells. Department of 242 Prithi Rajan Research Prithi Rajan, Associate Professor, Centre for Stem Cell Research, Biotechnology Dr. Alok Srivastava, Centre for Stem Cell Research.

Dr. Mammen Molecular remission with arsenic trioxide in acute promyelocytic Department of 243 Haematology Chandy leukemia Committee (Indian AMPL study group – IASG) approval Biotechnology

Fludarabine-based toxicity reduced conditioning regimen for Dr. Poonkuzhali Department of 244 Haematology HSCT- A pharmacokinetic, pharmacogenetic and Balasubramanian Biotechnology pharmacodynamic study

Dr. Elanthenral Follicular epithelial dysplasia- a putative preneoplastic lesion in Department of 245 Pathology Sigamani Hashimoto’s thyroiditis- a morphologic and molecular study. Biotechnology

Generation of an epigenetic factor shRNA library for studying the Centre for Stem Cell Department of 246 Dr. Sanjay Kumar mechanisms of stem cell differentiation, disease pathogenesis Research Biotechnology and drug resistance

247 Dr. Shaji RV Haematology Generation of induced pluripotent stem cells from human Department of somatic cells. Biotechnology

Mr. Johnson Genetic Heterogeneity of HCV strains in Indian sub-continent and Department of 248 Clinical Virology Christdas its implications on antiviral therapy and diagnostics. Biotechnology

Genome-wide RNAi screen for identification of novel regulators Department of 249 Dr. Shaji R.V Haematology of reprogramming Biotechnology

Department of 250 Dr. Molly Jacob Biochemistry How does inflammation affect the handling of iron in the body? Biotechnology

Dr. Suresh Department of 251 Bioengineering Implanted neural interfaces for artificial hand control. Devasahayam Biotechnology

Investigation of TLR mediated innate immune responses to Dr. Sitara Swarna Gastrointestinal Department of 252 Cryptosporidium parvum in human intestinal epithelial cell lines Rao Ajjampur Sciences Biotechnology using siRNA based post transcriptional silencing.

Investigations on the role of low dose radiation as Department of 253 Dr. Saikat Das Radiation Oncology chemopotentiator in medullary carcinoma thyroid Biotechnology

Department of 254 Dr. Molly Jacob Biochemistry Iron overload in alcoholic liver disease: why does it occur? Biotechnology

Is activation of haem oxygenase-1 involved in iron accumulation Department of 255 Dr. Joe Varghese Biochemistry in alcoholic liver disease? Biotechnology Department of 256 Dr. S. Gunasekaran Physiology Islet cell neogenesis from adult rat and pig ductal tissue in vitro. Biotechnology

Isolation of Cancer Stem Cells from primary and secondary high Dr. Christhunesa Department of 257 Neurological Sciences grade gliomas - their response to micro environmental cues and Soundararajan. C Biotechnology Notch signaling blockade

Dr. Solomon Isolation, expansion and differentiation of mesenchymal stem Department of 258 Physiology Sathishkumar cells from human adipose tissue. Biotechnology

Department of 259 Mr. Ajay Abraham Haematology Mechanisms of drug resistance in leukemia. Biotechnology

Department of 260 Dr. Poonkuzhali B Haematology Mechanisms of Imatibin resistance in chronic myeloid leukemia. Biotechnology

Dr. B.S. Gastrointestinal Metagenomic study of the fecal anaerobic bacteria flora in Department of 261 Ramakrishna Sciences healthy rural south Indian subjects. Biotechnology

Modulation of Adeno-associated virus (AAV) replication by host Haematology & Dr. Jayandharan G cell transcriptional repressors: Pharmacologic and RNAi Department of 262 Centre for Stem Cell Rao interference to improve AAV vector delivery during gene Biotechnology Research therapy.

Molecular and functional evaluation of genes involved in iron Department of 263 Dr. Eunice Sindhuvi Haematology absorption, transport and storage in the context of iron deficient. Biotechnology Department of 264 Dr. Shaji RV Haematology Molecular basis of Fanconi Anaemia in Indian population. Biotechnology

Molecular Characterization of Genes involved in Iron Department of 265 Ms. Rekha. A Haematology Homeostasis. Biotechnology

Dr. Asha Mary Molecular detection of neurotropic DNA viruses in important Department of 266 Clinical Virology Abraham neurological diseases seen in a tertiary hospital in India (south). Biotechnology

Dr. Auro Molecular genetics of hereditary rare bleeding disorders in Department of 267 Haematology Viswabandya Indian population Biotechnology

Department of 268 Dr. Shaji RV Haematology Molecular mechanisms of human globin gene regulation. Biotechnology

Muscle paralysis in acute organophosphate poisoning: Role of Department of 269 Dr. Anna Oommen Neurological Sciences nitric oxide and mitochondrial calcium handling. Biotechnology

Network R & D proposal for identification, screening and mass Dr. B.S. Department of 270 Gastroenterology production of probiotic strains and placebos for clinical trials Ramakrishna Biotechnology with an aim to future post-trial development and marketing.

Non classical HLA (G, F) and recurrent pregnancy loss- An Department of 271 Dr. Alka V Ekbote Clinical Genetics association study. Biotechnology

272 Dr. Indira Agarwal Child Health - II Pediatric Renal Biology Program: Research on Nephrotic Department of Syndrome Biotechnology

Department of 273 Dr. Subhashini John Radiation Therapy PET-MRI Automatic Tumour Detection and Recognition (ATR) Biotechnology

Pharmacogenetic and pharmacokinetics of daunorubicin in acute Department of 274 Ms. Savitha. V Haematology myeloid leukemia. Biotechnology

Dr. Poonkuzhali Pharmacogenetic of cytarabine and daunorubicin in acute Department of 275 Haematology Balasubramanian myeloid leukemia. Biotechnology

Phase III, randomized controlled trial to compare the one year loco-regional control between neoadjuvant chemotherapy with Department of 276 Dr. Saikat Das Radiation Oncology ultra fractioned radiotherapy followed by chemoradiation vs. Biotechnology chemoradiation alone in locally advanced carcinoma of cervix (FIGO stage IIb-IIB) in Vellore, India.

Centre for Stem Cell Department of 277 Dr. Rekha Samuel Placental pericytes and microvascular disease in type 2 diabetes Research Biotechnology

Possible roles of ERK signaling pathway and PI3K/Akt signaling Dr. Premila pathways in the pathogenesis of organophosphorus compound Department of 278 Biochemistry Abraham induced delayed neurotoxicity (OPIDN) – in vitro study using Biotechnology primary rat hippocampal neuron

Department of 279 Ms. Deepa. K Neurological Sciences Precision grip-a tool for assessing hand function Biotechnology Dr. Gagandeep Gastrointestinal Predictors of poor immune response to rotavirus vaccine in Department of 280 Kang Sciences infants Biotechnology

Preparedness for emerging hantaviruses in India: Development Department of 281 Dr. Priya Abraham Clinical Virology of diagnostic tools. Biotechnology

Prevalance of inhibitors in patients with severe hemophilia A in Department of 282 Dr. Vikram Mathews Haematology India: Impact of environmental and genetic factors on prevalence. Biotechnology

Department of 283 Dr. Anil Kuruvilla Neonatology Probiotics for prevention of necrotizing enterocolitis in neonates Biotechnology

Quantitation of HTLV-1 proviral DNA, mRNA and cell cycle Dr. Rajesh Department of 284 Virology dysregulation in patients with T-cell Leukemia/Lymphoma by Kannangai Biotechnology real-time PCR.

Dr. Murugan Centre for Stem Cell Regulating Human Bone Marrow-derived Stromal Cell Functions Department of 285 Ramalingam Research in 3D Microenvironment Suitable for Osteogenic Regeneration Biotechnology

Dr. Samuel Repair and regeneration of articular cartilage defects by Department of 286 Orthopaedics III Chittaranjan autologous chondrocyte transplantation in humans. Biotechnology

Dr. Suresh Robotic Assistance for Home-Based Rehabilitation of Stroke Department of 287 Bioengineering Devasahayam Paralyzed Hand Biotechnology

288 Diana M.E. Otto Centre for Stem Cell Role of semaphorins and respective receptors in mesenchymal Department of Research stem cells. Biotechnology

Roleofhuman papillomaviruses (HPV) in penile carcinoma among Department of 289 Dr. Priya Abraham Clinical Virology patients from the Indian subcontinent. Biotechnology

Dr. B.S. Gastrointestinal Safety and immunogenicity of a candidate live oral vaccine strain Department of 290 Ramakrishna Sciences of vibrio cholerae VAI. 3 in children 2 to 8 years of age. Biotechnology

Site-specific excisable AAV-based vector technology for Centre for Stem Cell Department of 291 Dr. Sanjay Kumar consistent and reliable generation of virus-free patient-specific Research Biotechnology induced Pluripotent Stem (iPS) Cells

Somatostatin receptor imaging with Ga68 DOTATATE PET and Department of 292 Dr. Ari G. Chacko Neurosurgery metabolic imaging with 18FDG-PET in the management of Biotechnology growth hormone secreting pituitary adenomas

Mr. M. Durai Physical Medicine and Spinal cord regeneration using stem cell transplantation & other Department of 293 Murugan Rehabilitation novel techniques. Biotechnology

Physical Medicine and Spinal cord regeneration using stem cell transplantation and Department of 294 Dr. George Tharion Rehabilitation other novel techniques. Biotechnology

Physical Medicine and Department of 295 Dr. George Tharion Spinal Cord Regeneration using Stem cell Transplantation. Rehabilitation Biotechnology

Dr. Anto Praveen Studies on association between genetic polymorphisms and Department of 296 Psychiatry Rajkumar clozapine drug response in treatment resistant schizophrenia. Biotechnology Department of 297 Mr. Sachin David Haematology Study of inhibitors in patients with severe haemophilia A. Biotechnology

Study of pathobiology of carcinogenesis in a mouse model of Department of 298 Dr. S. S. Prakash Biochemistry endometrial carcinoma Biotechnology

Study of Pharmacokinetics and pharmacogenetics of Busulfan Dr. Mammen Department of 299 Haematology and Cyclophosphamide in patients undergoing allogeneic bone Chandy Biotechnology marrow transplantation for Thalassaemia.

Study of polymorphisms in leprosy susceptibility genes; toll-like Dr. Debashish Medicine II & Department of 300 receptor (TLR2) and tumor necrosis factor alpha (TNF-α) and Danda Rheumatology Biotechnology HLA molecular typing in patients of SLE.

Sustainable and economically viable point-of-use water Department of 301 Dr. Gagandeep Kang Microbiology disinfection in rural areas to benefit SC/ST populations. Biotechnology

Dr. Kurien Anil Department of 302 Neonatology Synbiotics for prevention of necrotizing enterocolitis in neonates. Kuruvilla Biotechnology

The study of pregnant women with diabetes and screening for Department of 303 Dr. Nihal Thomas Endocrinology mutations related to common MODY (Maturity Onset Diabetes of Biotechnology the Young) genes and Polymorphisms in TCF7L2.

Gastrointestinal To evaluate the protective efficacy of three doses of oral rotavirus Department of 304 Dr. Gagandeep Kang Sciences vaccine (4) 116E, 105±0.5 ffu against severe rotavirus Biotechnology gastroenteritis: A phase III randomized double blind placebo controlled trial.

Department of 305 Dr. Eunice Sindhuvi Haematology Transcriptional and translational processes of E gene. Biotechnology

Treatment of large segmental bone defects with custom made Paediatric Department of 306 Dr. Vrisha Madhuri triphasic hydroxyapaptite scaffolds loaded with mesenchymal Orthopaedics Biotechnology stem cells in children.

Tyrosine kinase inhibitors in chronic myeloid leukemia. Ms. Preetha Ms. Preetha Markose, Junior Research Fellow, Hematology, Dr. Department of 307 Hematology Markose Poonkuzhali Balasubramanian, Dr. Eunice Sindhuvi E, Biotechnology Haematology.

Utilizing novel medical techniques/technologies and devices to Department of 308 Dr. Bobby John Cardiology enhance our understanding of common health Problems (Atrial Biotechnology arrhythmias and stroke) associated with rheumatic heart disease.

Utilizing novel medical techniques/technologies and devices to enhance our understanding of common health Problems (Atrial Department of 309 Dr. Bobby John Cardiology arrhythmias and stroke) associated With rheumatic heart Biotechnology disease.

Department of 310 Dr. Minnie Faith K Biochemistry Why does iron overload occur in alcoholic liver disease? Biotechnology

Centre for Stem Cell Non-invasive long-term in vivo vascular imaging using Department of 311 Dr. Rekha Samuel Research, multiphoton laser scanning microscopy. Biotechnology Department of 312 Dr. Shaji RV Haematology RNAi screen for identification of regulators of reprogramming Biotechnology

Department of Dr. Elanthenral Follicular epithelial dysplasia- a putative preneoplastic lesion in Biotechnology & 313 Pathology Sigamani Hashimoto’s thyroiditis- a morphologic and molecular study. Ministry of Science and technology

Department of Biotechnology / Department of Science and Technology / Centre for Stem Cell Science and 314 Dr. Rekha Samuel Vasculopathy in diffuse scleroderma (systemic sclerosis, SSc). Research Engineering Research Council / Institute of Stem Cell Biology and Regenerative Medicine

Department of Biotechnology /National Institutes Dr. Vedantam Understanding the inflammatory processes in neurocysticercosis; of Health (National 315 Biostatistics Rajshekhar A US – India partnership Institute of Neurological Disorders and Stroke) Department of Host determinants in the eicosanoid pathway modulate the Biotechnology and 316 Dr. D. J. Christopher Pulmonary Medicine inflammatory response, disease outcome, and treatment National Institute responsiveness in TB. of Health

Department of Study the role of cell adhesion mediated drug resistance in acute 317 Dr. Vikram Mathews Haematology Science and promyelocytic leukemia. Technology

A multiple real time PCR approach for the detection of Department of Dr. Rajesh 318 Clinical Virology opportunistic DNA viruses in HIV infected individuals in India Science & Kannangai (south). Technology

A study on the possible role of nitrosative stress and oxidative Department of Dr. Premila 319 Biochemistry stress in pathogenesis of Cyclophosphamide induced Science & Abraham hemorrhagic cystitis in the rat. Technology

Department of Assessment of hand deficit and recovery in cervical spondylotic 320 Ms. Deepa. K Neurological Sciences Science & myelopathy patients using precision grip task. Technology

Department of Gastrointestinal Baculovirus expression and antigenic characterization of capsid 321 Dr. Gagandeep Kang Science & Sciences proteins of Indian strains of Noroviruses. Technology

Characterization of Pneumococcus serotypes that colonise the Department of 322 Dr. Rupa Vedantam ENT III nasopharynx of Indian infants and their role as a risk factor for Science & acute suppurative otitis media. Technology Department of Dr. George M. Gastrointestinal Characterization of the Wilson’s disease protein in human 323 Science & Chandy Sciences carcinoma cell lines. Technology

Development of Instrumentation for long-term monitoring of Department of Dr. Suresh Neuromuscular and cardiovascular status, for diagnosis, therapy 324 Bioengineering Science & Devasahayam and rehabilitation( as part of DST’s Southern Hub for Healthcare Technology Instrumentation)

Department of Dr. Suresh 325 Bioengineering Enhanced prosthetic hand for Transhumeral Amputees. Science & Devasahayam Technology

Department of Establishment of an immunology laboratory to support the DBT 326 Dr. G. Sridharan Clinical Virology Science & (GOI) HIV vaccine initiative. Technology

Department of Dr. George M. Medicine 1 & Evaluation of serological and nucleic acid amplification tests for 327 Science & Varghese Infectious Diseases the diagnosis of scrub typhus in India. Technology

Department of Dr. George M. Gastrointestinal Genotype Phenotype correlation in Wilson’s disease within 328 Science & Chandy Sciences families. Technology

Dr. Rajesh 329 Clinical Virology Human immunodeficiency virus type-1 reverse transcriptase and Department of Kannangai protease gene mutation: An observational and traditional study Science & on anti-retroviral interactions. Technology

Department of Gastrointestinal 330 Dr. C.E. Eapen Introducing genetic algorithms for identifying Wilson’s disease. Science & Sciences Technology

Department of Dr. K.N. Involvement of group C and group G streptococci in induction of 331 Microbiology Science & Brahmadathan acute rheumatic fever and rheumatic heart diseases. Technology

Department of Mitochondrial bioenergetics and neuromuscular weakness of 332 Dr. Anna Oommen Neurology Science & acute organosphosphate poisoning. Technology

Department of Dr. Murugan Centre for Stem Cell Optimizing engineered hydrogels for stem cell delivery and 333 Science & Ramalingam Research differentiation in the heart. Technology

Optimizing an injectable cell-laden gradient hydrogel system for Department of Dr. Murugan Centre for Stem Cell 334 in situ stem cell delivery and differentiation in the articular Science & Ramalingam Research cartilage. Technology

Department of Dr. Premila Pathogenesis of Anti-HIV drug (Zidovudine) induced renal 335 Biochemistry Science & Abraham damage: possible role of oxidative stress and NFKB pathway. Technology

Pathogenesis of NSAID-induced renal toxicity: can zinc 336 Dr. Molly Jacob Biochemistry Department of ameliorate these effects? Science & Technology

Department of Dr. Sathya Pharmacological characterization of the intracellular 337 Physiology Science & Subramanian calciumstore in the frog-ventricle. Technology

Department of Dr. B.S. Gastrointestinal Pilot study of immunogenicity of a candidate vaccine strain in 338 Science & Ramakrishna Sciences Vibrio cholerae in South Indian volunteers. Technology

Department of Dr. Anup Gastrointestinal Role of Arginase in modulating nitric oxide signaling and 339 Science & Ramachandran Sciences intestinal damage during liver cirrhosis. Technology

Department of Dr. Debashish Clinical Immunology Study of single nucleotide polymorphisms (snps) in genes related 340 Science & Danda and Rheumatology to angiogenesis in Indian patients with takayasu arteritis. Technology

Department of Study of the role of reactive oxygen species in the bleeding 341 Dr. Vikram Mathews Haematology Science & diathesis of patients with acute promyelocytic leukemia. Technology

Department of Dr. George M. Gastrointestinal Transcript analysis of splice site and deletion mutations in Indian 342 Science & Chandy Sciences Wilson’s disease patients. Technology

Ms. Syrpailyne 343 Bioengineering Development of a Focused Repetitive Transcranial Magnetic Department of Wankhar Stimulator for the Treatment of Neuropsychiatric Disorders like Science & Depression: A Phase 1 Study. Technology

Department of Association of Single Nucleotide Polymorphisms in genes of the Neurochemistry Science & 344 Dr. B. S. B. Salomi coagulation and fibrinolytic system with the risk of Cerebral Laboratory Technology (DST) Venous Thrombosis (CVT). WOS-A scheme

Department of Science & Role of TLR4 ligands in inducing angiogenesis in patients with 345 Dr. K. Jayakanthan Clinical Microbiology Technology under Takayasu Arteritis. Young Scientists scheme

Department of Gastrointestinal Hydrogen sulphide and mitochondrial function: Its role in Science & 346 Ms. Kavitha. R Sciences inflammatory bowel disease. Technology Women Scientist Scheme A

A study on the beneficial effect of various PARP inhibitors in the Department of Dr. Premila 347 Biochemistry prevention of Cyclophosphamide induced hemorrhagic cyctitis in Science and Abraham the rat. Technology

Department of Dr. Prabhakaran An Inflammatory Switch Regulates the Pathogenesis of Brain 348 Pharmacology Science and Vasudevan Cancer from Neurocysticercosis Technology

Dr. B.S. Gastrointestinal Analysis of NOD2 gene defects in Indian patients with Crohn’s 349 Department of Ramakrishna Sciences disease. Science and Technology

Department of Dr. Vidya Rani Gastrointestinal 350 Cancer stem cells in oral squamous cell carcinoma. Science and Shyam Sundar Sciences Technology

Development of a focused repetitive transcranial magnetic Department of Ms. Syrpailynee 351 Bioengineering stimulator for the treatment of neuropsychiatric disorders like Science and Wankhar depression. Technology

Functional gastrointestinal disorders in Indian communities - Department of Gastrointestinal 352 Dr. George Kurian field and hospital studies to investigate genetic contributions and Science and Sciences to develop diagnostic tools. Technology

Department of Genetic Associations with Systemic Lupus Erythematous (SLE) in 353 Dr. Krati Shah Clinical Genetics Science and India. Technology

Department of Investigation on radiation dose to patient during image guidance 354 Dr. Paul Ravindran Radiation Physics Science and in radiotherapy. Technology

Network interactions in Temporal lobe epilepsy: An integrated Department of Dr. K. Srinivasa 355 Neurological Sciences approach using invitro studies and computational modeling in Science and Babu human brain and animal models. Technology

Centre for Stem Cell Pericytes alter the blood placental barrier in hyperglycemia of 356 Dr. Rekha Samuel Department of Research pregnancy. Science and Technology

Department of Dr. Rajesh Ramanna Neurochemistry Role (s) of Akt specific isoforms in pathophysiology of 357 Science and Valmiki Laboratory Alzheimer’s disease. Technology

Department of Centre for Stem Cell Role of junctional adhesion molecules and their various binding 358 Dr. Diana M.E. Otto Science and Research partners in mesenchymal stem cells. Technology

Department of Clinical Immunology Study of single nucleotide polymorphisms (snps) in genes related 359 Dr Debashish Danda Science and and to angiogenesis in Indian patients with takayasu arteritis. Technology

Study of the relationship between initial autonomic functions and Department of 360 Dr. Latha N Physiology subsequent motor and sensory recovery, intraumatic cervical Science and spinal cord injury patients. Technology

Department of 361 Dr. Paul Ravindran Radiotherapy Design and Development of a bench top X-ray cone beam CT. Science and Technology

Department of Design of a compliance monitored clubfoot brace for 362 Dr Vrisha Madhuri Pediatric Orthopaedic Science and management of clubfoot deformity in children. Technology

Gastrointestinal Genotype-Phenotype Correlations in Indian Patients with 363 Mr. Kiran Kumar B Department of Sciences Inflammatory Bowel Diseases Science and Technology

Department of In Vitro and in-vivo testing of a layer-by-layer assembled 3-D 364 Dr. Vrisha Madhuri Pediatric Orthopaedic Science and scaffold for articular cartilage tissue engineering. Technology

Department of Bi-directional effects of Adenosine 2A receptors in Traumatic Science and Mr. Parthiban K 365 Neurological Sciences Brain Injury (TBI): Understanding of time window based Technology – Fast Velayutham molecular signaling cascades towards therapeutic Approach. Track Scheme (DST-SERB)

Department of Science and Effects of silencing of LDL receptor in hepatocytes on metabolic Technology - 366 Dr. S.S. Prakash Biochemistry pathways and insulin signaling. Swarnajayanti Fellowships 2012 - 2013

Department of Transplantation of isolated human pancreatic islets for insulin Science and 367 Dr. S. Gunasekaran Physiology dependent diabetes mellitus Phase I: Xenotransplantation of Technology & isolated human pancreatic islets into rats/ monkeys. Indian Council of Medical Research

Role of calcium in muscle paralysis induced by organophosphate Department of Gastrointestinal poisoning. \ 368 Ms. Kavitha R Science and Sciences Ms. Kavitha R, The Wellcome Trust Laboratory, GI Sciences, Dr. Technology - Anup Ramachandran, GI Sciences Women Scientist Scheme – A

Department of Science and Development of methods and protocols for deep brain Dr. K. Srinivasa Technology, Under 369 Neurological sciences stimulation of amygdala to treat temporal lobe epilepsy and Babu Indo-Swiss Joint anxiety disorders. Research Programme

Protocol BC-0601. Study to assess the efficacy of the blood based gene expression test for Breast cancer in an Indian population in DiaGenic ASA, 370 Dr. Subhashini John Radiotherapy - II women with and without breast cancer in various geographic Norway locations.

Division of Clinical A randomized double – blind, placebo controlled study with a 2 * Trials, St. John’s 2 factorial design to evaluate rosuvastatin and Candesartan + Research Institute, hydrochlorothiazide in men aged > 55 years and women aged > St. John’s National 371 Dr. Nihal Thomas Endocrinology 65 years with one risk factor for cardiovascular disease such as Academy of Health smoking, elevated cholesterol, hypertension, diabetes and Sciences, obesity. Koramangala, Bangalore

A Multicentric, phase II clinical and pharmacological study of Dr. Reddy’s Dr. Raju Titus 372 Medical Oncology DRF-1042, a Novel Camptothecin Analog given orally in adult Laboratories Ltd., Chacko patients with Refractory Solid Tumors. Hyderabad

A Multiple-Site Study to Evaluate the Relative Bioavailability of a Dr. Reddy’s 373 Dr. Biju George Haematology Test Formulation of Azacitidine for Injection 100 mg/vial (Dr. Laboratories Ltd., Reddy’s Laboratories Limited) Compared to Vidaza® (azacitidine for injection)100 mg/vial (Celgene Corporation Celgene Hyderabad Corporation Summit, NJ 07901) under Fasted Conditions in Patients with Myelodysplastic Syndrome (MDS) who are on Azacitidine regimen.

A Randomized, Multi-centre, Double-blind, Parallel Group Study to Compare the Pharmacokinetics, Pharmacodynamic, Safety and Dr. Reddy’s Dr. Auro 374 Haematology Efficacy of Two Anti-CD20 Monoclonal Antibodies in Laboratories Ltd., Viswabandya Combination with CHOP in patients with CD20- Positive Diffuse Hyderabad Large B-Cell Lymphoma (RI-01-002)

A randomized controlled comparative trial to evaluate the Dr. Reddy’s 375 Dr. Subhashini John Radiotherapy - II efficacy and safety of 2- Deoxy D-Glucose (2DG) as a Laboratories Ltd., radiomodifier in the treatment of Glioblastoma Multiforme. Hyderabad

A randomized, open label, two-arm, multicenter study to evaluate Dr. Reddy’s the efficacy and safety of Darbepoetin as compared to 376 Dr. George T John Nephrology Laboratories Ltd., Erythropoietin in predialysis patients with anemia of chronic Hyderabad kidney disease (CKD) stage 3 and 4.

An open label, single arm study to evaluate the efficacy and safety Dr. Reddy’s Dr. Auro 377 Haematology of Rituximab in CD20 positive diffuse large B cell lymphoma Laboratories Ltd., Viswabandya when given along with CHOP chemotherapy. Hyderabad

An open-label, phase – I, accelerated, dose titration study of DRF – (5s,20s) – 1042, a noevel camptothecin analog given orally to Dr. Reddy’s Dr. Raju Titus 378 Medical Oncology adult patients with refractory solid tumors and it’s safety and Laboratories Ltd., Chacko efficacy in three refractory solid tumor types namely, colon, Hyderabad ovary and small cell lung carcinoma. Clinical trial of Grastim (G-CSF, DRL) in peripheral blood Dr. Reddy’s 379 Dr. Alok Srivastava Haematology progenitor cell (PBPC) transplantation (Allogeneic or Laboratories Ltd., autologous). Hyderabad

Dr. Reddy’s Dr. Raju Titus PALO/DRL/09/05 A Multicentric study to evaluate Palonosetron 380 Medical Oncology Laboratories Ltd., Chacko and Ondansetron in chemotherapy induced nausea and vomiting. Hyderabad

Excitability of denervated muscles in LMN (Lower Motor Neuron) lesion patients by Transcutaneous Electrical Stimulation in comparison to normal innervated muscles. DST grant for 381 Dr. Nissan Kunju Bioengineering Dr. Nissan Kunju, Ph.D. Research Scholar, Bioengineering, Dr. health care Suresh Devasahayam, Bioengineering, Dr. George Tharion, instrumentation Physical Medical and Rehabilitation, Dr. Manivannan M, Applied Mechanics, Indian Institute of Technology Madras.

Educational and A population-based surveillance of invasive disease caused by S. Research Grant Dr. Anand 382 Medicine Unit I Pneumoniae or H. influenzae or N. meningitides in children < 5 from Glaxo Manoharan years of age in India. Smithkline (GSK) India

Educational Dr. Anand Medicine Unit I & Research Grant 383 Pneumococcal Disease Monitoring in Adult Patients. Manoharan Infectious Diseases from Pfizer India Pvt. Ltd

MIPH Student, Effective 384 Dr. Aminu Evaluation dissemination products aimed at communicating the Liverpool school of Healthcare Mahmoud Umar Tropical Medicine, results of systematic reviews to clinicians in India. Research Pembroke Place, Consortium via the Liverpool, UK department for International development (DFID) UK.

Electro Role of adenylate cyclase, phosphodiesterase and microfilament 385 Dr. Manoj G Tyagi Pharmacology Convulsiometer in epilepsy. (Techno, India)

A comparison of platelet inhibition following a prasugrel 60 mg or prasugrel 30mg loading dose with or without pretreatment Dr. Sunil Thomas Eli Lilly & Company 386 Cardiology with a clopidogrel loading dose in acute coronary syndrome Chandy Pvt. Ltd. subjects who are to undergo percutaneous coronary intervention.

A phase 3, open label, crossover study to evaluate the efficacy and safety of Human Insulin Inhalation Powder (HIPP) compared Eli Lilly & Company 387 Dr. Nihal Thomas Endocrinology with once daily Insulin Glargine in Insulin naïve patients with Pvt. Ltd. type 2 diabetes mellitus on oral agents: Protocol H7U-MC-IDAZ.

A randomized phase 3 study of Enzastaurin versus Lomustine in Dr. Raju Titus Eli Lilly & Company 388 Medical Oncology the treatment of Recurrent, Intracranial Glioblastoma Chacko Pvt. Ltd. Multiforme.

A randomized phase 3 study of pemetrexed in combination with Eli Lilly & Company 389 Dr. Subhashini John Radiotherapy II Cisplatin versus cisplatin monotherapy in patients with recurrent Pvt. Ltd. or metastatic head and neck cancer. H3E-MC-JMHR. Protocol H3E-US-S047(C) Phase ½ Study of pemetrexed (Alimta®) plus Carboplatin, or Pemetrexed plus Cisplatin with Dr. Raju Titus Eli Lilly & Company 390 Medical Oncology Concurrent Radiation Therapy Folloed by Every-21-Day Chacko Pvt. Ltd. pemetrexed consolidation in patients with Favorable-Prognosis inoperable stage IIIA/B Non-Small-Cell Lung Cancer (NSCLC).

Protocol H7U-MC-IDAS – A Pivotal open-label, parallel study to evaluate the safety and efficacy of human Insulin inhalation Eli Lilly & Company 391 Dr. Nihal Thomas Endocrinology powder (HIIP) compared to injectable insulin in patients with Pvt. Ltd. diabetes and COPD or Asthma

A multicenter phase III randomized, double-blind placebo- EMD Dr. Raju Titus controlled study of the cancer vaccine stimuvax (L-BLP25 or 392 Medical Oncology Pharmaceuticals, Chacko BLP25 liposome vaccine) in non-small cell lung cancer (NSCLS) USA subjects with unresectable stage III diseases.

A 90-day, multicenter, double-blind, randomized, add-on study to evaluate the safety and efficacy of low and high dose of oral Emisphere 393 Dr. Nihal Thomas Endocrinology Insulin/4-CNAB tablets versus placebo in subjects with type 2 Technologies Inc., diabetes mellitus who have inadequate glycemic control with N.Y. Metformin monotherapy.

EMPOWER project Clinical Immunology Pilot study on oral microbiome in rheumatic disease using a 394 Dr. Sandhya. P to Vs CSIR India and Rheumatology community metagenome sequencing approach. (Grant OLP1105)

A Randomized, Double-Blind, Parallel Study of a Once Daily Epigenesis 395 Dr. D.J. Christopher Pulmonary Medicine Dosing of EPI-12323 versus Placebo in Symptomatic Moderate to Pharmaceuticals, Severe Asthmatics on Low-Dose Inhaled Corticosteroids and Long-Acting Beta-Agonists. LLC, USA

Comprehensive Approaches to understand Streptococcal Dr. K.N. 396 Microbiology diseases and their Sequelae to develop Innovative strategies for European Union Brahmadathan diagnosis, Therapy, prevention and control (ASSIST)

Gastrointestinal Production and delivery of antibody fragments against 397 Dr. Gagandeep Kang European Union Sciences gastrointestinal pathogens by lactobacilli.

To set up a centre at the Department of Psychiatry to retrieve, 398 Dr. Prathap Tharyan Psychiatry European Union and code controlled clinical trials for the Cochrane Collaboration.

External Center for Glycobiology, Gastrointestinal Role of sialic acid linked receptors in attachment and 399 Dr. Gagandeep Kang University of Sciences determining host specificity of rotavirus. California, San Diego

External DST academic program Study of muscle activation patterns and force exerted by normal 400 Dr. Nissan Kunju Bioengineering grant & DST grant subjects and paraplegic patients during wheelchair transfers. for medical device development

Dr. Dilip Mathai and Extramural Support Antiretroviral therapy adherence in the public health model of 401 Dr. Christine IDTRC (Tufts) for Viral HIV care. Wanke MD load testing Faculty of Medicine and the Office of Birth asphyxia and whole body cooling – A descriptive study in a Dr. Niranjan International 402 Neonatology tertiary care Perinatal center in south India, focusing on issues Thomas Relations at NTNU related to transport of asphyxiated babies. in Trondheim, Norway

Fast Track Department of Clinical Immunology Efficacy of Methotrexate and Sulphasalazine in pure Axial 403 Dr. Sandhya. P Science & & Rheumatology Spondyloarthritis. Technology project for young Scientist

Flinders University Wellcome Trust Pre-clinical evaluation of new oral rehydration solution 404 Dr. Pugazhendhi. S Innovation Centre Research Laboratory formulations for the treatment of diarrhea. for funding

Fogarty & Dr. Azara Sneha Gastrointestinal Community-based cluster randomized trial of ready-to-use Department of 405 Singh & Dr. Sciences therapeutic food in malnourished children <5 years of age. Gastrointestinal Gagandeep Kang Sciences

Fogarty AIDS International Economic evaluation of treatment of HIV with Dr. Thuppal V. Gastrointestinal Training and 406 zidovudine/stavudine and tenofovir regimens: A cost Sowmyanarayanan Sciences Research Program, effectiveness study Student training fund Fogarty AIDS International Dr. Thuppal V. Economic evaluation of treatment of HIV with zidovudine and Training and 407 IDTRC Sowmyanarayanan tenofovir regimen regimens: A cost effectiveness study Research Program, student training fund

Fogarty Impact of HIV infection among mothers on growth and International 408 Dr. Jasmin Prasad Community Health development of children. Center - National Institute of Health

Fogarty Rural Unit for Health Prevalence and risk factors for low levels of serum International 409 Dr. Rita Isaac and Social Affairs - micronutrients in HIV seropositive individuals in comparison Center - National RUHSA with seronegative individuals in South India. Institute of Health

Fogarty Randomized Trial of Diet supplementation in HIV and International 410 Dr. Thambu David Medicine II tuberculosis. Center - National Institute of Health

Incidence of pneumococcal pneumonia among HIV positive Fogarty Training Dr. Anand 411 Medicine Unit I patients at Government Hospital of Thoracic Medicine (GHTM), Grant, National Manoharan Chennai, Tamil Nadu. Institute of Health

Pneumococcal pneumonia among HIV positive patients in South 412 Dr. Dilip Mathai Medicine Fogarty Training India: Is there a case for vaccination? Grant, National Institute of Health

Foundation for Dr. Joy Sarojini Xpert™ MTB/Rif Demonstration study for molecular diagnosis of Innovative 413 Microbiology Michael tuberculosis. Diagnostic (FIND, Geneva)

Foundation for innovative Demonstration project iLED – Effectiveness of the PRIMOSTAR 414 Dr. Joy S Michael Microbiology diagnostics (FIND), iLED microscope for detection of Tuberculosis. Geneva, Switzerland

A randomized, double blind study comparing the efficacy and safety of a fixed combination of fenofibrate and metformin vs Fournier 415 Dr. Nihal Thomas Endocrinology metformin alone in patients with type 2 diabetes mellitus and Laboratories dyslipidemia not appropriately controlled with a statin. Protocol Ireland Ltd No. C LF23-0121 06 01.

Muscle cell death and protection in Dysferlinopathy: the roles of French Association 416 Dr. Anna Oommen Neurological Sciences NF-kB, oxidative stress and curcumin. against Myopathies

FRLHT (Foundation for Research on Evaluation of use of selected local health practices as nutritional Local Health 417 Dr. K.R. John Community Health supplement for management of anemia in adolescent girls in Traditions) Puthoornadu PHC of Tirupatur Taluka, Tamil Nadu. Bangalore and AYUSH(Ayurveda Yunany Sidha Homeopathy), Ministry of Health and family welfare, New Delhi

A phase III randomized, double blind, placebo-controlled, multi- centre study confirming the efficacy and safety of Genz-112638 Genzyme 418 Dr. Sumita Danda Clinical Genetics in patients with Gaucher disease type 1. Corporation

Evaluation of clinical efficacy, safety and tolerability of Dr. Mammen Genzyme 419 Haematology Thymoglobuline as primary therapy of Severe Aplastic Anemia Chandy Corporation (SAA).

Identify and characterize the disease status of patients with Gaucher Type 1 disease for potential inclusion in a subsequent Genzyme 420 Dr. Sumita Danda Clinical Genetics Unit Phase 3 clinical study which will evaluate the efficacy and safety Corporation of Genz-112638

A Phase 4 Prospective Study to Characterize the Genzyme India Pvt. 421 Dr. Sumita Danda Clinical Genetics Pharmacokinetics of Alglucosidase Alfa in Patients Aged 8-18 Ltd Years of Age.

Dr. Suceena TESTING study- Therapeutic Evaluation of STeroids in IgA George Clinical 422 Nephrology Alexander Nephropathy Global study India Pvt. Ltd

An international, multi-centre, open, parallel group, prospective, George Institute for 423 Dr. D.J. Christopher Pulmonary Medicine randomized, controlled trial to determine the effectiveness of International treatment with continuous positive airways pressure (CPAP) in Health, Hyderabad, addition to standard care in reducing cardiovascular (CV) Adelaide Institute morbidity and mortality in patients with co-existing CV disease for Sleep Health and moderate-severe obstructive sleep apnea (OSA) Incorporated, Australia, Philips Respironics Res Med Fisher and Paykel Compumedics, Australia

Prevalence of Host and viral genotypes in patients with chronic 424 Dr. C.E. Eapen Hepatology Giled Sciences, Inc hepatitis C and Chronic Hepatitis.

A double-blind randomized, multicenter, placebo-controlled, parallel group, dose ranging study to assess the efficacy, safety Dr. Raju Titus Glaxo Smith Kline 425 Medical Oncology and pharmacokinetics of an oral Thrombopoietin Recept agonist Chacko Ltd (SB-497115 – GR) administered at 50, 75 and 100 mg to cancer patients receiving multiple cycles of chemotherapy.

A longitudinal 2 – year bone marrow study of eltrombopag Glaxo Smith Kline 426 Dr. Vikram Mathews Haematology olamine (SB-497115-GR) in previously treated adults, with Ltd chronic immune (idiopathic) thrombocytopenic purpura (ITP).

A phase III, open, randomized, controlled primary vaccination study to demonstrate the non-inferiority of GSK Biologicals’ Dr. Valsan Philip meningococcal serogroup ACWY conjugate vaccine (134612, Glaxo Smith Kline 427 Child Health - I Verghese MenACWY-TT) given intramuscularly versus MencevaxTM ACWY Ltd given subcutaneously to healthy subjects aged 2 through 10 years of age. A randomized, double blind, placebo-controlled, multicenter, phase III study comparing the activity of paclitaxel plus Dr. Raju Titus Glaxo Smith Kline 428 Medical Oncology Trastuzumab plus Lapatinib to Paclitaxel plus Trastuzumab plus Chacko Ltd placebo in women with ErbB2 over expressing metastatic breast cancer.

A randomized, double blind, placebo-controlled, multicentre, phase II study of oral Lapatinib in combination with concurrent radiotherapy and Cisplatin versus radiotherapy and Cisplatin Glaxo Smith Kline 429 Dr. Subhashini John Radiotherapy II versus radiotherapy and Cisplatin alone, in subjects with stage III Ltd and IV A.B. squamous cell carcinoma of the Head and Neck (SCCHN).

A three part study of eltrombopag in thrombocytopenic subjects Glaxo Smith Kline 430 Dr. Biju George Haematology with myelodysplastic syndromes or acute myeloid leukemia Ltd

Gastrointestinal Acute liver failure-associated casual agents and outcome of Glaxo Smith Kline 431 Dr. R. Jeyamani Sciences patients aged from birth to 18 years in India. Ltd

Dr. Sara Community surveillance for invasive childhood pneumococcal Glaxo Smith Kline 432 LCECU Bhattacharji disease: pilot study (revised) Ltd

Dr. Sara Community surveillance for invasive childhood pneumococcal Glaxo Smith Kline 433 LCECU Bhattacharji disease: Pilot study. Ltd

Ofatumumab versus Rituximab Salvage Chemo immunotherapy Glaxo Smith Kline 434 Dr. Vikram Mathews Haematology followed by ASCT in Relapsed or Refractory DLBCL. Ltd Open, phase IIIb Multicentric, safety and reactogenicity study of Glaxo Smith Kline Biologicals reduced antigen content Glaxo Smith Kline 435 Dr. P. Raghupathy Child Health I diphtheria-tetanus - acellular pertussis vaccine (BOOSTRIXTM) Ltd administered in healthy children according to the international recommended prescribing information.

A Randomized, Double-Blind, Multicenter, Placebo-controlled, Phase III Superiority study to Assess the Safety and Efficacy of GlaxoSmithKline & 436 Dr. Dilip Mathai Medicine Topical Retapamulin Ointment, 1% versus Placebo Ointment Paraxel Applied Twice Daily for 5 days in the Treatment of Adult and International Ltd Pediatric Subjects with Secondarily-Infected Traumatic Lesions.

A phase II, open, multicenter trial in healthy Indian adults 18 to 64 years of age, to evaluate the immunogenicity and safety of one GlaxoSmithKline 437 Dr. Dilip Mathai IDTRC dose of monovalent A/California/7/2009 (HINI)v-like vaccine Biologicals manufactured in Quebec, Canada, adjuvanted with AS03A.

A phase III, open study in children previously enrolled in study 10PN-PD-DIT-037 PRI (111188) to assess the immunogenicity, safety and reactogenicity of GlaxoSmithKline (GSK) Biologicals’ Dr. Valsan Philip 10-valent pneumococcal conjugate vaccine when administered as GlaxoSmithKline 438 Child Health Varghese a booster dose at either 9-12 months or 15-18 months of age in Biologicals primed children or when administered as a catch-up vaccination (2+1 schedule) in unprimed children during the second year or life.

Dr. Valsan Philip A Phase III, randomized, single-blind, controlled study to assess GlaxoSmithKline 439 Child Health Varghese the immunogenicity, safety and reactogenicity of Biologicals GlaxoSmithKline (GSK) Biologicals' 10-valent pneumococcal conjugate vaccine as a 3-dose primary immunization course at 6, 10 and 14 weeks of age in India, co-administered with GSK biologicals' Tritanrix-Hep B / Hib (DTPw- HBV/Hib) vaccine.

A phase IV, observer-blind, randomized, controlled, multicentric study to assess the safety and immunogenicity of GSK Biologicals’ HPV-16/18 L1VLP AS04 vaccine (Cervarix™) administered GlaxoSmithKline 440 Dr. Dilip Mathai Medicine intramuscularly according to a three-dose schedule (Day 0, Week Biologicals 6, Month 6) in human immunodeficiency virus-infected (HIV+) female subjects aged 15 – 25 years, as compared to Merck’s HPV- 6/11/16/18 vaccine (Gardasil®)

Acute Liver failure-associated causal agents and outcome of Dr. Leni Grace GlaxoSmithKline 441 Child Health - I patients aged from birth to 18 years in India (CMC, Vellore, KEM, Mathew Biologicals Pune and PGI Chandigarh), a retrospective review 2003-2005.

Immunogenicity and safety study of two difference formulations Dr. Rajeev Well Baby Clinic, Child GlaxoSmithKline 442 of GlaxoSmithKline (GSK) Biologicals oral live attenuated human Zachariah Health Biologicals rotavirus (HRV) vaccine, Rotarix in healthy infants.

Immunogenicity and safety study of two different formulations of Dr. Rajeev GlaxoSmithKline 443 Well Baby Clinic GlaxoSmithKline (GSK) Biologicals oral live attenuated human Zachariah Biologicals rotavirus (HRV) vaccine, Rotarix in healthy infants

A phase III, randomized, observer-blind, placebo controlled, multicentre, clinical trial to assess the prophylactic efficacy, GlaxoSmithKline 444 Dr. Biju George Haematology safety, and immunogenicity of GSK Biologicals’ herpes zoster Biologicals gE/AS01B candidate vaccine when administered intramuscularly on a two dose schedule to adult autologous haematopoietic stem cell transplant (HCT) recipients.

ZOSTER-39 - A Phase III, randomized, observer-blind, placebo controlled multicentre study to assess the safety and immunogenicity of GSK Biologicals’ Herpes Zoster HZ/su GlaxoSmithKline 445 Dr. Biju George Haematology candidate vaccine when administered intramuscularly on a two- Biologicals dose schedule to adults aged 18 years and older with hematological malignancies.

Global Fund Against Tuberculosis, AIDS, Malaria (GFATAM) The prevalence and determinants of job stress and job –round 7; satisfaction, mental health problems and burnout and the 446 Dr. Prathap Tharyan Psychiatry counseling mediating effects of empathy and religious or spiritual beliefs in component (Gates HIV counselors. Foundation) disbursed by Tata Institute for Social Sciences, Mumbai

Global Research Does the result of solid culture for TB influence clinical decision 447 Dr. Dilip Mathai IDTRC Opportunities in making? Health, London

Global Women and Obstetrics and Psychosocial Distress among Pregnant Women in South India: Child Health 448 Dr. Jessie Lionel Gynecology Towards Intervention Development (WACh) see grant, USA. Dr. Vedantam Impact assessment and control of cysticercosis in the Indian Government of 449 Neurological Sciences Rajshekhar subcontinent. Belgium

450 Dr. Shalini Anandan Microbiology Survey of antibiotic resistance. GSK

Obstetrics and Treatment approaches for pre-eclampsia in low resource Gynuity Health 451 Dr. Annie Regi Gynecology settings. Projects

Dr. Thomas R. Obstetrics and Treatment Approaches for Preeclampsia in Low-Resource Gynuity Health 452 Easterling Gynecology Settings: Expanding Access to Magnesium Sulfate Projects, USA

Sertinodole Vs Risperidone safety outcome study: A randomized, H. Lundbeck A/S, 453 Dr. Prathap Tharyan Psychiatry II partially-blinded, parallel-group, active-controlled, post- Denmark marketing study.

Aetiology of fever in patients admitted to a tertiary hospital in Haukeland Univ. 454 Dr. Dilip Mathai Medicine I Tamil Nadu district in India. Hospital, Norway

Immuno-Pathogenic mechanisms in acute Febrile illness (IPF). Haukeland 455 Dr. Dilip Mathai Medicine Proposal I – Acute Malaria. University Hospital and Oslo University

Haukeland 456 Dr. Dilip Mathai Medicine Immunopathogenic Mechanism of Febrile Illness (IPF). University Hospital and Oslo University Safety and Efficacy of HO/03/03 10 µg in the treatment of plantar 457 Dr. Nihal Thomas Endocrinology HealOr. Ltd neuropathic diabetic foot ulcers.

458 Dr. K.R. John Community Health A study of Tribal’s status in India. Healthlink, UK

Helse Sor Ost, & Dr. George M. Role of toll-like receptors (TLRs) and Cytokines in the immune 459 IDTRC Univesity of Oslo, Varghese response due to scrub typhus. Norway

A randomized, controlled, double-blind phase III trial to compare the efficacy, safety and pharmacokinetics of GP2013 plus vs. Dr. Auro 460 Haematology MabThera plus CVP, followed by GP2013 or MabThera Hexal AG Viswabandya Maintenance therapy in patients with previously untreated, advanced stage follicular lymphoma.

To study the long term sequelae and their severity in children Hib Initiative, GAVI, 461 Dr. Dr. M.G. Deepak Community Health with history of meningitis with particular reference to Hib USA meningitis.

A randomized, phase 3, controlled, double-blind, parallel-group, multicenter study to evaluate the safety and efficacy of rituximab Dr. Debashish Hoffmann-La Roche 462 Medicine II in combination with methotrexate (MTX) compared to MTX Danda AG (India) alone, in methotrexate-native patients with active rheumatoid arthritis.

An expanded access program of TarcevaTM (Erlotinib) in Dr. Raju Titus Hoffmann-La Roche 463 Medical Oncology patients with advanced stage IIIB/IV non-small cell lung cancer Chacko AG (India) (NSCLC) Dr. Raju Titus A phase II Biomarker Identification Trial for Erlotinib Hoffmann-La Roche 464 Medical Oncology Chacko (Tarceva®) in Patients with Advanced Pancreatic Carcinoma. Ltd

Howard Hughes Medical Institute - Dr. Anup Gastrointestinal Resistance of Mycobacterium tuberculosis to killing by 465 International Ramachandran Sciences macrophages: Role of mitochondria and reactive. Research Scholars Program

A phase 2/3, randomized, double blind, placebo and active comparator controlled, parallel group, multicenter study to Icon Clinical 466 Dr. Nihal Thomas Endocrinology determine the safety and efficacy of Metaglidasen (MBX 102) in Research (I) Pvt. the treatment of type 2 diabetes in patients sub optimally Ltd. controlled on Insulin.

ICON Pharma / Phase II study of concurrent chemoirradiation with weekly Dr. Sunitha Susan Indian Council of 467 Radiation Oncology paclitaxel and cisplatin in the treatment of carcinoma of the Varghese Medical Research / cervix. Special funds

IDTRC, National Vector Borne Disease Control, Acute Undifferentiated Febrile illness (AUF) seen among patients India Sentry in secondary level community hospitals in India: A prospective 468 Dr. Dilip Mathai IDTRC Programme, Xcyton observational study of infectious etiology, clinical profile, Diagnostics, diagnosis and outcome. Defense Research Development Establishment A phase I/II open-label, dose-escalation study to determine the Dr. Mammen safety, tolerance, and preliminary activity of intravenous high- Immune Control 469 Haematology Chandy dose Fluphenazine HCL in patients with advanced multiple Inc, USA myeloma.

Dr. Sunil Thomas India Medtronic 470 Cardiology South Asian Systolic Heart Failure Registry (SASHFR) Chandy Pvt. Ltd

Indian Clinical Disease burden, clinical profile, practice patterns and outcomes 471 Dr. K.R.John Community Health Epidemiology of MDR TB. Network

Efficacy of chemoprophylactic regimen in children in contacts Indian Clinical Dr. Valsan Philip with adult patients with sputum positive pulmonary tuberculosis 472 Child Health I Epidemiology Verghese in reducing tuberculosis infection and disease: a Multicentric Network randomized controlled trial.

Randomized double blind placebo controlled trial of amoxicillin Indian Clinical 473 Dr. P. Raghupathy Child Health Unit I in the treatment of non-severe pneumonia with wheeze in Epidemiology children aged 2-59 months of age. A multi-centric study. Network

A Multicentric randomized controlled clinical trial of Adefovir, Gastrointestinal Indian Council of 474 Dr. George Kurien Adefovir+, Lamivudine, and combination of Adefovir and Sciences Medical Research Glycyrrhizin in HBV related decompensated cirrhosis.

A Multicentric, prospective, randomized controlled trial Indian Council of 475 Dr. Indira Agarwal Child Health II comparing the efficacy of treatment with intravenous Medical Research cyclophosphamide and alternate day prednisolone versus tacrolimus and alternate day prednisolone for patients with steroid resistant nephritic syndrome.

A Multiplex real time PCR approach to determine viral etiology of Indian Council of 476 Dr. Mahesh Moorthy Clinical Virology acute lower respiratory infections in children in a tertiary Medical Research hospital in Tamil Nadu.

A Multiplex real time PCR approach to determine viral etiology of Indian Council of 477 Dr. Mahesh Moorthy Clinical Virology acute lower respiratory infections in children in a tertiary Medical Research hospital in Tamil Nadu.

Dr. Asha K. III year Medical A prospective cohort study to assess the benefit of neutropenic Indian Council of 478 Varghese Student diet among patients undergoing chemotherapy. Medical Research

A study of Cardiovascular disease related lifestyles and their Indian Council of 479 Dr. V. Jacob Jose Cardiology behavioural determinants among different population goups in Medical Research India – Task force project.

A study on the possible beneficial effects of the B complex Dr. Premila Indian Council of 480 Biochemistry vitamin biotin, an activator of glucokinase in the Abraham Medical Research treatment/management of experimental gestational diabetes.

A study on the possible role of endoplasmic reticulum stress in Indian Council of 481 Premila Abraham Biochemistry cyclophosphamide induced damage to human urothelial cell line. Medical Research

Dr. Koshy George, Acute Encephalitis Syndrome (AES): study on infectious etiology, Pediatrician, Baptist Indian Council of 482 IDTRC risk factor assessment and treatment outcome Christian Hospital, Medical Research of children and adults with AES in a secondary level community Tezpur, Assam, Dr. Ashita, Dr. Lydia hospital at Tezpur, Assam (North Eastern India) John, Physician, Internal Medicine, Baptist Christian Hospital, Tezpur, Assam, Dr. Pratiba Esther Milton, Project Director, Baptist Christian Hospital, Mission Chariali, Tezpur, Assam, Dr. B. Ravikumar , Chairman and Managing Director, General Secretary, Association of Biotech Led Enterprises in India, X-Cyton Diagnostic Ltd, Dr. V. Ravi, Professor & Head, Head, Neurovirology, NIMHANS, Bangalore

Acute organophosphate poisoning: implications of the Dr. Amajad Iqbal Indian Council of 483 Neurochemistry glutamatergic system and oxidative stress in neurotoxicity and Kazi Medical Research the role of neuroprotective proteins. Rural Unit For Health An exploratory study on the effectiveness of establishing public Indian Council of 484 Dr. Rita Isaac and Social Affairs - private partnerships to reduce the burden of under 5 morbidity Medical Research RUHSA and mortality in rural India.

Anti-helminthic drug resistance in India –assessment of Dr. Sitara Swarna Gastrointestinal Indian Council of 485 benzimidazole resistance in clinical isolates of hookworm by Rao Ajjampur Sciences Medical Research detection of b tubulin gene polymorphisms and in vitro assays.

Paediatric Assessment of incidence of DDH of hip in the south Indian Indian Council of 486 Dr. Vrisha Madhuri Orthopaedics population using ultrasonographic technique Medical Research

Developmental Autism spectrum disorder: Clinico-radiological and Indian Council of 487 Dr. Beena Koshy Paediatrics Unit morphometric analysis from A tertiary Care centre. Medical Research

Biological, Virological and environmental determinants of Aedes Indian Council of 488 Dr. Sara Chandy Medicine species: A pilot study at Vellore, Tamil Nadu. Medical Research

CDKN1B V109G polymorphism among patients with medullary Dr. Simon Indian Council of 489 Endocrinology thyroid carcinoma: Evaluation of its prognostic value and its Rajaratnam Medical Research synergistic effect with RET polymorphism

Dr. Asha Mary Characterization of influenza-specific antibody repertoire by Indian Council of 490 Clinical Virology Abraham protein microarrays. Medical Research

Clinico-Epidemiologic and Molecular characterization of Indian Council of 491 Dr. Dilip Mathai Medicine I Extended-Spectrum Beta Lactamase (ESBL) producing Klebsiella Medical Research spp., E. Coli & Enterobacter spp causing Nosocomial and Community Infections.

Comparison of the efficacy of a 7-day versus a 14-day course of Dr. Kurien Anil intravenous antibiotics in the treatment of uncomplicated Indian Council of 492 Neonatology Kuruvilla, neonatal bacterial sepsis: a randomized controlled non- Medical Research inferiority trial

Conformational studies of Taenia solium metacestode proteins Indian Council of 493 Dr. Anna Oommen Neurological Sciences diagnostic for neurocysticercosis: Is there a role for unfolding to Medical Research improve antigenicity?

Cryptosporidial species, Cpgp40/15 polymorphisms and oocyst Dr. Sitara Swarna Gastrointestinal Indian Council of 494 burden associated with diarrhea in HIV infected patients in South Rao Ajjampur Sciences Medical Research India.

Gastrointestinal Development of the intestinal bacterial flora in the neonate in Indian Council of 495 B.S. Ramakrishna Sciences south India: A molecular analysis. Medical Research

Effectiveness of 3-day amoxycillin versus 5-day co-trimoxazole in Indian Council of 496 Dr. P. Raghupathy Child Health I the treatment of non-severe pneumonia in children aged 2-59 Medical Research months of age - A multi-centric open-labelled trial.

Dr. B.S. Gastrointestinal Effects of probiotic bacteria on intestinal epithelial and immune Indian Council of 497 Ramakrishna Sciences cells. Medical Research

Dr. John Antony Evaluation of a novel real-time multiplex PCR for diagnosis of Indian Council of 498 Microbiology Jude Prakash spotted fever, typhus fever and scrub typhus. Medical Research Dr. Anu Mary Evaluation of a programme to prevent vertical transmission of Indian Council of 499 Community Health Alexander hepatitis B in one rural block in Tamil Nadu. Medical Research

Evaluation of cellular and immune response in mice and patients Indian Council of 500 Vikram Mathews Haematology with acute promyelocytic leukemia treated with arsenic trioxide Medical Research

Evaluation of health effects and risk reduction interventions in stone quarries and stone crushing units of Vellore district, Tamil Indian Council of 501 Dr. Vinohar Balraj Community Health Nadu, India. (Part A). Medical Research Evaluation of risk and risk reduction interventions among workers in stone quarries and stone crushing units (Part B).

Evaluation of the role of aquaporin water channels and caveolin Indian Council of 502 Dr. Manoj G. Tyagi Pharmacology proteins in regulating vasopressin induced hemostatic Medical Research mechanism.

Evaluation of two anaesthetic protocols in neurosurgical cases Dr. K. Srinivasa Indian Council of 503 Neurophysiology with lesion in and around Peri-Rolandic area that require cortical Babu Medical Research mapping (A randomized controlled trial)

Dr. Asha Mary Indian Council of 504 Clinical Virology Expanded surveillance for severe acute respiratory infections. Abraham Medical Research

External Research grant project NEW PROPOSAL:(ICMR) Nodal Coordinating Center for surveillance network of Indian Council of 505 Dr. Balaji. V Microbiology antimicrobial resistance in Pseudomonasspp and Acinetobacter Medical Research spp. Feasibility study for establishing nationwide network of Dr. Oommen K. Indian Council of 506 Cardiology registries on management of acute coronary events (MACE George Medical Research registries)

Gastrointestinal FUT2 and ABO gene polymorphisms in determination of Indian Council of 507 Dr. Gagandeep Kang Sciences susceptibility to noroviral infections. Medical Research

Centre for Stem Cell Generating functional blood vessels using adult vascular stem Indian Council of 508 Dr. Rekha Samuel Research cells. Medical Research

Haematology & Generation of induced pluripotent stem cells for haematological Indian Council of 509 Dr. Shaji RV Centre for Stem Cell diseases Medical Research Research

Dr. Sitara Swarna Gastrointestinal Genetic susceptibility and innate immunity to cryptosporidial Indian Council of 510 Rao Ajjampur Sciences infections in childhood – A candidate gene approach. Medical Research

Dr. Vedantam Health education and targeted therapy for taeniasis as a control Indian Council of 511 Neurological Sciences Rajshekhar measure for neurocysticercosis Medical Research

Rural Unit for Health Dr. Rita Caroline Indian Council of 512 and Social Affairs - HIV, Intestinal Microbiota and ART Isaac Medical Research RUHSA

Hospital-based universal screening and rehabilitation for Indian Council of 513 Dr. Achamma Balraj ENT neonatal hearing loss. Medical Research Indian Council of 514 Dr. Anna Oommen Neurological Sciences Host immunity and susceptibility to neurocysticercosis. Medical Research

Indian Council of 515 Dr. Dilip Mathai Medicine I HPV infection in Indian HIV-seropositive men. Medical Research

HPV-related neoplasia among HIV-seropositive Indian men who Indian Council of 516 Dr Dilip Mathai IDTRC have sex with men. Medical Research

Human Immunodeficiency Virus type 1 reverse transcriptase and Dr. Rajesh protease gene mutations: An observational and prediction study Indian Council of 517 Medicine Unit I Kannangai on antiretroviral infections. Dr. Rajesh Kannangai, Clinical Medical Research Virology, Dr. G. Sridharan, Clinical Virology,

Associate Professor, Systems Biology, CR Identification of novel regulators and gene-regulatory networks Indian Council of 518 Dr. Sailu Yellaboina Rao AIMSCS, controlling human embryonic stem cell maintenance. Medical Research Gachibowli

Indian Council of 519 Dr. Dilip Mathai IDTRC Incidence of HIV among Indian men who have sex with men. Medical Research

Medicine I & Indian Council of 520 Dr. Dilip Mathai Incident HPV infection among Indian HIV-seropositive MSM. Infections Diseases Medical Research

Indian Council of Medical Research taskforce project on Suicide Indian Council of 521 Dr. K.S. Jacob Psychiatry behaviour Medical Research Interventional program to reduce the risk factors for Coronary Indian Council of 522 Dr. V. Jacob Jose Cardiology artery disease in Indian population. Medical Research

Dr. K. Srinivasa Intra-operative electrophysiological monitoring under controlled Indian Council of 523 Neurological Sciences Babu blood pressure. Medical Research

Investigation of the emergence of polymorphisms indicating drug resistance in the reverse transcriptase (RT) gene of HIV-1 strains Dr. Rajesh Indian Council of 524 Virology isolated from plasma of pregnant women before administration Kannangai Medical Research and after completion of prophylaxis to prevent mother-to-child transmission (MTCT) of HIV-1.

Investigation of the role of urokinase like plasminogen activator Indian Council of 525 Dr. Manoj G Tyagi Pharmacology on vasopressin induced signal transduction in diabetes insipidus. Medical Research

Dr. Vinod Joseph JVMM programme on control of RF/RHD “Nodal coordinator unit Indian Council of 526 Community Medicine Abraham of Satellite centers for RF/RHD control at CMC, Vellore”. Medical Research

Gastrointestinal Metabolomic study of the intestinal flora in health and in patients Indian Council of 527 Ms. Pooja Sciences with inflammatory bowel disease. Medical Research

Molecular and serological investigations of hantavirus infections Indian Council of 528 Dr. G. Sridharan Clinical Virology in Vellore District of South India. Medical Research

Dr. George M. Molecular Epidemiology and Genetic Diversity of Orientia Indian Council of 529 Medicine 1 Varghese tsutsugamushi from Patients with Scrub Typhus in India Medical Research Multi Center study on Antimicrobial Resistance Monitoring of Indian Council of 530 Dr. Balaji V Clinical Microbiology Salmonella Typhi and Salmonella Paratyphi A- An attempt to Medical Research make national guidelines to treat Enteric fever

Multicentric, randomized, double-blind, placebo-controlled trial to compare the efficacy of 3-months’ versus 6-months’ therapy Indian Council of 531 Dr. Indira Agarwal Child Health II with prednisolone for the first episode of idiopathic nephritic Medical Research syndrome in children.

Dr. Asha Mary Multi-site monitoring of human influenza viruses in India – Indian Council of 532 Virology Abraham Phase I. Medical Research

Gastrointestinal National Rotavirus Surveillance Programme in Pediatric In- Indian Council of 533 Dr. Gagandeep Kang Sciences patients and Out-patients Medical Research

Dr. Samuel P Developmental Neurodevelopment outcomes of very low birth weight infant Indian Council of 534 Oommen Pediatrics Unit born in a tertiary health centre. Medical Research

Indian Council of 535 Dr. Subhashini John Radiation therapy Patterns of care and survival studies – cancer breast. Medical Research

Dr. Poonkuzhali Pharmacogenetic of cytarabine and daunorubicin Resistance in Indian Council of 536 Haematology Balasubramanian the Leukemic Stem Cell Compartment in acute myeloid leukemia. Medical Research

Dr. Poonkuzhali Pharmacogenomics of drugs used in Hematopoietic Stem cell Indian Council of 537 Haematology Balasubramanian Transplantation Medical Research Prevalence and incidence of human papilloma virus infections Dr. Abraham Obstetrics and Indian Council of 538 and cervical neoplasia in women who have had renal or bone Peedicayil Gynaecology Medical Research marrow transplant.

Prevalence and Incidence of non-communicable diseases Indian Council of 539 Dr. Nihal Thomas Endocrinology (diabetes, Obesity, cardio-vascular risk and metabolic bone Medical Research phenotypes) in the Vellore birth cohort after 40 years

Prevalence of atrial fibrillation in Kanyambadi block (Southern Indian Council of 540 Dr. Bobby John Cardiology India) in adults aged 30years and above. Medical Research

Prevalence of atrial fibrillation in Vellore (URBAN) among adults Indian Council of 541 Dr. Bobby John Cardiology aged 30 years and above. Medical Research

Prevalence of connexin 26 (GJB2) gene mutations in patients Indian Council of 542 Dr. Sumita Danda Clinical Genetics Unit with congenital sensorineural hearing loss and correlation with Medical Research their audiological profile.

Prevalence of coronary heart disease and its risk factors in Indian Council of 543 Dr. V. Jacob Jose Cardiology residents of urban and rural areas of Vellore district – a repeat Medical Research survey.

Prospective characterization of the clinical profile and mutations Prakash Jain, HPB associated with Multiple Endocrine Neoplasia-Type1 (MEN-1) Indian Council of 544 Dr. H. S. Asha Surgery and to identify the first degree relatives at risk of developing Medical Research MEN-1. Dr. Renita Ruth S - Prospective phenotypic and molecular characterization of Indian Council of 545 Clinical Microbiology PhD carbapenemase producing Enterobacteriaceae in India. Medical Research

Indian Council of 546 Dr. Priya Abraham Clinical Virology Characterization of heptatitis B virus drug resistance in Indian Medical Research subcontinent patients.

Registry on management of acute coronary event (MACE Indian Council of 547 Dr. Paul V. George Cardiology Registry) - Pilot Phase Medical Research

Screening for alkaptonuria to provide clinical and genetic Indian Council of 548 Dr. Sumita Danda Clinical Genetics profiling of the disease in the Narikuravas tribe of Tamilnadu. Medical Research

Serological and molecular investigations of hantavirus infections Indian Council of 549 Dr. G. Sridharan Clinical Virology in North Arcot district of South India. Medical Research

Gastrointestinal Seroprevalence of celiac disease and prevalence of its genetic Indian Council of 550 Dr. Anna Pulimood Sciences determinant, HLA-DQ genotypes 2 and 8, in South India. Medical Research

Indian Council of 551 Dr. J. Suganthy Anatomy Study of antigen presenting cells in human reproductive organs. Medical Research

Surveillance of antimicrobial resistance pattern in diarrheagenic Escherichia coli, Shigellaspp, Vibrio cholerae, Campylobacter Indian Council of 552 Dr. Balaji. V Clinical Microbiology sppandClostridium difficilecausing gastro-intestinal infections Medical Research involves characterization by phenotypic and molecular methods. Surveillance of Infection in neonates (0-28 days) (ICMR task Indian Council of 553 Dr. AK Jana Neonatology force study) Medical Research

The application of Multiple Treatment Meta Analysis in Mr. Richard South Asian Cochrane evaluating the efficacy and acceptability of pharmacological Indian Council of 554 Kirubakaran Network & Centre interventions in people with Schizophrenia and related Medical Research psychoses.

Mr. Deepak The Role of Direct Cortical Projections to the Hippocampus in Indian Council of 555 Neurophysiology Unit Subramanian controlling seizure propagation: an invitro Study Medical Research

The rolf of NF-kβ in muscle wasting of Limb Girdle Muscular Indian Council of 556 Dr. Anna Oommen Neurochemistry Dystrophy 2A. Medical Research

To evaluate the anticancer potency and mechanism of action of a Dr. Premila Indian Council of 557 Biochemistry novel synthetic curcumin analogue, dimethoxycurcumin in a Abraham Medical Research mouse model of endometrial cancer.

To identify the deletions / duplications of NF1 gene in Dr. Gautham Indian Council of 558 Clinical Genetics Unit neurofibromatosis type 1 patients belonging To Indian Arunachal. U Medical Research subcontinent

To investigate the roles of nitrosative stress and peroxisomal stress in the pathogenesis of cyclophosphamide- induced kidney Dr. Premila damage and possible ways to reduce the damage by the Indian Council of 559 Biochemistry Abraham administration of selective inducible nitric oxide synthase Medical Research inhibitor, aminoguanidine and peroxisomal proliferation alpha antagonist GW6471 Vaccine probe study to estimate the burden of Hib Meningitis and Indian Council of 560 Dr. Vinohar Balraj Community Health Pneumonia Preventable by Vaccination in India. Medical Research

Indian Council of 561 Dr. Kuryan George Community Health Vellore Tuberculosis Control Demonstration Project Medical Research

Why do patients with Helicobacter pylori infection develop iron Indian Council of 562 Dr. Molly Jacob Biochemistry deficiency anemia? Medical Research

Feasibility of timely reperfusion in ST-Elevation Myocardial Indian Council of 563 Dr. George Joseph Cardiology Infarction. Medical Research

Dr. Poonkuzhali Modulation of drug resistance in Acute myeloid leukemia: role of Indian Council of 564 Haematology Balasubramanian Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) and ABCB6. Medical Research

Indian Council of Mr. Amjad Iqbal Preconditioning with stress: possible neuroprotective role in Medical Research - 565 Neurological Sciences Kazi organophosphate poisoning. Senior Research Fellow

Indian Council of Dr. Mathew Medical Research 566 Neurological Sciences Neurological complications in patients receiving HAART. Alexander and Fogarty International, USA

Transfusion & HLA Haplotype frequency analysis within India: Pre-requisite for Indian Council of 567 Dr. Dolly Daniel Immunohaematology Bone Marrow Donor Registry and Cord Blood Bank planning. Medical Research and University Minnesota

Indian Council of Pre-conditioning stress induced modification of muscle Medical Research 568 Ms. Poornima Neurological Sciences acetylcholinesterase prevents muscle weakness that occurs in for a Senior acute organophosphate pesticide poisoning. Research Fellowship

Indian Institute of Identifying lens opacities in the 1969-73 Vellore Birth Cohort - A 569 Dr B Antonisamy Biostatistics Public Health, pilot study on ageing parameters Hyderabad

Virtual Reality based Minimally Invasive Surgical Simulator (VR- Indian Institute of General Surgery Unit 570 Dr. M. Manivannan MISS) with haptics feedback. Indian Institute of Technology, Technology, III Chennai. Chennai.

Indo Australia strategic Research Fund, DST-New The development and evaluation of m-Health service in the Delhi, India, 571 Prof. Dilip Mathai IDTRC control of Tuberculosis (TB) in India Australia India Institute, University of Melbourne, Australia

Generation of a mouse model of congenital pseudarthrosis of Pediatric Indo Danish 572 Dr. Vrisha Madhuri tibia (CPT) by injection of Mesenchymal stem cells (MSCs) Orthopaedics derived from human lipofibromatosis tissue isolated from CPT Collaboration biopsies in children. A study under “musculoskeletal stem cells in tissue regeneration”

Paediatric Indo- Danish 573 Dr. Vrisha Madhuri Cartilage regeneration in an osteoarthritis rat knee model. Orthopedics Collaboration

Indo- Danish Project (International Efficacy of cultured mesenchymal stem cells (MSCs) loaded over Pediatric project by DBT 574 Dr. Vrisha Madhuri the PCL electrospun scaffolds for regeneration of articular Orthopaedics Govt. of India and cartilage defects in goat hip joint. Danish Council for Strategic research, Denmark

Indo- Danish Project (International project by Paediatric To study the effect of shock wave on growth plate in rat Department of 575 Dr. Vrisha Madhuri Orthopaedics metatarsal organ culture. Biotechnology, Govt of India and Danish Council for Strategic research, Denmark

Indo German Molecular Medicine Wilson’s disease in India: Development of Chip-(WINChip) based agency through 576 Dr. S. Santhosh Unit - Gastrointestinal diagnosis. Department of Sciences Science and Technology / Bundesministerium für Bildung und Forschung, Germany

Indo-Australian Dr. B.S. Gastrointestinal Esterified starch and oral rehydration solution as a treatment for 577 Biotechnology Ramakrishna Sciences acute infectious diarrhoea. Fund

Indo-Danish Fund (Dept of Pediatric Isolation and characterization of cancer stem cells from human biotechnology, 578 Dr. Sanjay Chilbule Orthopaedics osteosarcoma tissue Govt. of India and - Danish council for strategic research

Epidemiology and magnitude of human rickettsioses in Vellore 579 Dr. Elizabeth Mathai Microbiology Indo-French district, Tamil Nadu and Munnar, Kerala.

Indo Norway Global Gastrointestinal Salivary antibodies to evaluate intestinal responses to rotavirus 580 Dr. Gagandeep Kang Vaccine Program Sciences vaccination in Indian infants (Globvac)

Indo Norway Global Gastrointestinal Salivary antibodies to evaluate intestinal responses to rotavirus 581 Ms. Anu Paul Vaccine Program Sciences vaccination in Indian infants (Globvac)

A questionnaire survey to assess the quality of Informed consent 582 Dr. Raju Titus Medical Oncology INDOX Cancer among the clinical trial participants in the INDOX cancer research Chacko network. Research Network

INDOX Cancer 583 Dr Marie Therese Pathology A study of the consistency of reporting of breast pathology Research Network

Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers - Dr. Raju Titus INDOX Cancer 584 Medical Oncology An International, Multi-centre, Double Blind, Randomized Chacko Research Network Placebo Controlled Phase III Trial.

Dr Raju Titus Risk Factors for Breast Cancer in India: INDOX Case-Control INDOX Cancer 585 Medical Oncology Chacko Study. Research Network

Dr Raju Titus INDOX Cancer 586 Medical Oncology Risk factors for colorectal cancer in India- Case-Control Study. Chacko Research Network

A Phase III, double-blind, placebo-controlled study of post- Innogene operative adjuvant concurrent chemo-radiotherapy with or 587 Dr. Subhashini John Radiotherapy Kalbiotech Pte. without nimotuzumab for stage III/IV head and neck squamous LTD, Singapore cell cancer

Phase I/II/III Pharmacokinetic and Outcome Study of Inspiration 588 Dr. Alok Srivastava Haematology Inspiration’s Recombinant Factor IX Product, IB1001, in Subjects Biopharmaceuticals with Hemophilia B

Study of Inspiration’s Recombinant Factor Inspiration 589 Dr. Alok Srivastava Haematology IX Product, IB1001, in Previously Treated Pediatric Subjects with Biopharmaceuticals Hemophilia B. , Inc Institut national de la santé et de la Evaluation of cellular and immune response in mice and patients 590 Ms. Ansu Abu Alex Haematology recherche médicale with acute promyelocytic leukemia treated with arsenic trioxide. / Indian Council of Medical Research

Storage of samples for Genome sequencing and Genotyping of Institute of Dr. Joy Sarojini Mycobacterium tuberculosis isolates from patients with Genomics and 591 Microbiology Michael extrapulmonary tuberculosis (EPTB) and their Immunological Integrative Biology, profile. CSIR, Delhi

A multi-center, prospective, open-label, clinical trial to assess the safety and the efficacy of a new intravenous immune globulin 592 Dr. Vikram Mathews Haematology Instituto Grifols, S.A (IGIV3I Grifols 10%) in patients with idiopathic (immune) thrombocytopenic purpura.

A multicentre, randomized, open label, two-period, two treatment, two-way crossover, bioequivalence study comparing Intas Capecitabine tablets 500 mg (Manufactured by Intas Pharmaceuticals 593 Dr. Subhashini John Radiotherapy pharmaceuticals Ltd., India) to the reference listed drug Ltd, & Roche XELODA® 500 mg tablets (Manufactured by Roche Pharma AG, Pharma , Gujarat Germany) in patients of locally advanced or metastatic breast cancer or metastatic colorectal cancer under fed condition.

Intas A multicentre pilot study to assess the safety and efficacy of IPL- Dr. George M. Gastrointestinal Pharmaceuticals 594 PO2 (Interferon alpha 2B) in the treatment of Hepatitis B and Chandy Sciences Ltd, & Roche Hepatitis C. Pharma, Gujarat A multicentre, randomized, open label, two-period, two treatment, two-way crossover, bioequivalence study comparing Intas Capecitabine tablets 500 mg (Manufactured by Intas Pharmaceuticals 595 Dr. Subhashini John Radiotherapy pharmaceuticals Ltd., India) to the reference listed drug Ltd, & Roche XELODA® 500 mg tablets (Manufactured by Roche Pharma AG, Pharma, Gujarat Germany) in patients of locally advanced or metastatic breast cancer or metastatic colorectal cancer under fed condition.

A prospective, non-comparative, open label, multi-center study to Intas Dr. Raju Titus evaluate safety and efficacy of Pegfilgrastim (IPL-PO5) for Pharmaceuticals 596 Medical Oncology Chacko prevention of Neutropenia in the patients receiving cancer Ltd, & Roche chemotherapy. Pharma, Gujarat

An Evaluation of Safety and Efficacy of recombinant Intas Dr. Chakko Korula erythropoietin (EPO) (IPL-PO3) in the treatment of anemia in Pharmaceuticals 597 Nephrology Jacob patients with chronic kidney disease (CKD). A prospective, non- Ltd, & Roche comparative, open label, multicenter study. Pharma, Gujarat

A pilot study to evaluate the feasibility and clinical efficacy of International Dr. Thomas Samuel 598 Radiation Therapy conventional chemoirradiation followed by brachytherapy Atomic Energy Ram versus IMRT chemoirradiation in cervical cancer. Agency, Vienna

Investigation on the use of Ferrous and Polymer Gel dosimetry International 599 Dr. Paul Ravindran Radiation Physics with optical readout system for quality assurance of intensity Atomic Energy modulated radiotherapy and radio surgery. Agency,Vienna

To investigate the relationship between end to end accuracy and 600 Dr. Paul Ravindran Radiotherapy International quality assurance extent and depth in radiotherapy. Atomic Energy Agency,Vienna

International Center for Genetic Engineering and Biotechnology New Delhi. / Supported 601 Dr. Ranjan Nanda Medicine Electronic nose to smell tuberculosis from breath VOCs by Bill and Melinda Gates Foundation and Canadian Grand Challenge Initiatives.

International National Pulse Polio evaluation phase II. Evaluation of AFP Community Health Clinical 602 Dr. Rema Devi Surveillance & Universal immunization program in India (2004- Medicine Epidemiology 2005): An India CLEN Program Evaluation Network study. Network

To describe epidemiological characteristics of infections caused by Salmonella enterica serotype typhi in patients attending study International centers in India with respective to their clinical syndrome, Clinical 603 Dr. Priscilla Rupali Medicine I antimicrobial susceptibility patterns, risk factors and serotype Epidemiology distribution and also to estimate the incidence of typhoid in the Network / US AID community.

International Prospective molecular Epidemiology study to monitor Dr. Balaji Health 604 Microbiology Carbapenem resistance rates of Enterobacteriaceae, Veeraraghavan Management Pseudomonas spp. and Acinetobacter spp. in India Associates, Inc Prospective Molecular study to monitor antibiotic resistance International pattern of gram positive and gram negative isolates & to evaluate Health 605 Dr. Balaji. V Microbiology the efficacy of Ceftaroline (5th generation cephalosporin) as well Management as avibactam – AstraZeneca program. Associates, Inc

International Phenotypic and molecular characterization of the β-lactamases in Health 606 Dr. Balaji. V Microbiology Enterobacteriaceae –SMART program. Management Associates, USA

International Junior Research Grant Effect of 4 – Aminopyridine on pacemaker currents in rabbits 607 Dr. Anand Bhaskar Physiology Awarded by Sinoatrial node. Physiological Society, London

International Dr. George M. Genotyping or orientia tsutsugamushi from patients with scrub 608 IDTRC Society of Varghese typhus. Infectious Diseases

A randomized controlled trial to evaluate the safety and International Gastrointestinal 609 Dr. Gagandeep Kang immunogenicity of a scaled-up lot of the third generation, killed Vaccine Institute, Sciences whole cell oral cholera vaccine. Korea.

Randomized, blinded, controlled age-descending study to assess International safety and immunogenicity of Vi-DT typhoid conjugate vaccine in 610 Dr. Gagandeep Kang Microbiology Vaccine Institute, comparison to the licensed Vi polysaccharide among healthy Korea. Indian volunteers aged two years and above. Quality of life and attitudes of HIV `patients in Southeran India towards their use of Highly Active Anti-Retroviral Treatment Iowa University, 611 Dr. Dilip Mathai Medicine I (HAART) and its associated Cardiovascular Risk and Body-fat USA abnormalities.

Efficacy and safety of hydroxychloroquiine in treatment of Ipca Laboratories 612 Dr. Nihal Thomas Endocrinology hydroxychloroquine in treatment of type II diabetes mellitus A Ltd double blind randomized comparison with pioglitazone.

Efficacy and safety of hydroxychloroquine and methotrexate IPCA Laboratories 613 Dr. Sathish Kumar Child Health combination in treatment of juvenile rheumatoid arthritis: a Ltd. Mumbai double blind, randomized, comparison with methotrexate alone.

Dr. B.S. Efficacy of the probiotic bacterial cocktail Bifilac in experimental Jhaver Res. 614 Gastroenterology Ramakrishna colitis. Foundation Ltd.

Dr. B.S. A pilot study of bifilac in the treatment of mild to moderate Jhaver Research 615 Gastroenterology Ramakrishna ulcerative colitis. Foundation

Association between introduction of Haemophilus influenzae Dr. Valsan Philip John Hopkins 616 Child Health type b (Hib) vaccine and admissions due to Hib meningitis at Verghese University CMC, Vellore, India.

Risk factors associated with severity and poor outcomes in acute Dr. Asha Mary respiratory infections associated with influenza infection John Hopkins 617 Clinical Virology Abraham compared to non-influenza acute respiratory infections among University hospitalized children in Southern India. Dr. Sara Johns Hopkins 618 LCECU Health care utilization survey in Vellore, India Bhattacharji University

Multicentric study in a paediatric population from a rural Dr. Binu Susan Johns Hopkins 619 Pharmacology background to assess recent exposure (both documented and Mathew University non-documented) to commonly prescribed antibiotics.

Prospective evaluation of rapid antigen detection tests for Dr. Anand Streptococcus pneumoniae, Respiratory Syncytial Virus (RSV), Johns Hopkins 620 Medicine I Manoharan Legionella pneumophila and influenza in community acquired University pneumonia (CAP).

Dr. Sara Risk factors and consequences of S. Pneumoniae colonization in Johns Hopkins 621 LCECU Bhattacharji the nasopharynx of infants in Vellore. University

Johns Hopkins Dr. Abraham Obstetrics and University & 622 Molecular markers of cervical neoplasia. Peedicayil Gynaecology National Cancer Institute

Johns Hopkins University/ Indian Cigarette smoking and invasive pneumococcal disease – a case 623 Dr. Kurien Thomas Medicine II Clinical control study Vellore, India. Epidemiology Network

Nasal carriage study to estimate the proportion of children who 624 Dr. Anuradha Bose Community Health Johns Hopkins are carrying Hib in the study areas. University/ Indian Council of Medical Research

A Randomized open-label, multicenter, phase 3 study of Epoetin Dr. Raju Titus Alfa plus standard supportive care versus standard supportive Johnson & Johnson 625 Medical Oncology Chacko care in Anemic patients with Metastatic breast cancer receiving Limited, India first-line standard chemotherapy.

A Randomized, Double-Blind, Placebo Controlled, Parallel Group Johnson & Johnson 626 Dr. D.J. Christopher Pulmonary Medicine Study to Investigate the Effect of JNJ-18054478 in Subjects with Limited, India Asthma.

Protocol 676070DIA2001. A randomized, double-blind, multiple dose study in subjects with diabetic nephropathy to evaluate the Johnson & Johnson 627 Dr. Nihal Thomas Endocrinology effect of RWJ-676070 on albuminuria, when added to Limited, India angiotensin-converting enzyme inhibitor and / or antiotensin II receptor blocker treatment.

A Randomized, multicenter, Double-Blind, Parallel, Placebo- Johnson & Johnson Controlled, Multicenter Study of the Effects of JNJ-28431754 on Pharmaceutical 628 Dr. Nihal Thomas Endocrinology Cardiovascular Outcomes in Adult Subjects With Type 2 Diabetes Research & Mellitus ( The CANVAS Trial: CANagliflozin Cardio Vascular Development, L.L.C Assessment Study)

Karolinska 629 Dr. K. Senthil Vasan Endocrinology Study of Immunogenetics of type 1 diabetes in South India. Hospital, Sweden

Study of prevalence of diabetes associated antibodies and specific 630 Dr. K. Senthil Vasan Endocrinology Karolinska haplotypes in subjects with Gestational diabetes in South India and predict the future risk for diabetes. Hospital, Sweden

School education including injury prevention, life skills and Kathrn Wasserman Dr. Sara 631 LCECU health in government and government aided middle schools in Davis Projects for Bhattacharji, Vellore Town. Peace, USA

632 Dr. Rohin Mittal Surgery Use of novel seton device in the treatment of fistula in ano. Keighlycolo Limited

A pivotal trial to determine the efficacy and safety of AP23573 Kendle India 633 Dr. Subhashini John Radiotherapy when administered as maintenance therapy to patients with Private Ltd. metastatic soft-tissue or bone sarcomas.

Study of mitochondrial mutations in Fibromyalgia syndromes Lady Tata 634 Dr. Sumita Danda Clinical Genetics Unit (FMS) Memorial Grant

Evaluation of the Role of Lenalidomide in Decreasing Cell Lady Tata 635 Dr. Vikram Mathews Haematology Adhesion Mediated Innate Drug Resistance and Enhancing Memorial Trust Immunologic Response in Acute Myeloid Leukemia.

Dr. Poonkuzhali Identification of novel nuclear receptor drug targets using siRNA Lady Tata 636 Haematology Balasubramanian screen in myeloid leukemias Memorial Trust

Molecular mechanisms involved in the enhanced efficacy of neo- Lady Tata 637 Dr. Saikat Das Radiation Oncology adjuvant chemotherapy and ultra-fractionated low dose Memorial Trust radiation in carcinoma cervix: A translational study.

638 Dr. Subhashini John Radiotherapy A two – way crossover experimental evaluation of relative Lambda bioavailabilties of two formulations of Temozolomide 250 Mg Therapeutic capsules in adult human male and/or female patients under Research Limited fasting conditions (Trial No. 228-07).

Protocol No. 16853-D – An open-label randomized phase II study of two different dosing regimens of Capecitabine in combination with intravenous docetaxel (Q3W) in patients with locally Dr. Raju Titus 639 Medical Oncology advanced and / or Metastatic breast cancer. & Protocol LaRoche Inc Chacko No.16853-RG, version dated 12 August 2005: Roche sample respiratory research project No. 1l6853 RG for use in conjunction with protocol No.16853D.

Dr. B. Paul Life Sciences 640 Radiation Oncology Development of a system for 3 D Image guided Radiotherapy. Ravindran Research Board

Life Sciences Investigation on the use of Gel dosimeter with optical readout Research Board, Dr. B. Paul 641 Radiation Oncology system as a tool for quality assurance of Intensity Modulated Defense Research & Ravindran Radiotherapy. Development Organisation

Lifespan/Tufts/Bro Dr. A. Sitara Swarna Gastrointestinal Immune response to Cryptosporidial Antigens in HIV infected 642 wn Center for AIDS Rao Ajjampur Sciences adults in South India. Research)

Study Code – LRP/CRU/GEN/001/III/01 – Comparison of once Gastrointestinal daily Mesalamine (Adult and Paediatric Drug Product) developed 643 B.S. Ramakrishna Lupin Ltd. Sciences by Lupin Limited to Asacol® tablets and Lialda® tablets in the treatment of mild to moderate ulcerative colitis. M/s Siemens Dr. Akhila Application of smartphone photography and 3G wireless Technology Service 644 General Surgery Sridharamurthy technology in free flap Monitoring: A prospective study. Pvt. Limited , Bangalore

Open, Randomized clinical study to evaluate efficacy and safety of Macleods 645 Dr. Indira Agarwal Child Health II Deflazacort versus Prednisolone in Idiopathic Nephrotic Phamaecuticals syndrome.

Evaluation of efficacy and tolerability of Deflazacort versus Macleods 646 Dr. D.J. Christopher Pulmonary Medicine Prednisolone in the treatment of OPD exacerbation of bronchial Pharmaceuticals asthma.

An Open, Comparative, Randomized Clinical Trial to Evaluate the Macleods Obstetrics and 647 Dr. Ruby Jose Efficacy and Safety of Atosiban Acetate versus Nifedipine in the Pharmaceuticals Gynaecology Treatment of Preterm Labour. Limited

March of Dimes Targeted delivery of human coagulation factor VII in myeloid Foundation, USA- Dr. Jayandharan G 648 Haematology compartment of hematopoietic stem cells for gene therapy of Basil O’ Connor Rao hemophilia B by Adeno-associated virus (AAV) vectors. Starter research Scholar Award

Prospective, Open-Label, Multi-Center, Phase III Clinical Study To Max Neeman Investigate The Efficacy And Safety Of Human Factor VWF/VIII International, on 649 Dr. Alok Srivastava Haematology Concentrate (Wilate®) In Subjects With Inherited Type 3 Von behalf of Willebrand Disease (VWD) Who Undergo Major Surgical Octapharma AG Procedures. A collaborative research project supported by the McGill India 650 Dr. Peter Daley IDTRC & Med - I Strategic Research Initiative (MISRI). Subtitle: Parallel evaluation McGill University of New Diagnostics for Tuberculosis in India.

Rural Unit for Health 651 Dr. K.R. John and Social Affairs - Assessing patient cost due to Tuberculosis. McGill University RUHSA

McGill University, A low cost, multiplexed, point-of-care test for extra-pulmonary 652 Dr. DJ Christopher Pulmonary Medicine Canada & Grand tuberculosis. Challenges Canada

Clinical impact of point-of-care use of Xpert MTB/RIF and McGill University, 653 Dr DJ Christopher Pulmonary Medicine TrueNAT MTB molecular tests for the diagnosis of tuberculosis in Canada & Grand a high burden setting Challenges Canada

Evaluation of efficacy and tolerability of Deflazacort versus Mcleods 654 Dr. D.J. Christopher Pulmonary Medicine prednisolone in the treatment of OPD exacerbation in the Pharmaceuticals treatment of bronchial asthma.

Determination of baseline MIC distribution of arbekacin, 655 Dr. Balaji V Clinical Microbiology cefminox, fosfomycin and biapenem against clinical isolates of Meiji, Japan E.coli, K. pneumoniae, P.aeruginosa and A.baumannii

A prospective, open label, multi-centric, observational registry Merck Ltd, India, 656 Dr. Sunil Chandy Cardiology for heart failure patients across India. CM Care division Establishing an adult vaccination clinic at Christian Medical Merck 657 Dr. Kurien Thomas Medicine II College Vellore. Pharmaceuticals

Merck 658 Dr. V. Balaji Microbiology Study for Monitoring Antimicrobial Resistance Trends – SMART. Pharmaceuticals

A Phase III, double-blind, placebo controlled randomized trial to determine the efficacy and safety of a dose range of 50 to 1000 mg/day of safinamide, as an add-on therapy, in subjects with Dr. Mathew 659 Neurological Sciences idiopathic Parkinson’s Disease with motor fluctuations, treated Merck Sereno Alexander with a stable dose of levodopa and who may be receiving concomitant treatment with stable doses of a dopamine agonist, an anticholinergic and/or amantadine.

Protocol No. 27919. A phase III double blind placebo controlled randomized trial to determine the efficacy and safety of a dose range of 50 to 100 g/day of Safinamide, as add-on therapy, in Dr. Mathew 660 Neurology subjects with idiopathic Parkinson’s disease with motor Merck Serono Alexander fluctuations, treated with a stable dose of levo-dopa and who may be receiving concomitant treatment with stable doses of a dopamine agonist, an anticholinergic and / or amantadine.

A phase III, randomized, double-blind, placebo-controlled, multi- Dr. Mathew Merck Serono 661 Neurological Sciences center clinical trial of oral Cladribine in subjects with a first Alexander International clinical event, at high risk of converting to Multiple Sclerosis.

Dr. Mathew Merck Serono 662 Neurological Sciences A phase III, randomized, double-blind, placebo-controlled, multi- Alexander center clinical trial of oral Cladribine in subjects with a first International clinical event, at high risk of converting to Multiple Sclerosis.

Medication Use Patterns, Treatment Satisfaction, and Inadequate Control of Osteoporosis Study (MUSIC-OS): an Asia Pacific study Merck Sharp & 663 Dr. Thomas Paul Endocrinology of postmenopausal women treated for osteoporosis in clinical Dohme Corp. practice

A Phase IIb, Partially-Blinded, Randomized, Active Comparator- Controlled Study to Evaluate the Dr. Rikki Rorima Pharmacokinetics/Pharmacodynamics, Safety, and Tolerability of Merck Sharp and 664 Child Health John Fosaprepitant in Pediatric Patients for the Prevention of Dohme Corp Chemotherapy-Induced Nausea and Vomiting (CINV) Associated with Emetogenic Chemotherapy.

Dr. Anand Merck Sharpe 665 Medicine I In-vitro a newer Carbapenem – Ertapenam. Manoharan Dhomme (MSD)

A Phase 2 Randomized double blinded Placebo and - active comparator controlled study to evaluate the safety and efficacy of 666 Dr. Nihal Thomas Endocrinology Metabolex Inc MBX-102/ JNJ-39659100 in patient with type 2 diabetes mellitus with inadequate control on Metformin monotherapy.

MGR University 667 Dr. MJ Paul Endocrine Surgery Role of magnesium in post thyroidectomy hypocalcemia. Grant

A Phase 3 open-label study to determine the long-term safety and Millenium Gastrointestinal 668 Dr. Ashok Chacko efficacy of MLN0002 in patients with ulcerative colitis Crohn’s Pharmaceuticals, Sciences disease. USA A phase 3, open-label study to determine the long-term safety Millenium Gastrointestinal 669 Dr. Ashok Chacko and efficacy of MLN0002 in patients with ulcerative colitis and Pharmaceuticals, Sciences Crohn’s disease. USA

A Phase 3, randomized, placebo controlled, blinded, multicenter Millenium Gastrointestinal study of the induction and maintenance of clinical response and 670 Dr. Ashok Chacko Pharmaceuticals, Sciences remission by MLN0002 in patients with moderate to severe USA ulcerative colitis.

A phase 3, randomized, placebo controlled, blinded, multicenter Millenium Gastrointestinal study of the induction and maintenance of clinical response and 671 Dr. Ashok Chacko Pharmaceuticals, Sciences remission by MLN0002 in patients with moderate to ulcerative USA colitis.

Mochida Memorial Foundation for Medical and Pharmaceutical Research External Dr. Debashish Clinical Immunology Pilot study for genome wide scanning (GWS) of Indian patients Collaborator / 672 Danda & Rheumatology with Takayasu arteritis. National Institute of Biomedical Genomics Kalyani West Bengal / Department of Biotechnology

The Rishi Valley Vascular Disease Project – an observational Monash University, 673 Dr. Nihal Thomas Endocrinology public health project in vascular health in a rural South Indian Australia community living below the poverty line, with long-term follow- up.

Controlling hypertension in rural India – overcoming the barriers Monash University, 674 Dr. Nihal Thomas Endocrinology to diagnosis and effective treatment. Australia

Monash University, Controlling Hypertension In Rural India – Overcoming the 675 Dr. Nihal Thomas Endocrinology Australia & NHMR barriers to diagnosis and effective treatment Australia

Muscular Dr. Anup Gastrointestinal Role of nitric oxide and mitochondrial biogenesis in development 676 Dystrophy Ramachandran Sciences of muscle damage in Duchenne muscular dystrophy. Association

Nandha College of Role of adenylate cyclase, phosphodiesterase and microfilament 677 Dr. Manoj G Tyagi Pharmacology Pharmacy and in epilepsy. Research Institute

National AIDS Control Randomized clinical trial comparing Nevirapine (NVP) containing Organisation / regimen to Efavirenz (EFZ) containing regimen in South Indian 678 Dr. Dilip Mathai Medicine I National AIDS HIV positive patients on Antiretroviral and Antituberculosis Research Institute / therapy. Tuberculosis Resea rch Center

Dr. Satyajit Mayor & National Centre for 679 Biochemistry Effect of hepcidin on iron transport molecules. Dr. Molly Jacob Biological Sciences Dr. Tessy T. Generation of novel signal transduction based therapies targeting National Centre for 680 Maliekal & Dr. Geeta Neurological Sciences gliomas. Biological Sciences Chacko

Nanobiotechnology in anticancer therapy and development of National Centre for 681 Dr. Subhashini John Radiotherapy II nanoparticle based drug delivery system of Temozolomide for Biological Sciences central nervous system tumors.

Dr. Anup Gastrointestinal Placental mitochondroia and liver damage in acute fatty liver of National Centre for 682 Ramachandran Sciences pregnancy. Biological Sciences

National Centre for Biological Sciences Dr. Mathew A Clinico-Genetic study of Autosomal Dominant Spino-cerebellar 683 Neurological Sciences & CMC Alexander Ataxias in the Indian population. Collaborative project

An international randomized study evaluating the efficacy and National safety of fondaparinux sodium versus control therapy and Coordination office Dr. Sunil Thomas 684 Cardiology glucose-insulin-potassium infusion versus control in a broad for OASIS, St. John’s Chandy range of patients with ST segment elevation acute myocardial Medical College, infarction (OASIS-6 STEMI). Bangalore.

National Health and A randomized blinded placebo controlled trial of hydrocortisone Medical Research 685 Dr. J.V. Peter Medical ICU in critically ill patients with septic shock Council Australia (NIHMRC) National Health and A multi-centre, randomized, double-blind, placebo controlled Medical Research clinical trial examining the efficacy and safety of low-dose aspirin Council Clinical 686 Dr. Edwin Stephen Surgery Unit II after initiated anticoagulation to prevent recurrent venous Trials Centre, The thromboembolism. University of Sydney

National Health and Family-Led RehabiliTaTion after stroke in India ( The ATTEND- 687 Dr. Sanjith Aaron Neurology Medical Research Trial) Council of Australia

National Health and Safety and efficacy of pentoxifylline in the treatment of Dr. Atanu Kumar Medical Research 688 Neonatology necrotizing enterocolitis in preterm neonates – A randomized, Jana Council, Canberra, placebo controlled pilot trial. Australia

National Health and A pilot study on measurement of novel urinary bio-markers of Medical Research 689 Dr. Anand Zachariah Medicine I acute kidney injury caused by nephrotoxins- CMC study focused Council, (NHMRC), on Cleistanthus Collinus. Australia

Gastrointestinal National Institute 690 Dr. Gagandeep Kang Caliciviral infection and disease in Southern India. Sciences of Health

Dr. Abraham Obstetrics and National Institute 691 HPV infection and cervical neoplasia in HIV positive women. Peedicayil Gynaecology of Health

692 Dr. Rita Isaac Rural Unit for Health Impact of intestinal dysfunction on antiretroviral therapy in National Institute and Social Affairs - India. of Health RUHSA

Dr. Roy Thomas Neurological Sciences National Institute 693 Pediatric Epilepsy in India. Daniel & et al of Health

Dr. Patrica Hibberd Gastrointestinal National Institute 694 Probiotics for cryptosporidial diarrhea and growth faltering. Dr. Gagandeep Kang Sciences of health

Gastrointestinal National Institute 695 Dr. Gagandeep Kang Probiotics for infectious diarrhea in children in South India. Sciences of Health

Obstetrics and Tracking and monitoring care to HIV positive or high risk National Institute 696 Dr. Jessie Lionel Gynaecology mothers and their children. of Health

Gastrointestinal Transmission dynamics of cryptosporidial infections in children National Institute 697 Dr. Rajiv Sarkar Sciences in a semi-urban slum in south India. of Health

Gastrointestinal National Institute 698 Dr. Gagandeep Kang Transmission dynamics of cryptosporidial infections in India. Sciences of Health

Gastrointestinal National Institute 699 Dr. Gagandeep Kang Tufts-CMC framework program for Global Health Innovation. Sciences of Health

Metabolic Characteristics of Lean Diabetes in Rural and Semi- National Institute 700 Dr. Nihal Thomas Endocrinology Urban India. of Health – Fogarty National Institute Ms. Aarthi Sexual partnership concurrency and HIV infection in Southern of Health- Fogarty 701 Dermatology Kandasamy India. International Center

Scientist, National Characterizing the metabolic efficiency of neo-hepatocytes National Institute Dr. Pramod Institute of 702 generated from monocytes and comparing it with human of Immunology, Upadhyay Immunology, New hepatocytes. New Delhi Delhi

National Institute Gastrointestinal Intestinal and milk glycan expression in restriction of neonatal 703 Dr. Gagandeep Kang of Immunology, Sciences infection. New Delhi

Dr. Honorine Ward Gastrointestinal Immune responses to cryptosporidiosis in a birth cohort of National Institutes 704 & Dr. Gagandeep Sciences children in south India. of Health Kang

Dr. Sitara Swarna Gastrointestinal Innate Immune and inflammatory gene polymorphisms in National Institutes 705 Rao Ajjampur Sciences cryptosporidiosis in India. of Health

Rural Unit for Health Impact of intestinal dysfunction on antiretroviral therapy in National Institutes 706 Dr. Rita Isaac and Social Affairs - India. of Health, USA RUHSA

Validation of Microscopic Observational Broth-Drug National 707 Dr. K.R. John Community Health Susceptibility Assay (MODS) for rapid low-cost culture and Tuberculosis susceptibility of Mycobacterium tuberculosis among HIV positive control and negative TB suspects in South India. Dr. K.R. John, Professor, Community Health, Dr. Peter Daley, Dr. Dilip Mathai, Medicine I, Dr. Joy Sarojini, Microbiology.

National Dr. P. Kumar & Repeat zonal level tuberculin surveys for estimating Annual risk 708 Community Health Tuberculosis Dr. K. R. John of tuberculosis infection (ARTI). Institute, Bangalore

National University Search for new biomarkers and therapeutic targets in acute of Singapore and 709 Dr. Vikram Mathews Haematology promyelocytic leukemia: A collaboration between Christian Indian Council of Medical College and National University of Singapore. Medical Research

A prospective observation study of clinical outcome (case National Vector 710 Dr. Dilip Mathai IDTRC fatality) among patients diagnosed to have malaria at various Borne Disease strata of health care facilities in Bilaspur District, Chhattisgarh. Control Program

A multicenter, open-label, randomized, phase 2 study to evaluate Dr. Raju Titus the efficacy and safety of NKTR-102 (PEG-Irinotecan) versus Nektar 711 Medical Oncology Chacko Irinotecan in patients with second-line, irinotecan-naïve, KRAS- therapeutics, USA Mutant, Metastatic Colorectal cancer (mCRC)

A prospective randomized controlled single center study of 712 Dr. Bobby Chacko Nephrology mycophenolate sodium (RenforR) in patients with IgA Nicholas Piramal Nephropathy.

Gastrointestinal 713 Dr. Elliott Garber Molecular characterization and geospatial analysis of NIH Fogarty and Dr. Gagandeep Sciences Cryptosporidium isolates from Humans and Cattle in Southern International Kang India. Center)

NIH Fogarty Chalamydia trachomatis: A study of the prevalence of disease in Obstetrics and International 714 Dr. Annie Regi pregnant women and rates of transmission to the infant in Gynaecology Clinical Research Vellore, India. Project

Metabolic Characteristics of Lean Diabetes in Rural and Semi- 715 Dr. Nihal Thomas Endocrinology NIH-Fogarty Urban India.

To study the impact of a Community Based Rehabilitation (CBR) Rehabilitation Northumbria 716 S. Guru Nagarajan programme on the quality of life of people with disabilities Institute University, U.K residing in urban slums, South India.

A prospective study on the etiology, risk factors, antibiotic susceptibility profile and outcome of bacterial sepsis among Norway India children (up to ≤5 years) hospitalized into the Sick Newborn Care Partnership 717 Dr. Dilip Mathai IDTRC Units (SNCU) and pediatric ICU at Alwar district hospital, Initiative (NIPI), Rajasthan, supported by the Norway India Partnership Initiative Govt. of India (NIPI) in India: Focus on sepsis prevention and treatment

Gastrointestinal Identification of biomarkers for the prediction and early Nottingham 718 Dr. C.E. Eapen Sciences diagnosis of anti-tuberculosis drug-induced liver injury. University

CAMN107E2401Extending molecular responses with Nilotinib in Novartis Healthcare 719 Dr. Alok Srivastava Haematology newly diagnosed chronic myeloid leukemia (CML) patients in Private Limited chronic phase (ENESTxtnd). A 12 week treatment, randomized, double blind, double dummy, study to assess the superiority of Indacaterol (150 µg o.d.) via a Novartis Healthcare 720 Dr. D.J. Christopher Pulmonary Medicine SDDPI in patients with moderate to severe COPD, using Pvt. Ltd Salameterol (50 µg b.i.d) as an active comparator delivered via a DISKUS inhaler.

A 24-month, multi-center, open-label, randomized, controlled Dr. Santosh trial to investigate efficacy, safety and evolution of cardiovascular Novartis Healthcare 721 Nephrology Varghese parameters in de novo renal transplant recipients after early Pvt. Ltd calcineurin inhibitor to Everolimus conversion.

A 26-week treatment, multicenter, randomized, double blind, double dummy, placebo controlled, parallel group study to assess Novartis Healthcare 722 Dr. D. J. Christopher Pulmonary Medicine the efficacy and safety of indacaterol (150ug o.d.) in patients with Pvt. Ltd chronic obstructive pulmonary disease, using salmeterol (50 ug bi.d.) as an active control.

A Double-blind, randomized, placebo-controlled multicenter trial Dr. Santosh Novartis Healthcare 723 Nephrology to compare the phosphate lowering efficacy of different doses of Varghese Pvt. Ltd SBR759 to placebo

A Long-term, Multi-centre, International, Randomized Double- Novartis Healthcare 724 Dr. Nihal Thomas Endocrinology blind, Placebo controlled Trial to Determine Liraglutide Effects Pvt. Ltd on Cardiovascular Events

A long-term, randomized, double-blind, placebo-controlled, Novartis Healthcare 725 Dr. Nihal Thomas Endocrinology Multinational, multi-centre trial to evaluate cardiovascular and Pvt. Ltd other long-term outcomes with semaglutide in subjects with type 2 diabetes.

A multicenter, double-blind, randomized, active controlled study to compare the effect of 52 weeks treatment with LAF237 50 mg Novartis Healthcare 726 Dr. Nihal Thomas Endocrinology bid to Gliclazinde upto 320 mg daily as Add-on therapy in Pvt. Ltd patients with type 2 diabetes inadequately controlled with Metformin monotherapy.

A multi-center, randomized, double-blind study to evaluate the efficacy and long-term safety of vildagliptin modified release Novartis Healthcare 727 Dr. Nihal Thomas Endocrinology (MR) as add-on therapy to metformin in patients with type 2 Pvt. Ltd diabetes.

A Multi-center, single arm, Phase II Study of Adjuvant Imatinib Dr. Raju Titus (Glivec) in Patients following the resection of primary Novartis Healthcare 728 Medical Oncology Chacko Gastrointestinal Stormal Tumor (GIST) as per Protocol Pvt. Ltd No:CST1571BIC08

A phase III multicenter, randomized study of oral LDK378 versus Dr. Raju Titus standard chemotherapy in previously untreated adult patients Novartis Healthcare 729 Medical Oncology Chacko with ALK rearranged (ALK positive), stage IIIB or IV, non- Pvt. Ltd squamous non-small cell lung cancer

A Phase III Open-Label Extension study to Assess the Safety and Efficacy of Tobramycin Inhalation Powder after Manufacturing Novartis Healthcare 730 Dr. D.J. Christopher Pulmonary Medicine Process Modification (T1pnew) in Cystic Fibrosis (CF) subjects Pvt. Ltd who Completed Participation in Study CTBM100C2303. A phase III open-label extension study to assess the safety and efficacy of tobramycin inhalation powder after manufacturing Novartis Healthcare 731 Dr. DJ Christopher Pulmonary Medicine process modification (TIPnew) in cystic fibrosis (CF) patients Pvt. Ltd who completed participation in study CTBM100C2303E1.

A phase IIIb multicenter, 52 week treatment, randomized, blinded, double dummy, parallel group efficacy study comparing Novartis Healthcare 732 Dr. D.J. Christopher Pulmonary Medicine the effect of inhaled indacaterol 150 µg o.d. vs inhaled tiotropium Pvt. Ltd 18 µg o.d. on lung function, rate of exacerbations and related outcomes in patients with COPD.

A placebo and active controlled study to assess the long - term safety of once daily QVA149 for 52 weeks in Chronic Obstructive Novartis Healthcare 733 Dr DJ Christopher Pulmonary Medicine Pulmonary Disease (COPD) patients with moderate to severe Pvt. Ltd airflow limitation”.

A randomized phase III study of imatinib dose optimization Novartis Healthcare 734 Dr. Alok Srivastava Haematology compared with nilotinib in patients with chronic myelogenous Pvt. Ltd leukemia and suboptimal response to standard-dose imatinib.

A randomized, double- blind, double-dummy, 4-week treatment, parallel-group study to evaluate the efficacy and safety of two Novartis Healthcare 735 Dr DJ Christopher Pulmonary Medicine doses of mometasone furoate delivered via Concept1 or Pvt. Ltd Twisthaler® in adult and adolescent patients persistent asthma.

A randomized, double-blind, double-dummy, 4-week treatment, Novartis Healthcare 736 Dr. DJ Christopher Pulmonary Medicine parallel- group study to evaluate the efficacy and safety of two doses of mometasone furoate delivered via Concept1 or Pvt. Ltd Twisthaler® in adult and Adolescent patients with persistent asthma.

Endocrinology, A randomized, double-blind, multicenter, phase III study to Novartis Healthcare 737 Dr. Asha H. S Diabetes and evaluate the efficacy and safety of pasireotide LAR in patients Pvt. Ltd Metabolism with Cushing’s disease.

An international multicenter, non-randomized, open-labeled study to evaluate the efficacy of lower dose dexamethasone / Novartis Healthcare 738 Dr. Alok Srivastava Haematology thalidomide and higher frequency zometa in the treatment of Pvt. Ltd previously untreated patients with multiple myeloma.

Gastrointestinal An open label, response adaptive studyof telbivudine in adults Novartis Healthcare 739 Dr. C.E. Eapen Sciences with HBeAg positive compensated chronic hepatitis B. Pvt. Ltd

An Open-Label, Multi-Center Phase II Study to Evaluate Dr. Raju Titus Novartis Healthcare 740 Medical Oncology Everolimus as Monotherapy Treatment for Patients with Chacko Pvt. Ltd Metastatic Recurrent and/or Unresectable Renal Cell Carcinoma.

CTBM100C2303: A Randomized, Double-Blind, Placebo- Controlled, Multi-Center Phase III Study in Cystic Fibrosis (CF) Novartis Healthcare 741 Dr. DJ Christopher Pulmonary Medicine Subjects to Assess Efficacy, Safety and Pharmacokinetics of Pvt. Ltd Tobramycin Inhalation Powder from a Modified Manufacturing Process (TIPnew).

EU-CORESM – European CUBICIN® outcome registry and Dr. George M. Novartis Healthcare 742 IDTRC experience for the treatment of serious Gram positive infections: Varghese Pvt. Ltd A retrospective post marketing surveillance of Daptomycin. NN 1998-1616 – Inhaled preprandial human insulin with the AERxR iDMS versus subcutaneous injected insulin aspart in Novartis Healthcare 743 Dr. Nihal Thomas Endocrinology subjects with diabetes and asthma: a 52-week, open-label, Pvt. Ltd multinational, randomized, parallel trial to investigate long-term safety.

NN 1998-1617 – Inhaled preprandial human insulin with the AERxR iDMS versus subcutaneous injected insulin aspart in Novartis Healthcare 744 Dr. Nihal Thomas Endocrinology subjects with diabetes and chronic obstructive pulmonary Pvt. Ltd disease: a 52-week, open-label, multicentre, randomized, parallel trial to investigate long-term safety.

NN1250-3668: A 26 week randomized, controlled, open label, multicenter, multinational, three-arm, treat to target trial comparing efficacy and safety of three different dosing regimens Novartis Healthcare 745 Dr. Nihal Thomas Endocrinology of either soluble insulin basal analogue (SIBA) or insulin glargine Pvt. Ltd with or without combination with OAD treatment, in subjects with type 2 diabetes mellitus.

Trial ID NN1998-1682. Inhaled pre-prandial human insulin with the AERx iDMS plus glimepiride versus rosiglitazone plus Novartis Healthcare 746 Dr. Nihal Thomas Endocrinology glimepiride in type 2 diabetes: a 26-week, open-label, Pvt. Ltd multicentre, randomized, parallel trial to investigate efficacy and safety.

Glomerular Research And Clinical Experiments- Multicentre Dr. Suceena 747 Nephrology Randomized Controlled Trial on Pharmacokinetics of Enteric Novartis India Alexander Coated Mycophenolate Sodium in Lupus Nephritis Efficacy and Safety of NNC 0078-0000-0007 in Treatment of 748 Dr. Alok Srivastava Haematology Acute Bleeding Episodes in Patients with Congenital Novo Nordisk Haemophilia and Inhibitors

Insulin detemir in Type 1 subjects with diabetes – DETEMIR Novo Nordisk, 749 Dr. Nihal Thomas Endocrinology study. Denmark

A 16 week randomized, open labeled, four armed, treat to target, parallel-group trial, comparing SIBA-D once daily, SIBA-E once daily, SIBA-D Monday, Wednesday and Friday, and Insulin Novo Nordisk India 750 Dr. Nihal Thomas Endocrinology glargine once daily, all in combination with Metformin in subjects Pvt. Ltd. with type 2 Diabetes failing on OAD treatment. NovoNordisk India Pvt. Ltd.

A multi-centred prospective, double-blind, randomized, placebo- controlled dose finding study of the efficacy and safety of 2 target NV Organon, 751 Dr. Prathap Tharyan Psychiatry II doses of Org 34517 used as adjunctive therapy in subjects with Netherlands psychotic major depression (major depressive episode, severe, with psychotic features).

A prospective, controlled, randomized, cross-over study investigating the pharmacokinetic properties, surrogate efficacy 752 Dr. Alok Srivastava Haematology Octapharma and safety of Octafibrin compared to Haemocomplettan® P/ RiaSTAPTM in subjects with congenital fibrinogen deficiency

Effect of proprietary novel chemical entity OCID 4681-S-01 on Orchid chemicals 753 Dr. Shaji RV Haematology sickle cell disease and normal human erythroid cells in primary and culture. pharmaceuticals Ltd

Ovation Safety and efficacy of Melperone in the treatment of patients with 754 Dr. Sanjith Aaron Neurology Pharmaceuticals, psychosis associated with Parkinson’s disease OV – 1003. USA

Community Health & Enzyme linked immunospot method for diagnosis of tuberculosis 755 Dr. Anuradha Bose Oxford University Child Health in children.

A Multicenter, Open-label, Randomized, Phase II/III study to evaluate the safety and efficacy of combretastatin A-4 phosphate Dr. Raju Titus 756 Medical Oncology in combination with paclitaxel and carboplatin in comparison OXiGENE, Inc. Chacko with paclitaxel and carboplatin alone in the treatment against anaplastic thyroid carcinoma.

A Randomized Controlled Trial to compare the Efficacy of Dr. Swasti Panacea Biotech , 757 Child Health Mycophenolate Mofetil versus Cyclophosphamide for Induction Chaturvedi Roche, New Delhi Treatment of Lupus Nephritis in Children

Dr. Chakko Korula Evaluation of efficacy and tolerability of tacrolimus in patients of Panacea Biotech , 758 Nephrology Jacob renal transplantation. Roche, New Delhi

Open-labelled randomized multicentric comparative study to evaluate the immunogenicity and reactogenicity of Easy four TM Dr. Leni Grace Panacea Biotech , 759 Child Health I (DTWP-Haemophilus influenzae B vaccine, Panacea Biotec Ltd) Mathew Roche, New Delhi with Tetract-Hib (DTWP – Haemophilus influenzae B vaccine, Aventis Pasteur) in infants. Transplant Immune Monitoring Studies - I: A pilot study to assess Panacea Biotech , 760 Dr. T.S. Vijayakumar Nephrology correlation of pre transplant anti donor cellular immunity with Roche, New Delhi post transplant outcome in live related renal allograft recipients

Partly supported by Study of single nucleotide polymorphisms (SNPs) at genes a CSIR funded Clinical Immunology involved in innate immune system with special reference to 761 Dr. Ruchika Goel project grant to Dr and Rheumatology recent genome wide association studies, in Takayasu Arteritis Thangaraj K from (TA). CCMB, Hyderabad

A Randomized, double-blinded, placebo-controlled, dose-ranging 762 Dr. Indira Agarwal Child Health PDL Biopharma study of cardene® I.V. in pediatric subjects with hypertension.

12-week, randomized, double blind, double-dummy, placebo- Dr. Dr. Antony controlled, parallel-group multicenter trial to evaluate the 763 Urology I Pfizer Ltd., Mumbai Devasia efficacy and safety of Fesoterodine in comparison to Tolterodine ER in patients with Overactive bladder.

A multicenter, randomized, double-blind, phase 3 study of Dr. Raju Titus Sunitinib in metastatic colorectal cancer patients receiving 764 Medical Oncology Pfizer Ltd., Mumbai Chacko Irinotecan, 5-Fluorouracil and Leucovorin (FOLFIRI) as first line treatment.. Study Code A 6181122.

A phase 2, randomized, double – blind, placebo-controlled, six week study of the efficacy and safety of Tofimilast dry powder for 765 Dr. D.J. Christopher Pulmonary Medicine Pfizer Ltd., Mumbai inhalation in adults with persistent asthma, protocol No. A2641021. A Phase 4, Open-label, Single-arm, Multicenter Study To Describe 766 Dr. DJ Christopher Pulmonary Medicine The Safety Of 13-Valent Pneumococcal Conjugate Vaccine In Pfizer Ltd., Mumbai Healthy Adults ≥50 Years Of Age In India.

A pivotal phase 2 study of the anti-angiogenesis agent AG- 013736 in patients with 131 I-refractory metastatic or Dr. Raju Titus 767 Medical Oncology unresctable locally-advanced papillary, follicular, or hurthle-cell Pfizer Ltd., Mumbai Chacko thyroid cancer who are also refractory to, or intolerant of, or have clinical contraindication to, doxorubicin treatment.

A treatment protocol for patients with gastrointestinal stromal Dr. Raju Titus tumor who are ineligible for participation in other SU011248 768 Medical Oncology Pfizer Ltd., Mumbai Chacko protocols and are refractory to or intolerant of imatinib mesylate. Protocol No. A6181036.

An open-label Bosutinib treatment extension study for subjects 769 Dr. Vikram Mathews Haematology with chronic myeloid leukemia (cml) who have previously Pfizer Ltd., Mumbai participated in Bosutinib studies B1871006 or B1871008.

Linezolid Vs Vancomycin / Cefazolin in the treatment of Dr. Meshack G. Haemodialysis patients with catheter related Gram-Positive 770 Nephrology Pfizer Ltd., Mumbai Kirubakaran Bloodstream infections – Protocol No. A 5951105

Phase I trial to study if the addition of fludarabine to the standard regimen of Anti-thymocyte globulin (ATG) and cyclosporine will 771 Dr. Biju George Hematology Pfizer Ltd., Mumbai improve remission rates in patients with severe and very severe aplastic anemia (SAA/VSAA) Protocol A6061031. A phase 2B long-term, randomized, open – label safety and tolerability trial comparing (S-S) – Reboxetine 772 Dr. Nihal Thomas Endocrinology Pfizer Ltd., Mumbai (PNU-165442G) with routine care in patients with chronic painful diabetic peripheral neuropathy (DPN).

Protocol No. A2171086. A 16 week open label outpatient randomized, parallel study assessing the impact of two different initial dose prescriptions for dry powder inhaled insulin 773 Dr. Nihal Thomas Endocrinology Pfizer Ltd., Mumbai (ExuberaÒ) on Glycemic control in patients with type 2 diabetes mellitus who are poorly controlled on a combination of two or more oral agents.

Randomized comparative trial of azithromycin plus chloroquine 774 Dr. S. Subramanian Medicine III versus pyrimethamine-sulfadoxime and chloroquine for the Pfizer Ltd., Mumbai treatment of uncomplicated P.falciparum malaria.

Protocol No. SYR-322-TZD-009 A multicenter, randomized, Pharmaceutical double-blind, placebo-controlled study to determine the efficacy 775 Dr. Nihal Thomas Endocrinology Product and safety of SYR110322 (SYR-322) when used in combination Development with Pioglitazone in subjects with type 2 diabetes.

A Randomized, Double-blind, Placebo-controlled, Comparative Phase 3 Multicenter Study to Evaluate the Safety and Efficacy of Pharmanet Clinical 776 Dr. Thomas V Paul Endocrinology BA058 for Injection for Prevention of Fracture in Ambulatory Services PVT Ltd Postmenopausal Women with Severe Osteoporosis and at Risk of Fracture.

777 Dr. Niranjan Neonatology NICU workstation of the future – closed Loop FiO2: optimal Philips Electronics Thomas manual control. India Limited

A Multicenter, Phase II/III Study to Assess Radiation Induced Mucositis in Participants with Locally Advanced Squamous Cell Piramal Healthcare 778 Dr. Subhashini John Dr. Subhashini John Carcinoma of the Head and Neck Administered Cisplatin and Limited Radiation with or without P276-00

A Randomized, Open-Label, Multi-Centre, Parallel group,Phase III Dr Raju Titus Study to Compare P276-00 in Combination withGemcitabine Piramal Healthcare 779 Medical Oncology Chacko versus Gemcitabine Alone in Chemo-naïveSubject with Limited Unresectable Metastatic or LocallyAdvanced Pancreatic Cancer.

Randomized, Double-blind, Parallel Group, Placebo-controlled, Dr. Debashish Clinical Immunology Piramal Healthcare 780 Prospective, Phase III Study to Evaluate the Efficacy and Safety of Danda and Rheumatology Limited Tinefcon® in Patients with Active Ankylosing Spondylitis.

An open label, multicenter phase I/II study of selective cyclin dependent kinase inhibitor P276-00 in combination with Piramal Life 781 Dr. Subhashini John Radiation Oncology radiation in subjects with recurrent and/or locally advanced Sciences, Mumbai squamous cell carcinoma of head and neck.

The POISE study : A large simple trial of metoprolol versus Population Health 782 Dr. Sunil Agarwal Surgery II placebo in patients undergoing noncardiac surgery at moderate Research Inst, and high risk of a perioperative cardiac event Canada

Perioperative ischemic evaluation 2 trail, a large, international, Population Health Dr. Dheepak 783 Vascular Surgery placebo-controlled, factorial trail to assess the impact of Research Institute / Selvaraj clonidine and acetyl-salicylic acid (ASA) in patients undergoing St. John's National noncardiac surgery who are at risk of a perioperative Academy of Health cardiovascualr event. Science

Population Health Cardiothoracic 784 Dr. Shiv Kumar Nair Steroids In Cardiac Surgery (SIRS) trial Research Institute, Surgery Hamilton, Canada

Dr. Benjamin 785 Surgery Unit V The Prosper Trial. Prosper, UK Perakath

Rural Unit for Health Costing of pneumonia in hospitalized infants and children aged 2 Public Health 786 Dr. K.R. John and Social Affairs - to 24 months, at a secondary and tertiary level hospital of a not- Foundation of India RUHSA for-profit organization.

(Study SPP301CRD15) A randomized, double blind, placebo controlled parallel group study to assess the effect of the 787 Dr. Nihal Thomas Endocrinology endothelin receptor antagonist avosentan on time to doubling of Quintiles serum creatinine, end stage renal disease or death in patients with type 2 diabetes mellitus and diabetic nephropathy.

A phase III, double blind, randomized study to evaluate safety and efficacy of Isavuconazole a water soluble azole versus 788 Dr. O.C. Abraham Medicine I Quintiles voriconazole for primary treatment of invasive fungal disease caused by Aspergillus species or other Filamentous fungi.

A phase III, double blind, randomized study to evaluate the safety and efficacy of Isavuconazole a water soluble azole against a 789 Dr. O.C. Abraham Medicine I Quintiles Caspofungin followed by Voriconazole regimen in the treatment of Candidemia and other invasive candida infections. Clinical trial protocol CXA 30009: A phase III, 12 –week, multicentre, double blind, randomized placebo and active Dr. Debashish comparator – controlled, parallel group study to investigate the 790 Medicine II Quintiles Danda efficacy and safety of GW406381, 5mg, 10 mg, 25 mg and 50nmg administered orally once daily, in Adults with Rheumatoid arthritis.

Effects of Arzoxifene on Vertebral fracture incidence and on 791 Dr. M.S. Seshadri Endocrinology invasive Breast Cancer incidence in Postmenopausal women with Quintiles Osteoporosis or with low bone density.

A 26-week placebo-controlled efficacy and safety study of Mometasone Furoate / Formoterol Fumarate combination 792 Dr. D.J. Christopher Pulmonary Medicine formulation compared with Mometasone Furoate and Quintiles Research Formoterol monotherapy in subjects with persistant asthma previously treated with low-dose inhaled Glucocorticosteroids.

A 26-week placebo-controlled efficacy and safety study of Mometasone Furoate / Formoterol Fumarate combination formulation compared with Mometasone Furoate and 793 Dr. D.J. Christopher Pulmonary Medicine Quintiles Research Formoterol monotherapy in subjects with persistent asthma previously treated with medium-dose inhaled Glucocorticosteroids.

R21 National 794 Dr. Lisa E. Manhart Biostatistics Integrating depression screening into HIV care in Southern India. Institute of Health Grant Rapid Grant for Young Investigator Effect of 4-aminopyridine on L-type calcium currents in isolated 795 Dr. Anand Bhaskar Physiology scheme of rabbit ventricular cardiomyocytes. Department of Biotechnology

Ratan Tata Trust Treatment of standard risk precursor B cell acute lymphoblastic for treatment of 796 Dr. Aby Abraham Clinical Haematology leukemia(ALL), with a modified BFM ALL protocol without high cancer of dose intravenous methotrexate or cranial irradiation underprivileged patients

A Novel Indigenous Paclitaxel eluting porous carbon – carbon Relisys Medical 797 Dr. Paul George Cardiology nano particle coated cobalt chromium stent evaluation (The Devices Ltd COREL Registry).

Research & Dr. Suresh Development of a multichannel myoelectric EMG processor for Development 798 Bioengineering Devasahayam movement control of upper extremity exo-skeleton Establishment, Pune

Phase 2 clinical trial to evaluate efficacy of Cabazitaxel in patients Dr. Raju Titus with resistant/recurrent gastric cancer who have failed one line Research Grant 799 Medical Oncology Chacko of chemotherapy either in the neoadjuvant, adjuvant or from Sanofi metastatic setting.

A multi-centre study on subjects with an early onset of diabetes 800 Dr. Mathew John Endocrinology Research Society in India MEDI) for the Study of Diabetes In India

Research Society Isolation of viable porcine pancreatic islets for 801 Dr. S. Gunasekaran Physiology for the Study of xenotransplantation into rats. Diabetes In India

Research Society Light microscopic study of allo-transplanted rat pancreatic islets 802 Mrs. Ayesha Noor Physiology for the Study of with tracolimus (FK-506) as immunosuppressant. Diabetes In India

Research Society Light microscopic study of allo-transplanted rat pancreatic islets 803 Dr. S. Gunasekaran Physiology for the Study of with tracolimus (FK-506) as immunosuppressant. Diabetes In India

A multi-centric study on treatment of abdominal tuberculosis Revised National (intestinal or peritoneal): A randomized controlled trial to Gastrointestinal Tuberculosis 804 B.S. Ramakrishna compare the 6 months of Cat I treatment with 9 months of Cat I Sciences Control Program Treatment (extension for 3 months) in abdominal tuberculosis (Govt. of India) under the Revised National Tuberculosis Control Program.

Revised National Gastrointestinal Data collection for the Indian Society of Gastroenterology Task Tuberculosis 805 B.S. Ramakrishna Sciences Force on Inflammatory Bowel Disease. Control Programme (Govt. of India)

A prospective, randomized, double blind, placebo-controlled, Dr. Mathew Roche Products 806 Neurology parallel group, multicentre, 36-week trial to assess the efficacy Alexander and safety of adjunct mycophenolate mofetil (MMF) to maintain (India) Pvt. Ltd. or improve symptom control with reduced corticosteroids in subjects with active myasthenia gravis. Protocol:WX 17798.

ML28550 - An Open label, Prospective, Post Marketing Study to Evaluate the Safety, Tolerability and Efficacy of Rituximab with Dr. Debashish Clinical Immunology Roche Products 807 Glucocorticoids in adult patients with Wegner’s Granulomatosis Danda and Rheumatology (India) Pvt. Ltd. (Granulomatosis with Polyangiitis – GPA) or Microscopic Polyangiitis.

Open randomised study to evaluate efficacy and safety of oral Roche Products 808 Dr. George T. John Nephrology valganciclovir versus IV ganciclovir for the treatment of CMV (India) Pvt. Ltd. disease in solid organ transplant recipients.

A Multi centre, pilot phase II trial assessing the efficacy and safety Roche Scientific Dr. Raju Titus of Bevacizumab + Gemcitabine + Carboplatin as first line 809 Medical Oncology Company (India) Chacko treatment for patients diagnosed with Triple Negative Metastatic Private Limited Breast Cancer.

A Multicenter, Open-Label, Single-Arm Study of Pertuzumab in Roche Scientific Dr. Raju Titus Combination with Trastuzumab and a Taxane in First Line 810 Medical Oncology Company (India) Chacko Treatment with HER2- Positive Advanced (Metastatic or Locally Private Limited Recurrent) Breast Cancer.

A study to observe the safety, tolerability and efficacy of Roche Scientific Dr. Debashish Clinical Immunology tocilizumab in patients with active rheumatoid arthritis who 811 Company (India) Danda & Rheumatology have an inadequate response to current non-biologic DMARD Private Limited and/or Anti TNF therapy.

An open-label multicentre phase IV study of trastuzumab in Roche Scientific 812 Dr. Raju Titus Medical Oncology combination with the standard chemotherapy (as per the routine Company (India) Chacko clinical practice) as first-line therapy in patients with HER2 Private Limited positive metastatic gastric cancer.

Roche Scientific Dr. Raju Titus An open-label, Multicentric study to assess the safety of 813 Medical Oncology Company (India) Chacko RO5185426 in patients with metastatic melanoma. Private Limited

ML 218 22 titled “A single arm, open label study to assess the Roche Scientific efficacy, safety and tolerability of two weekly administration of 814 Dr. George T John Nephrology Company (India) intravenous MIRCERA for the treatment of chronic renal anaemia Pvt. Ltd. in dialysis patients not currently treated with ESA”

A single arm study to assess the benefit of balloon mitral Royal Adelaide 815 Dr. John Roshan Cardiology valvotomy on vascular dynamic function in rheumatic mitral Hospital stenosis.

Electrophysiological and electroanatomical characterization of Royal Adelaide 816 Dr. Bobby John Cardiology the atria in patients with rheumatic mitral stenosis. Hospital

Royal Adelaide A single arm study to assess the benefit of mitral valvotomy on Hospital / 817 Dr. John Roshan Cardiology platelet function in rheumatic mitral stenosis. Cardiology Unit Fund

Electroanatomical characterization of the atria in patients with Royal Adelaide 818 Dr. Bobby John Cardiology rheumatic mitral stenosis. Hospital

819 Dr. B Paul Radiation Oncology Monte Carlo Modeling of Medical Electron Linear Accelerator. RP AD, BARC, Ravindran Mumbai

Adaptation of a Light Emitting Diode (LED) based motion capture RSNA – Dr. B. Paul 820 Radiotherapy system for patient positioning and intra-fraction movement Radiological Society Ravindran assessment in Radiotherapy. of North America)

Phase I trial of Paclitaxel as radiosensitiser with Cisplatin in Samarth Pharma 821 Dr. E. Prasad Radiotherapy - II treatment of Carcinoma cervix. Pvt. Ltd

A pilot study to evaluate the feasibility, tolerance and efficacy of addition of hyperthermia to external beam radiotherapy [EBRT] 822 Dr. Subhashini John Radiotherapy Sandoz on patients with locally advanced non- metastatic inoperable head and neck cancer for palliation of symptoms

Pivotal study in breast cancer patients investigating efficacy and 823 Dr. Subhashini John Radiation Therapy Sandoz safety of LA-EP2006 and Neulasta®

Dose-Ranging study to evaluate the safety and efficacy of Sankyo Pharma & 824 Dr. Indira Agarwal Child Health II Olmesartan Medoxomil in children and adolescents with development – hypertension. Quintiles

Evaluation of susceptibility of staphylococcus isolates including 825 Dr. V. Balaji Microbiology Methicillin Resistant Staphylococcus aureus (MRSA) to Sanofi Teicoplanin from hospitalized patients in high risk areas.

Randomized Study of LAROTAXEL + Cisplatin (LC) vs. Dr. Raju Titus Sanofi – Synthelabo 826 Medical Oncology Gemcitabine Cisplatin (GC) in the First Line Treatment of Locally Chacko (India) Limited Advanced/Metastatic Urothelial Tract or Bladder Cancer. An observational study to determine thromboembolism Dr. Benjamin Sanofi (India 827 Surgery prophylaxis in oncology patients who are undergoing abdominal Perakath Limited or pelvic surgery.

A multinational, Randomized, double-blind study, comparing the Dr. Raju Titus efficacy of aflibercept once every 2 weeks versus placebo in 828 Medical Oncology Sanofi Aventis Chacko patients treated with Gemcitabine for metastatic pancreatic cancer. Dr. Raju Titus Chacko, Medical Oncology,

829 Dr. Oommen George Cardiology Current / Oasis 7 Sanofi Aventis

Importance of Long-Term Follow-up of the ORIGIN Participants: 830 Dr. Nihal Thomas Endocrinology Sanofi Aventis ORIGINALE (ORIGIN And Legacy Effects) Follow-up Study.

Sanofi Aventis & Surveillance of influenza disease in Vellore (South India) at a 831 Dr. Shoba David Clinical Virology John Hopkins tertiary care teaching hospital. University

A phase 4 prospective study to characterize the 832 Dr. Sumita Danda Clinical Genetics pharmacokinetics of alglucosidase alfa in patients aged 8-18 Sanofi Company years of age.

Immunogenicity and safety of the Aventis Pasteur DTacP- IPV//PRP-T Combined Vaccine (PENTAXIMTM) Given as a Sanofi Pasteur Dr. Valsan Philip 833 Child Health I Three-Dose Primary Vaccination at 6,10 and 14 weeks of age and International, Varghese followed by a Booster Dose at 18-19 months of age in Healthy France infants in India. International randomized study to evaluate the addition of Docetaxel to the combination of Cisplatin – 5 flurouracil (TCF) vs. 834 Dr. Subashini John Radiotherapy II Sanofi-Aventis Cisplatin -5 flurouracil (CF) in the induction treatment of nasopharyngeal carcinoma (NPC) in children and adolescents.

Dr. Raju Titus A prospective, non-interventional, cohort survey on VTE risk in Sanofi-Aventis 835 Medical Oncology Chacko patients receiving new chemotherapy for cancer Pharmaceuticals

Sanofi-Aventis Dr. Raju Titus Abreast. A breast cancer registry of adjuvant strategies 836 Medical Oncology Pharmaceuticals Chacko XRP6976D/9001. Inc

Schering Research 837 Dr. Jacob Jose Cardiology II Early ACS –SPRI. Institute

Dr. Rekha Aley Ultravist 370 mg 1/ml: Safety and efficacy in computed 838 Radiology Schering, Germany Cherian tomography of head and body – a phase III b clinical trial.

RADAR P05320- Observational trial on the value of diagnostic Dr. Debashish Clinical Immunology Schering-Plough 839 criteria in the diagnosis of spinal spondyloarthropathies in Danda & Rheumatology Research Institute patients with chronic low back pain.

School of Business Comparison of efficacy of Semi-flexion and Polycentric orthotic Management & 840 Mr. Rajdeep Ojha Bioengineering knee joints against single axis knee joint with drop lock in Technology & patients with quadriceps weakness: A pilot Study. Defense Bioengineering and Electro medical Laboratory

School of Medicine, Dr. B.S. Gastrointestinal 841 Investigations in inflammatory bowel disease in India. Washington Ramakrishna Sciences University

School Screening for Refractive Errors – determining the positive Sentinel Dr. Madhiraju 842 Ophthalmology predictive value of school teachers in detecting refractive errors Surveillance Unit Nandanandan in school children – a pilot study Research Allocation

SENTRY Program India quality healthcare improvement Initiative (India-SENTRY 843 Dr. Dilip Mathai Medicine I JMI Laboratoriesm, surveillance). USA

Transfusion Medicine Role of independent controls in the management of quality in Sera Care Life 844 Dr. Dolly Daniel & infectious disease assays in the blood bank. Sciences Immunohaematology

SNX-1012-CLN2-006. A phase 2, randomized, double masked, placebo controlled study to evaluate the efficacy of SNX-1012 in 845 Dr. Subashini John Radiotherapy II reducing the duration and severity of ulcerative oral mucositis in Serenex Inc. patients receiving cytotoxic chemotherapy for breast or lung cancer.

A randomized, open label, active controlled, phase II/III clinical study to assess the safety and immunogenicity of SIIL’s purified Serum Institute of 846 Dr. Anuradha Bose Community Health. vero cell rabies vaccine (PVRV) in patients with potential rabies India Limited exposure. Potential rabies exposure. A Randomized, Open Label, Active Controlled, Phase II/III Clinical Study to Assess the Safety and Immunogenicity of SIIL’s Purified Serum Institute of 847 Dr. Anuradha Bose Community Health Vero Cell Rabies Vaccine (PVRV) in Patients with Potential India, Ltd Rabies Exposure.

A single blind, multicentre, comparative, vaccine Shantha Dr. Leni Grace interchangeability trial of Shantetra and Tritanrix (Diptheria – 848 Child Health I Biotechnics Ltd. Mathew Tetanus – Pertussis and Hepatitis B combination vaccines) in Hyderabad, INDIA infants.

Phase I Randomized Double-Blind Placebo-Controlled Study To Evaluate The Safety And Tolerability Of A Single Administration Shantha Gastrointestinal (106.25 Ffu Of Each Constituent Serotype Per 0.5 Ml) Of Live 849 Dr. Gagandeep Kang Biotechnics Ltd. Sciences Attenuated Tetravalent (G1-G4) Bovine-Human Reassortant Hyderabad, INDIA Rotavirus Vaccine [Brv-Tv] Administered To Healthy Indian Adult Males

Phase I/II, Randomized double-blind, placebo-controlled, dosage selection study to evaluate the safety, tolerability and Shantha Gastrointestinal 850 Dr. Gagandeep Kang immunogenicity of a 3-dose series of live attenuated tetravalent Biotechnics Ltd. Sciences (G1-G4) Bovine Human Resassortant Rotavirus Vaccine [BRV-TV] Hyderabad, INDIA administered to healthy Indian Infants.

Phase I/II, Randomized, Double-Blind, Placebo-Controlled, Dosage Selection (105.0, 105.8 or 106.4 FFU of Each Constituent Shantha Gastrointestinal 851 Dr. Gagandeep Kang Serotype per 2.0 ml) Study to Evaluate the Safety, Tolerability Biotechnics Ltd. Sciences and Immunogenicity of a 3-Dose Series of All In One Formulation Hyderabad, INDIA of the Live Attenuated Tetravalent (G1-G4) Bovine-Human Reassortant Rotavirus Vaccine [BRV-TV] Administered to Healthy Indian Infants.

Prevalence and genotype distribution of HPV in cervical infection, Shantha Dr. Abraham Obstetrics and 852 and its attribution to cervical intraepithelial neoplasia and Biotechnics Ltd. Peedicayil Gynaecology cervical cancer in Indian Women. Hyderabad, INDIA

Safety, Immune Lot-to-Lot Consistency and Non-Inferiority of Shan 5 (DTwP-HepB-Hib) Vaccine in Comparison Shantha Dr. Leni Grace 853 Child Health to Pentavac SD When Administered as a Single Booster Dose at Biotechnics Ltd. Mathew 15-18 months and Three Doses at 6-8, 10-12 and 14-16 Weeks of Hyderabad, INDIA Age in Healthy Indian Children and Infants.

A randomized placebo-controlled efficacy and safety study of 1- year treatment duration with high and medium dose inhaled mometasone furoate/formoterol combination formulation Shchering – Plough 854 Dr. D.J. Christopher Pulmonary Medicine compared with formoterol and high-dose inhaled mometasone Research Institute furoate immunotherapy in subjects with moderate to severe COPD.

Dr. George M. Gastrointestinal Shreya Life 855 Safety and efficacy of Recombinant HB vaccine in healthy adults. Chandy Sciences Sciences

SIDA (Swedish International Development Brand logo recognition by 3-10 year old Indian children: a pilot 856 Dr. Sujith J Chandy Clinical Pharmacology Cooperation study Agency), Minor Field Studies scholarship Piloting a handheld fetal heart monitor with a uterine contraction Siemens SISL, 857 Dr. Daisy Singh Community Health sensor. Bangalore

Siemens A pilot study of the Cellscope as a screening device for oral 858 Dr. Meera Thomas Pathology Technology and cancer. Services Pvt. Ltd

Dr. Debashish Medicine II & Clinical studies with Rituximab + Methotrexate in Rheumatoid SIRO Clinpharm 859 Danda Rheumatology Arthritis. Pvt. Ltd

Protocol GRC-4039-204 – A Phase II, 12-week randomized, double-blind, triple dummy, parallel group, placebo-Controlled, SIRO Clinpharm 860 Dr. DJ Christopher Pulmonary Medicine dose range finding study to evaluate safety, tolerability and Pvt. Ltd efficacy of revamilast in subjects with Chronic persistent asthma.

To compare the safety of and to document the efficacy of Amphotericin B lipid complex with that of conventional SIRO Clinpharm 861 Dr. Alok Srivastava Haematology Amphotericin B for empirical antifungal therapy in patients with Pvt. Ltd. febrile neutropenia. Prospective, randomized, controlled, open, single center, phase III clinical study.

Sitaram Bhartia Detection and management of coronary heart disease patients Inst. of Science & 862 Dr. Jacob Jose Cardiology (DEMAT). Research, New Delhi

863 Dr. P. Padmaja Microbiology Zygomycosis – a prospective study on patients with zygomycosis Society for Indian –part of society for Indian Human and Animal Mycology (SIHAM) Human and Animal Zygomycosis network. Mycology (SIHAM) and Life Care

Soft Team Solutions 864 Dr. Subhashini John Radiation Therapy PET-MRI Automatic Tumour Detection and Recognition (ATR) Ltd.

South Asian Clinical The effect of nitric oxide on mitochondria of the brain in acute 865 Dr. Anna Oommen Neurochemistry Toxicology organophosphate poisoning. Collaboration

A project towards improving the management of acute South Asian Clinical Dr. Kishore organophosphate poisoning. A CMC inter-departmental project in Toxicology 866 Medical ICU Pichamuthu collaboration with the South Asian Clinical Toxicology Research Collaboration (SACTRC). Collaboration

South Asian Clinical Dr. Sathya Toxicology 867 Physiology Pathophysiological mechanisms in Oduvanthalai poisoning. Subramanian Research Collaboration

South Asian Cochrane Centre (existing programme A national study of snake envenomation syndrome –species 868 Dr. Anand Zachariah Medicine grant Effective correlation and clinical outcomes of snake bite. Health Care Research Consortium)

869 Dr. Subhashini John Radiation Oncology An International, Multi-Center, Randomized, Double Blind Spectrum Placebo Controlled Phase II Study to Evaluate the Safety and Pharmaceuticals Efficacy of Lucanthone Administered as an Adjunct to Radiation Inc. and Temozolomide for Primary Therapy of Glioblastoma Multiforme.

Sri Chitra Tirunal Institute of Medical Use of nano-bead hydroxyapatite implants in infected open Paediatric Sciences and 870 Dr. Vrisha Madhuri fractures, failed implant surgeries and osteomyelitis for defect Orthopaedics Technology, management and local delivery of appropriate antibiotics. Trivandrum, Kerala, India

Stem Cell A Phase II B prospective, randomized, double-blind, placebo Dr. Mathew Therapeutics Corp. 871 Neurological Sciences controlled study of NTxTM-265: human chronic gonadotropic Alexander Calgary, Alberta, (hCG) and epoetin alfa (EPO) in acute ischemic stroke patients. Canada

A phase IIb prospective, randomized, double-blind, placebo Stem Cell Dr. Mathew controlled, multi-center, dose escalation study of NTx®-265: Therapeutics Corp., 872 Neurological Sciences Alexander human chorionic gonadotropin (hCG) and epoetin alfa (EPO) in Calgary, Alberta, acute ischemic stroke patients (REGENESIS-LED) Canada

392MD/15/C study: A randomized, active control, double-blind, double-dummy, parallel-group, multi-national study to assess the Strakan Dr. Raju Titus efficacy, tolerability and safety of the granisetron transdermal 873 Medical Oncology Pharmaceuticals Chacko delivery system (GTDS) in chemotherapy-induced nausea and Ltd. vomiting (CINV) associated with the administration of moderately or highly emetogenic multi-day chemotherapy. Sun Dr. Santhosh Obstetrics and A trial of progesterone to prevent preterm labor in twin 874 Pharmaceuticals Thomas Samuel Gynecology gestations with short cervix. Limited

Sun 875 Dr. Subhashini John Radiotherapy In practice usage and performance (IPUP) study of Pilocarpine. Pharmaceuticals Limited

Swarna Jayanti Fellowship Award, Dr. Jayandharan G Centre for Stem Cell Optimized Adeno-associated virus mediated gene transfer 876 Department of Rao Research strategies for phenotypic correction of haemophilia B. Science and Technology, GoI.

Swedish Dr. Gagandeep Gastrointestinal Hospital-based randomized control trial of racecadotril in acute International 877 Kang Sciences diarrhoeal disease in children 6 months to 5 years of age. Development Agency

Dr. Wilhelm Laska, Joseph AJ., Swedish Gastroenterology, 9 B, 182 66 A survey of patient characteristics, indications and outcomes of Government 878 Gastroenterology, Djursholm, Sweden upper GI endoscopy in a developing country authority in charge Carl Johan of financial aid Sundberg, MD, PhD

Protocol No. 01-05-TL-322OPI-001. A multicenter randomized, Takeda Global 879 Dr. Nihal Thomas Endocrinology double blind, placebo-controlled study to determine the efficacy Research & Dev. and safety of combination of SYR-322 (SYR110322) and Pioglitazone HCL (ACTOS) in subjects with Type 2 diabetes. Centre, UK

A phase 3 study to evaluate the efficacy and safety of TAK-390 TAP 880 Dr. Ashok Chacko Gastroenterology MR (60 mg QD and 90 mg OD) and an active comparator, Pharmaceutical Pantoprazole (30 mg QD) on healing of erosive esophagitis. Products, USA

A phase 3 study to evaluate the safety and efficacy of TAK-390 TAP MR (60 mg QD and 90 mg QD) compared to placebo in 881 Dr. Ashok Chacko Gastroenterology Pharmaceutical maintenance of healing in subjects with healed erosive Products, USA esophagitis.

Tata Institute of Gastrointestinal Metabolonomics of sera of patients with Wilson’s disease: 1H 882 Dr. C E Eapen Fundamental Sciences NMR investigation. Research, Mumbai

The Defense Dr. T. Lazar Mathew Characterization of HLA DR4 allelles and candidate non-HLA Research and 883 Clinical Pathology & Dr. Dolly Daniel alleles associated with Juvenile rheumatoid arthritis in India. Development Organisation

Dr. K. N. The Himalaya Drug 884 Microbiology Evaluation of efficacy and safety of pure hands in hand hygiene. Brahmadathan Company

The Massachusetts Evaluation of the Sensitivity and Specificity of a rapid sNS1 Duplo Dr. Asha Mary Institute of 885 Clinical Virology (IgM/IgG) test for diagnosis of dengue: A Pilot Multi-country Abraham Technology / SD Study Bioline The New England Life Science Group, Collection of clinical sample sets; sputum, blood and urine, from Inc. (NELSG), USA & 886 Dr. K. R. John Community Health patients potentially infected with Mycobacterium tuberculosis Agada Health Sciences Pvt. Ltd. Chennai

The Wellcome Trust – DBT India 887 Dr. Joe Varghese Biochemistry Why does iron overload associated with insulin resistance occur? Alliance (Early Career Fellowships)

A placebo controlled, randomized, parallel cohort, safety and tolerability study of two dose levels of liposomal amikacin for 888 Dr. D. J. Christopher Pulmonary Medicine Transave, Inc inhalation (arikace™) in patients with bronchiectasis complicated by chronic infection due to Pseudomonas aeruginosa.

A prospective, multi-center, randomized, double-masked, safety, Translational Dr. Andrew tolerability and efficacy study of four iontophoretic doses of 889 Ophthalmology Medicine India Pvt. Braganza dexamethasone phosphate ophthalmic solution in patients with Ltd. non-infectious acute anterior segments uveitis.

A prospective observational longitudinal study to evaluate Triesta Sciences (I) 890 Dr. Subhashini John Radiotherapy - II Molecular Markers for disease staging and clinical response in Pvt. Ltd., Bangalore Breast carcinoma.

An observational longitudinal study to evaluate molecular 891 Dr. Benjamin General Surgery V Triesta Sciences (I) markers of disease staging, disease progression, disease Perakath outcomes and treatment response in colorectal carcinoma. Pvt. Ltd., Bangalore

An observational study on Archived Fine Needle Aspiration Cytology (FNAC) / Formalin Fixed Paraffin Embedded (FFPE) Triesta Sciences (I) 892 Dr. Subhashini John Radiotherapy - II tissue to evaluate Molecular Markers of Disease progression and Pvt. Ltd., Bangalore response to therapy in Breast Cancer.

Safety, efficacy and survival following concomitant chemo- Triesta Sciences (I) 893 Dr. Subhashini John Radiotherapy - II irradiation followed by adjuvant therapy with Temozolamide and Pvt. Ltd., Bangalore Thalidomide in high grade Gliomas.

Dr. Ranjani A study on the feasibility of improving the efficiency of TB Tuberculosis 894 Ramachandran & Community Health diagnosis in HIV infected individuals attending VCTCs. Research Centre Dr. K. R. John

Dr. Ranjani Tuberculosis 895 Ramachandran & Community Health HIV surveillance among Tuberculosis patients. Dr. K. R. John Research Centre

Use of Allopathic and Non-Allopathic Medical systems by persons Tufts University, 896 Dr. Rita Isaac Community Health infected by HIV in Vellore, South India. USA

Dr. Mary V. Evaluation of the ADA – MTB kit for diagnosis of tuberculosis in 897 Clinical Microbiology Tulip Diagnostics Jesudason Serum, plasma, biological fluids.

UEBM, Madras Dr. Atanu Kumar Study on Barriers to Exclusive breastfeeding in infants upto 6 898 Neonatology Medical College, Jana months of Age Chennai Rural Unit for Health UGC – UK-INDIA 899 Dr. Rita Isaac and Social Affairs - Vellore-Aberdeen Nutrition Exchange Education and RUHSA Research Initiative

Evaluation of the psychometric properties of sensor-based UK India Education Mr. Samuel Physical Medicine and 900 assessment of motor capacity and function of the upper limb and Research Kamalesh Kumar Rehabilitation following stroke. Initiative

UK-India Gastrointestinal Impact of demographic and social change on gastroenteric viral 901 Dr. Gagandeep Kang Educational and Sciences infections. Research Initiative

UNICEF/UNDP/Wo rld Bank/WHO Special Programme Dr. Joy Sarojini Improving the diagnosis of tuberculosis through optimization of 902 Microbiology for Research and Michael sputum smear microscopy. Training in Tropical Diseases (TDR)

Dr. Regina Mary R, Scholastic performance in adolescent women students: Is there Gastrointestinal University Grants 903 Associate Professor, an association with early childhood diarrhea and bowel Sciences Commission Auxilium College microflora?

Dr. Jiji Elizabeth Obstetrics and Progesterone after previous preterm birth for prevention of University of 904 Mathews Gynecology neonatal respiratory distress syndrome. Adelaide

905 Dr. C. K. Ben Selvan Surgery III Intra abdominal hypertension and its effect on gastrointestinal University of mucosal pH; a randomized prospective clinical trial to study the Auckland, NZ role of colonoscopic decompression and its effect on Gastro intestinal mucosal pH and intra abdominal hypertension.

Dr. Ingrid Miljeteig, Dr. Ole Frithjof Priority setting in low income countries: Ethical aspects of the University of 906 Neonatology Norheim & Dr. A.K. use and development of clinical guidelines in neonatology. Bergen, Norway Jana

Banking of patient samples for developing genomics and proteomics technologies to type and characterize emerging and University of Dr. Asha Mary 907 Clinical Virology re-emergent viruses in terms of viral genotypes, epidemiological California, Abraham markers of disease, diagnoses and identification of protective Berkeley, USA epitopes for vaccines.

University of Q-H20: A new class of household consumer products for low cost 908 Dr. Vinohar Balraj Community Health California, drinking water treatment. Berkeley, USA

University of Baseline characteristics and the prospective impact of exercise in 909 Dr. Nihal Thomas Endocrinology Copenhagen, young South Indian males with low birth weight. Denmark

Mr. Elango Physical Medicine and The role of follow-up home visits in the rehabilitation of people University of 910 Arumugam Rehabilitation living with a disability in India and on Rehabilitation staff. Melbourne

Sugical Intensive Care University of 911 Dr. Vasudha Rational fluid therapy in Asia. Unit Muenster Understanding parental perceptions on shaking of infants and its University of North 912 Dr. Paul Russell Psychiatry possible implications – A qualitative study. Carolina

Dr. Jiji Elizabeth Obstetrics and Coronis – International study of caesarean surgical techniques a University of 913 Mathews Gynecology randomized fractional factorial trial. Oxford

Dr. Simon University of 914 Pathology WNT beta catenin signaling pathway in MEN 1 pituitary tumors. Rajaratnam Oxford

Immune Reconstitution Syndrome in Solid Organ Transplant University of 915 Dr. Basu G Nephrology Recipients with Tuberculosis Pittsburgh

Rural Unit for Health Dr. Frank Tesoriero University of South 916 and Social Affairs - Healthy District Research programme project. Dr. K.R. John Australia RUHSA

Dr. Lisa E. Manhart Effect of Stigma on HIV Care Seeking Behaviours and Mental University of 917 Biostatistics & Dr. L. Jeyaseelan Health in Tamil Nadu, India. Washington

University Research Council of Effect of 4-Aminopyridine on calcium handling in mammalian 918 Dr. Anand Bhaskar Physiology The Tamil Nadu Dr. heart: a calcium imaging study. M. G. R. Medical University, Chennai

Dr. Shakti Kumar Clinical consequences of an outbreak of bronchoscopic pseudo- 919 Pulmonary Medicine USAID WHO Bal infection caused by rapidly growing non-tuberculous mycobacteria (Mycobacterium fortuitum and Mycobacterium Chelonae).

Evaluation of newer diagnostic tools and feasibility of consensus USAID World Dr. Joy Sarojini 920 Microbiology case definition in the diagnosis of intrathoracic tuberculosis in Health Michael children. Organisation

Screening & Identification of blood markers for cardio vascular Vellore Institute of 921 Dr. George Joseph Cardiology risk assessment in males under 40 years and in premenopausal Technology females. University

Screening and Analysis of Estrogen Receptor gene (ESRI) Vellore Institute of 922 Dr. Deepa Braganza Psychiatry polymorphism in patients of Indian Origin, suffering from Technology Schizophrenia. University

Veteran affairs merit award to Prof Dr. Debashish Clinical Immunology Study of Epigenetic modifications in Takayasu arteritis by 923 R Hal Scofield by Danda & Rheumatology Genome-wide methylation study. Department of Veteran affairs, USA

Voluntary Register A study on comprehensive community based rehabilitation 924 Dr. K. R. John Community Health of Clinical project for vulnerable groups in K.V. Kuppam Block. Technologists

Washington Gastrointestinal Studies of the colonic Microflora and flora-host immune University & 925 Ms. M. Kalpana Sciences interactions in inflammatory bowel disease. Crohn’s and Colitis Foundation Dissecting the molecular regulators of blood induced joint Wellcome Trust Dr. Jayandharan G Centre for Stem Cell 926 damage to develop targeted gene transfer strategies for DBT Intermediate Rao Research haemophilia. Fellowship

Gastrointestinal A rapid low-cost molecular diagnostic instrument for the 927 Dr. Gagandeep Kang Wellcome Trust, UK Sciences developing world.

Dr. Suresh Affordable sensor-based system for independent upper- 928 Bioengineering Wellcome Trust, UK Devasahayam extremity Neuro rehabilitation and assessment.

Do antipsychotics affect brain structure on MRI? A randomized 929 Dr. K. S. Jacob Psychiatry controlled trial of haloperidol versus olanzapine in drug naïve Wellcome Trust, UK patients with schizophrenia in India.

Does the presence of inflammation affect the handling of iron in 930 Dr. Molly Jacob Biochemistry Wellcome Trust, UK the body?

Wellcome Comparison of efficacy of single or multiple cycle(s) of preventive Trust/Department 931 Dr. Rajiv Sarkar Community Health chemotherapy with albendazole in reducing the hookworm of Biotechnology reinfection rate in an endemic tribal population. India Alliance

Wellcome Phase II study to evaluate the role of bortezomib in the Trust/Department 932 Dr. Vikram Mathews Clinical Haematology management of relapsed acute promyelocytic leukemia. of Biotechnology India Alliance Phenotypic and Molecular characterization of carbapenem resistance in Klebsiella sp., Pseudomonas aeruginosa and 933 Dr. V. Balaji Clinical Microbiology Wockhardt Inc. Acinetobacter baumanii isolates and to determine synergism between sulbactam, carbapenem and colistin

Women & Children Mrs. Vinitha Paul Post-hospitalization Parenting/ Care giving Processes for Research Institute, 934 College of Nursing Ravindran Families of Children who have sustained Burns University of Alberta, Canada

World Federation of Neurology Funded to Wake 935 Dr. Sanjith Aaron Neurological Sciences International Maternal Newborn Stroke Registry Protocol. Forest University, Winston-Salem, NC, USA

Crash – 2 trial. Clinical randomization of Antifibrinolytic in significant Haemorrhage- A randomized placebo-controlled trial Accident & World Health 936 Dr. Suresh S. David among Trauma patients with significant haemorrhage of the Emergency Medicine Organisation effects of Antifibrinolytic treatment of death and transfusion requirement.

Determination of appropriate value of mid-upper arm circumference (MUAC) to identify severe acute malnutrition World Health 937 Dr. Kuryan George Community Health (SAM) children with weight for height as reference in the Indian Organisation population—a multi-centric study. Pivotal study to evaluate the immunogenicity and safety of a Dr. Siddhivinayak World Health 938 Biostatistics measles vaccine given by aerosolized inhalation: randomized Hirve Organisation controlled trial.

World Health 939 Dr. Anuradha Bose Community Health Prospective surveillance for intussusceptions in South India. Organisation

Dr. Jayaprakash Taeniasis in Southern India: Prevalence in pig-rearing World Health 940 Community Health Muliyil communities. Organisation

Gastrointestinal Efficacy of Albendazole in reducing fecal egg counts in hookworm World Health 941 Dr. Gagandeep Kang Sciences infestation in previously treated individuals. Organization

Efficacy of Albendazole in reducing fecal egg counts of soil Dr. Vipin Sam World Health 942 Clinical Microbiology transmitted helminthes (Ascaris lumbricoides, hookworm, Alexander. G Organization Trichuris trichuria) in previously treated individuals.

Factors associated with STH (soil transmitted helminth) World Health 943 Dr. Deepthi Kattula Community Health infestation in children aged 6-14 yrs: A community-based case- Organization control study.

A phase IV open-label, single-arm, multicenter study to describe the safety and immunogenicity of 13-valent pneumococcal 944 Dr. DJ Christopher Pulmonary Medicine Wyeth Limited conjugate vaccine in adults 50 to 65 years of age and in children 6 to 17 years of age in India.

945 Dr. Subhashini John Radiotherapy - II A phase III randomized double-blind study of oral CCI-779 Wyeth administered in combination with Letrozole vs. Letrozole alone Pharmaceuticals as first line hormonal therapy in postmenopausal women with Inc locally advanced or metastatic breast cancer.

A Phase III Randomized, Open-Label, Two-Arm Study of Wyeth Dr. Raju Titus Neratinib Plus Paclitaxel Versus Trastuzumab Plus Paclitaxel as 946 Medical Oncology Pharmaceuticals Chacko First Line Treatment for ErbB2-Positive Locally Recurrent or India Limited Metastatic Breast Cancer.

Wyeth 947 Dr. Dilip Mathai Medicine I Invitro evaluation of Tigecycline. Pharmaceuticals India Limited

A phase 3, randomized, active-controlled, double-blind trial Wyeth Dr. Valsan Philip evaluating the safety, tolerability and immunogenicity of a 13- 948 Child Health - I Pharmaceuticals, Varghese valent pneumococcal conjugate vaccine in healthy infants given USA with routine pediatric vaccinations in India.

Wyeth Dr. Mammen A phase I / II study of SKI-606 in Philadelphia Chromosome 949 Haematology Pharmaceuticals, Chandy Positive Leukemia’s. USA

Protocol 3180A1-200-WW. A 24-week randomized, double-blind, Wyeth 950 Dr. Nihal Thomas Endocrinology placebo-controlled, multicenter study of the safety and efficacy of Pharmaceuticals, PPM-204 in subjects with type 2 diabetes. USA

Dr. Mammen A Phase 3 Randomized, Open-Label Study of Bosutinib Versus Wyeth Research, 951 Haematology Chandy Imatinib in Subjects with Newly Diagnosed Chronic Phase Mumbai Philadelphia Chromosome Positive Chronic Myelogenous Leukemia

A double blind, Randomized, Placebo-controlled, Parallel, Multi- Center study of the safety and efficacy of two dosages of XTL Development 952 Dr. Nihal Thomas Endocrinology Bicifidane in adult outpatients with chronic neuropathic pain Inc associated with diabetic peripheral neuropathy. XTL Development Inc.

A multi-centre, open label, phase III clinical trial to evaluate the Dr. Raju Titus Zenotech 953 Medical Oncology safety and efficacy of filgrastim (zenotech) in cancer patients Chacko Pharmaceuticals with grade 3 or 4 chemotherapy induced neutropenia.